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SUMMARY 
Structural variations (SVs) are an important and abundant source of variation in the 
human genome, encompassing a greater proportion of the genome as compared to 
single nucleotide polymorphisms (SNPs). This thesis investigates different aspects of 
SV analysis, focusing on copy number variations (CNVs) and regions of homozygosity 
(ROHs). It is divided into four main studies, each focusing on a different set of aims.  
In Study I, Identification of recurrent regions of copy-number variation across multiple 
individuals, we develop an algorithm and software to identify common CNV regions 
using individually segmented data. The identified common regions allow us to 
investigate population characteristics of CNVs, as well as to perform association 
studies.  
In Study II, Multi-platform segmentation for joint detection of copy number variants, 
we develop an algorithm to identify CNVs using intensity data from more than one 
platform. The algorithm is useful when researchers have data from multiple platforms 
on the same individual.  
In Study III, Regions of homozygosity in three Southeast-Asian populations, we identify 
ROHs in three Singapore populations, namely the Chinese, Malays and Indians. We 
characterize the regions and provide population summary statistics. We also investigate 
the relationship between the occurrence of ROHs and haplotype frequency, regional 
linkage disequilibrium (LD) and positive selection. The results show that frequency of 
occurrence of ROHs is positively associated with haplotype frequency and regional 
LD. The majority of regions detected for recent positive selection and regions with 
differential LD between populations overlap with the ROH loci. When we consider 
both the location of the ROHs and the allelic form of the ROHs, we are able to separate 
the populations by principal component analysis, demonstrating that ROHs contain 
information on population structure and the demographic history of a population. 
Last but not least, in Study IV, Statistical challenges associated with detecting copy 
number variants with next-generation sequencing technology, we describe and discuss 
areas of potential biases in CNV detection for each of four commonly used methods. In 
particular, we focus on issues pertaining to (1) mappability, (2) GC-content bias, (3) 
quality-control measures of reads, and (4) difficulties in identifying duplications. To 
gain insights to some of the issues discussed, we download real data from the 1000 
Genomes Project and analyze it in terms of depth of coverage (DOC). We show 
examples of how reads in repeated regions can affect CNV detection, demonstrate 
current GC correction algorithms, investigate sensitivity of DOC algorithm before and 
after quality-control of reads and discuss reasons for which duplications are harder to 






I first started dabbling with genetic data during my 4
th
 year as a Statistics 
undergraduate in 2007. I was working on the Affymetrix 500K SNP array, one of the 
densest SNP microarrays at that time. Barely 5 years later, there are arrays with more 
than 5 million SNPs, not to mention Next-generation sequencing arrays that produce 
billions of reads in a single run. The technologies to study genetics have certainly 
evolved very rapidly, bringing with it new challenges in terms of statistical and 
bioinformatics analyses.   
When I first learnt of the term „CNV‟, the concept sounded simple to me: That we 
have regions of the genome that are deleted/duplicated, and that based on the intensity 
of our measurements, less intense means less of that particular region, and vice versa. 
“Not too complex!” I thought naively. As I continue to learn more, the multitude of 
problems/challenges that comes associated with the analysis of noise-rich CNV data 
is enormous. As put across aptly by John Ioannidis on genetic data from microarrays 
in general, “…this noise is so data-rich that minimum, subtle, and unconscious 
manipulation can generate spurious “significant” biological findings that withstand 
validations by the best scientists, in the best journals. Biomedical science would then 
be entrenched in some ultramodern middle ages, where tons of noise is accepted as 
“knowledge”. – The Lancet 365: 454-455.  
Nevertheless, I hope that with these four years of hard work, I have helped made a 
little more sense out of the massive amount of genetic data we have.   
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Chapter 1 – INTRODUCTION  
Genetic variation in the human genome can take many forms, including single-
nucleotide polymorphisms (SNPs), copy number variations (CNVs), indels, regions 
of homozygosity (ROHs), and other structural variants (SVs). In the last couple of 
years, genome-wide association studies (GWAS) have been widely used to correlate 
genetic differences to phenotypic variation, but they were largely focused on SNPs.  
CNVs and other SVs were less appreciated until two landmark studies in 2004 
identified widespread deletions and duplications in the human genome (Sebat et al., 
2004; Iafrate et al., 2004). By now, CNVs are widely recognized as a prevalent form 
of variation in the genome, encompassing a greater proportion of the genome as 
compared to SNPs. An estimated 1.2% of a single genome differs from the reference 
human genome when considering CNVs, as compared to 0.1% by SNPs (Pang et al., 
2010). Recent studies have found CNVs to be associated with complex diseases such 
as human immunodeficiency virus (HIV) infection, cancer, diabetes, mental disorders, 
obesity, Parkinson‟s disease and autoimmune diseases (Wain et al., 2009; The 
Wellcome Trust Case Control Consortium 2010). ROHs are also more abundant than 
previously thought (Gibson et al., 2006), and are associated with complex diseases 
such as schizophrenia and late-onset Alzheimer‟s disease (Lencz et al., 2007; Nalls et 
al., 2009). 
That, as compared to SNPs, the association of CNVs and ROHs with complex 
diseases is not as well-studied is in part due to greater complexity in identifying these 
multi-base, multi-allelic variants, and also greater complexity in performing 
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association studies with these variants. Early works on CNVs/ROHs have focused 
largely on identifying and characterizing regions in the genome which harbour them. 
This has been necessary in laying the foundation to improve our understanding of 
CNVs/ROHs for subsequent association analysis with human complex diseases.  
The most common technologies for CNVs identification in the last couple of years are 
high density SNP arrays and array comparative genomic hybridization (aCGH) arrays; 
the former (SNP arrays) are also commonly used for detection of ROHs. However, 
the data generated from these techniques are noisy, and identifying CNVs 
comprehensively with high resolution still remains a technical and statistical 
challenge. aCGH and SNP arrays are also limited by the resolution of the array to 
determine precise locations of CNV breakpoints, and are unable to locate copy-
neutral events such as inversions and translocations. 
Sanger sequencing, often seen as the gold standard for CNV detection, is able to 
detect CNVs with higher accuracy and resolution, to detect balanced rearrangements 
such as inversions and translocations, as well as to detect CNVs in regions where 
probe density of other platforms is low. However, the technique is not feasible for a 
large number of genomes due to time and budget constraints. Next-generation 
sequencing (NGS) attempts to combine the benefits of array technology and 
sequencing. The biggest advantage of NGS over traditional Sanger sequencing is the 
ability to sequence millions of reads in a single run at a comparatively inexpensive 
cost (Metzker, 2010). However, with billions of reads generated per individual, there 
is an increasing need for more bioinformatics support and computers with larger 
storage and higher computing powers, and for such support to keep pace with the 
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rapidly changing technologies. Already, there is a great demand for information 
technology infrastructure and bioinformatics team to analyse the massive amount of 
data, with speculations that the costs associated with down-handling, storing and 
analysis of the data could be more than the production of the data. 
There is still a need for the development of new statistical/bioinformatics methods 





Chapter 2 – BACKGROUND  
In this chapter, I will introduce some concepts in CNV/ROH analysis, including 
definitions and introduction to existing technology, software and algorithms in 
detection of CNV/ROH. These will facilitate the understanding of subsequent 
chapters. 
2.1 Terminology and nomenclature 
Human genetic variations refer to differences in the deoxyribonucleic acid (DNA) 
sequences among different individuals; they can take many forms, including single-
nucleotide polymorphisms (SNPs), indels, copy number variations (CNVs), and other 
copy-neutral variations such as inversions, translocations and regions of 
homozygosity (ROHs). These genetic variations span a spectrum of sizes, ranging 
from 1 base-pair (bp) changes to whole chromosomal changes (e.g. aneuploidy). The 
occurrences of these genetic variations are attributed to different diverse mechanisms. 
For example, the predominant mechanisms for CNV formation include non-allelic 
homologous recombination and non-homologous end joining (Hastings et al., 2009; 
Conrad et al., 2010). ROHs are thought to be a result of autozygosity or uniparental 
isodisomy (Gibson et al., 2006).  
Table 2.1 summarizes the definitions of variants from single base changes to the sub-
microscopic level (larger variants are not discussed). Note that the definitions for the 
different classes of genetic variants based on size are often unclear at the edges of 
each class. For example, larger indels may sometimes be termed CNVs even when 
their sizes are less than 1 kb. 
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1 bp SNVs are variations of 
a single nucleotide (see 
Figure 1). When the 
variation is common 
(usually defined as 
having a frequency of 
more than 1%), we call 
it a SNP (Figure 2.1). 
Most SNPs are single  
nucleotide substitutions,  
although single nucleotide 
deletions/insertions may  







number of tandem 
repeats (VNTRs) 
2 to < 1000 
bp 
Indels are typically 
defined as insertions or 
deletions that are 
smaller than 1 kb and 
larger than 1 bp.  
The size cut off is rather 
arbitrary; Database of 
Genomic Variants (DGV) 
defines indels in the size 





1000 bp to 
sub-
microscopic 
CNVs are additions or 
deletions in the number 
of copies of a segment 
of DNA (larger than 1 
kb in length) when 
compared to a 
reference genome 
(Figure 2.2). 
Some large indels larger 
than 500 bp may also be 
termed CNVs. Common 
CNV larger than 1% 
population frequency are 
termed copy number 
polymorphism (CNP). 
ROHs > 500 bp ROHs are continuous 
stretches of the genome 
(usually more than 500 
kb) without 
heterozygosity in the 
diploid state.  
 
Table 2.1: Definition of the different classes of genetic variations, partly adapted from 









Figure 2.2: Schematic and simplified diagram of a deletion and duplication (adapted 
from Ku et al., 2010). 
 
ROHs are sometimes termed loss of homozygosity (LOH), which includes 
hemizygous deletions (where there is only one copy of the region). Genotypes of 
SNPs within hemizygous deletions may be erroneously called as homozygous 
resulting in a region that may seem to be a ROH based on SNP genotypes alone. 
Figure 2.3 illustrates the differences in intensity patterns for ROH and one-copy 
deletion; while both ROH and one-copy deletion have similar B allele frequency 
(BAF) patterns, the Log R ratio (LRR) for ROH is around zero while it is below zero 
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for one-copy deletion. In this thesis, ROH always refer to the copy-neutral variant, 
where the region is in diploid state and all bases within the region are homozygous.   
 
Figure 2.3: (Left panel) ROH signature with LRR around zero and no clusters at BAF 
of 0.5. (Right panel) One copy deletion signature with decreased LRR and similar 
pattern of BAF as ROH. The x-axis is the genomic probe location and each point 
represents a probe in the SNP array. (Figure from Ku et al., 2011). 
2.2 CNV and ROH detection technologies 
In the last decade or so, the most commonly used technologies for CNV detection are 
whole-genome array comparative genome hybridization (aCGH) and high-density 
SNP arrays. ROHs are typically detected using high-density SNP arrays. 
CNVs/ROHs detected using these technologies are unfortunately limited by the 
density of the probes, as well as the location of the probes. For example, array 
platforms with more than 1 million probes have a lower detection limit of 10-25 kb in 
the size of CNV (McCarroll et al., 2008). Sanger sequencing provides better 
resolution and accuracy, but it is not cost/time-effective to use on a genome-wide 
scale for many individuals. The recent development of next generation sequencing 
(NGS) platforms that allow massive parallel sequencing have the potential to discover 
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smaller CNVs that were not previously discovered, detect balanced rearrangements 
such as inversions and translocations, as well as detect rare CNVs for which SNP 
arrays have no probes for. The biggest advantage over traditional Sanger sequencing 
is the ability to produce large amount of sequencing data in a single run.  
However, as compared to SNPs, detection of CNVs is more challenging because of its 
complexity as a multi-base, multi-allelic variant. As a result, different algorithms and 
methods often give vastly different estimates in the number and breakpoints of CNVs. 
Currently, in the Database of Genomic Variants (DGV), there are more than 130,000 
(merged) CNVs from 37 different studies, encompassing more than 52% of the 
genome; a likely gross overestimation of the true percentage of the genome 
encompassed by CNVs. This is because all the different studies use a heterogonous 
array of technologies, algorithms, filtering parameters, and samples.  
2.3 CNV and ROH detection algorithms 
Detection of CNVs from aCGH arrays is mostly based on locating change-points in 
intensity-ratio patterns that would partition each chromosome into several discrete 
segments. On the other hand, the hidden Markov model (HMM) is particularly 
popular for detection of CNVs from SNP arrays, where the hidden states provide a 
natural way of combining information from the total signal intensity (known as log R 
ratio, LRR) and the relative allele frequency (known as B allele frequency, BAF) 
values. Briefly, the HMM assumes several possible hidden states such as „deletion‟, 
„normal‟, „region of homozygosity‟ and „duplication‟ and analyse the most possible 
state-transition path, assuming that the copy numbers of nearby SNPs are dependent 
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(Wang et al., 2007). Illustrated in Figure 2.4, a „normal copy‟ has three BAF clusters 
and the LRR is centred around zero; a ROH has LRR centred around zero but only 
two clusters at both extremes of the BAF.  
The output from a CNV detection algorithm provides the following information: (1) 
Chromosome number (2) Start location (3) End location (4) Copy number. For 
example, this is a typical output from PennCNV:  
chr6:32565228-32593190 numsnp=30 "length=27,963" "state1,cn=0"  
It tells us that in Chromosome 6 of this individual, from the position 32565228 to 
position 32593190, there is a deletion where this individual has zero copies as 
compared to the reference panel. There are 30 probes in this region in the platform 
used, and the length of the region is 27,963 bases.   
 
Figure 2.4: Figure from Wang et al., 2007, illustrating the unique patterns in LRR and 
BAF of the different copy number states. A „normal copy‟ has three BAF clusters and 
the LRR is centred around zero; a ROH has LRR centred around zero but only two 
clusters at both extremes of the BAF.  
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2.4 Sequencing technologies 
2.4.1 First generation sequencing 
First generation sequencing is typically referred to as „Sanger sequencing‟, and is 
introduced by Frederick Sanger in 1977 (Sanger, 1977). It is the main form of 
sequencing technique used over the last 30 years until the arrival of next-generation 
sequencers in 2005. Sanger sequencing is able to sequence reads of length ~ 800- 
1000 bases (Hert et al., 2008; Schloss et al., 2008; Venter et al., 2001).  
However, Sanger sequencing is laborious and costly; its inability to process more than 
96 sequence reads at a time limits its application to large scale genome-wide 
sequencing efforts for many individuals (Mardis, 2008). For example, it took nearly 
ten years and three billion dollars to sequence the first human genome in the Human 
Genome Project (Schadt et al., 2010). 
2.4.2 Next-generation sequencing (NGS) 
Next-generation sequencing (NGS) or also known as high-throughput sequencing 
(HTS) is able to simultaneously sequence millions of DNA reads. This ability to 
produce large amount of sequencing data in a single run at a comparatively 
inexpensive cost is its biggest advantage over traditional Sanger sequencing (Metzker, 
2010). Currently available NGS sequencers in the market include the Roche 454 
Genome Sequencer FLX System, Illumina Genome Analyzer, Illumina HiSeq and 
Applied Biosystems‟ Supported Oligonucletide Ligation Detection System (SOLiD). 
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NGS has the potential to discover smaller CNVs that were not previously discovered, 
to detect balanced rearrangements such as inversions and translocations, as well as to 
detect CNVs in regions where probe density of other platforms, such as SNP arrays, 
is low. NGS technologies have facilitated and accelerated the process of identifying 
genetic variations through whole-genome re-sequencing projects, including the 1000 
Genomes Project.  
However, there are some technical features of NGS that result in several challenges. 
Firstly, due to an effect called „dephasing‟, there is an increase in noise and 
sequencing errors as the read length extends, thereby limiting the read lengths of NGS 
to ~35 – 400 bases (Schadt et al., 2010). The short read lengths in turn complicate 
alignment and assembly. Secondly, in order to generate a large number of DNA 
molecules, polymerase chain reaction (PCR) amplification is required. This 
amplification process biases the frequency in which different portions of the genome 
are sequenced (Schadt et al., 2010).   
2.4.3 CNV detection using NGS 
Broadly, there are four complementary methods for CNV detection using NGS data, 
namely (1) depth of coverage (DOC, also known as read-depth (RD) methods), (2) 
paired-end mapping (PEM), (3) split-read (SR) and (4) assembly-based (AS) methods 
(Alkan et al., 2011). Except for the latter, the other three classes of methods require 
first mapping the sequenced reads to a known reference genome. The different 
methods are usually complementary to one another as the underlying concepts excel 
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at detecting certain types of variants, and a large proportion of discovered variants 
remain unique to a particular approach (Alkan et al., 2011). 
Some algorithms use a combination of methods for more accurate detection of CNVs. 
For example, CNVer supplements DOC with PEM information in a unified 
framework (Medvedev et al., 2010). Genome STRiP combines information from 
DOC, PEM, SR as well as other features of sequence data at population level 
(Handsaker et al., 2011). Genome STRiP is one of the highest performing method 
used in the 1000 Genomes pilot Project, indicating that there is benefit in combining 
different approaches (Mills et al., 2011).    
Depth of coverage  
DOC methods typically count the number of reads that fall in each pre-specified 
window of a certain size (Abyzov et al., 2011; Yoon et al., 2009). The underlying 
concept of identifying CNVs using DOC is similar is that of using intensity data: a 
lower than expected DOC /intensity indicates deletion and a higher than expected 
DOC /intensity indicates duplication (Figure 2.5). The algorithm relies heavily on the 
assumption that the sequencing process is uniform, i.e., the number of reads mapping 
to a region is proportional to the number of copies. However, certain biases such as 
GC-content and mappability cause this assumption to be unrealistic; regions of the 
genome may be over or under-sampled regardless of the copy number of the region, 
often resulting in spurious signals. DOC algorithms usually detect large CNVs and 
are unable to detect copy neutral events such as inversions and translocations. Single-




Figure 2.5: Schematic diagram illustrating the concept of depth of coverage method 
for CNV detection. If the sample has an additional copy relative to the reference 
genome, when the reads are mapped to the reference, we would observe an increase 
in depth of coverage in the region.  
Paired-end mapping 
PEM methods require the reads to be paired (Chen et al., 2009). The concept is that 
the fragments of DNA from which the reads are to be sequenced have a fragment 
length (or also known as insert size) of a certain distribution, and a longer than 
expected fragment length indicates a deletion in the studied genome compared to a 
reference while a shorter than expected fragment length indicates an insertion. Based 
on the patterns from which the paired reads are mapped to the reference, read pair 
analysis can also detect inversions and translocations. The size of CNVs detected 
using PEM is limited by the insert size and as a result, PEM often detects smaller 
CNVs. For example, PEM does not allow the discovery of insertions larger than the 
insert size (Dalca et al., 2010).   
Split-read 
SR methods uses paired reads as well. They focus on pairs of reads where one read is 
mapped to the reference while the other read failed to be aligned (Ye et al., 2009). 
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The idea is that where the location of the unmapped read may span the breakpoint of 
the CNV. SR analysis has the advantage of being able to pinpoint the location of the 
breakpoints.  
Assembly-based  
AS methods, on the other hand, do not align the reads to a known reference but 
construct the genome piece-by-piece, which is known as de novo sequencing. Some 
AS methods use the reference genome as a guide to resolve repeats. This is known as 
comparative assembly (Pop et al., 2004). AS methods can discover new non-
reference sequence insertions. AS methods works best for small genomes such as 
bacterial genomes and are less widely used in NGS sequencing of humans because 
the short reads from NGS makes assembly in repeat regions difficult (Ye et al., 2009). 
Even though assembly algorithms continue to improve, due to the short read lengths, 
de novo sequencing using NGS are still not capable of achieving similar quality as 
that using Sanger sequencing (Schadt et al., 2010).  
2.5 Repetitive DNA 
Repetitive DNA refers to sequences that are highly similar or identical to sequences 
in other parts of the genome. They are abundant in the human genome and covers 
almost 50% of the human genome (Treangen et al., 2012). Table 2.2 summarises 
repeat type, number, percentage of genome covered and approximate length of each 
repeat class. The repeat type is broadly characterized into tandem or interspersed 
repeats where the former refer to repeats that are adjacent to each other while the 
latter refers to repeats that are separated by hundreds, thousands or millions of bases.  
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In next generation sequencing, reads from repetitive regions may map equally well to 
several locations in the reference genome. Due to the ambiguity in the alignment step, 
these reads often cause problems in SNP and SV detection. Reads that can be mapped 
equally well to more than one location are termed multi-reads. 
Repeat class Repeat type Number % genome Length (bp) 
Minisatellite, 
microsatellite or satellite 
Tandem 426, 918 3% 2 -100 
SINEs Interspersed 1, 797, 575 15% 100 - 300 
DNA transposon Interspersed 463, 776 3% 200 - 2000 
LTR retrotransposon Interspersed 718, 125 9% 200 - 5000 
LINEs Interspersed 1, 506, 845 21% 500 - 8000 
rDNA Tandem 698 0.01% 2000 - 43000 
Segmental duplications 
and other classes 
Tandem or 
interspersed 
2, 270 0.20% 1000 - 100000 
Table 2.2: This table summarises for each repeat class, the repeat type (tandem or 
interspersed), number in the hg19 human genome, percentage of the hg19 human 
genome covered, and approximate lower and upper bounds for the lengths of the 
repeat. (Table adapted from Treangen et al., 2012). Short interspersed nuclear 
elements (SINEs), Long terminal repeat (LTR), Long interspersed nuclear elements 
(LINEs), ribosomal DNA (rDNA).  
2.6 Copy number variation region (CNVR)  
CNVR or also known as CNV loci or common CNV or recurrent CNV are CNVs that 
occur in the same/similar location across several individuals. Most CNV detection 
algorithms identify CNVs individual-by-individual, but common CNVs are known to 
exist among different individuals. However, the identification of the individual-
specific CNVs is not precise, especially in terms of the breakpoints. This poses a 
challenge when we want to summarize the population characteristics or perform 
association studies, because it is unclear if CNV1 from individual 1 describes 
biologically the same event as CNV2 from individual 2 if their breakpoints do not 
match exactly.  
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2.7 Hardy Weinberg Equilibrium of CNVR 
Suppose a bi-allelic SNP has allele frequencies p and q (where p+q = 1) for alleles a 
and b respectively, regardless of gender. Assuming random mating, in the next 
generation, the frequencies of the aa, ab and bb genotypes are p
2
, 2pq and q
2
 
respectively. The allele frequencies of a and b have not changed and remain p and q, 





, and so forth. This is known as Hardy Weinberg Equilibrium (HWE); i.e., that 
the frequency of alleles and genotypes remain constant from generation to generation 
in a large population assuming random mating. The Pearson‟s chi-squared test is 
typically used to test for departure from these expected frequencies, indicating 
violation of HWE.  
Since it has been observed that the majority of common CNV regions are inherited 
(Locke et al., 2006), we expect, for a population of normal, healthy individuals, the 
integer copy numbers for the majority of CNVRs to be in HWE. This is supported by 
McCarroll et al., (2008)‟s study that found that 98% of common bi-allelic CNVRs do 
not violate HWE. McCarroll et al., (2008) also found that about 90% of common 
CNVs are bi-allelic.  
In principal, HWE applies to both bi-allelic CNVRs and multi-allelic CNVRs. Bi-
allelic CNVs are those with only two alleles, forming three possible copy numbers. 
For example, CNVs with copy numbers 0, 1, 2 or 2, 3, 4 are considered bi-allelic. 
Multi-allelic CNVs are those with more than two alleles, for example, with alleles „0‟, 
„1‟ and „2‟, the possible copy numbers are 0, 1, 2, 3 and 4. Testing HWE for bi-allelic 
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CNVs is straightforward and similar to the test for SNPs. However, for multi-allelic 
CNVRs, HWE test cannot be performed directly on the unphased copy-number 
because there is an issue with different combinations of alleles producing the same 
copy-number. For example, with alleles „0‟, „1‟ and „2‟, the copy number 2 can have 
genotype (1, 1) or (0, 2).   
2.8 GWAS of CNVs 
Genome-wide association studies (GWAS) using SNPs have been widely performed 
over the last couple of years, resulting in over 1400 published associations (at p ≤ 
5x10
-8
) for 237 traits (from the National Human Genome Research Institute: 
http://www.genome.gov/26525384). This is in part due to greater accuracy and 
completeness with which SNPs, as compared to CNVs, can be assayed.  
Earlier studies on CNV discovery have paved the way for subsequent association 
studies of CNVs. For example, the Wellcome Trust Case Control Consortium 
(WTCCC) performed a large scale GWAS study of CNVs in 16000 cases of eight 
common diseases using a customized aCGH that was designed based on previously 
identified CNVs (Wellcome Trust Case Control Consortium, 2010). The WTCCC 
study found several CNV loci to be associated with Crohn‟s disease, rheumatoid 
arthritis, type 1 diabetes and type 2 diabetes. However, these loci have been 
previously identified through SNP based GWAS, reflecting the observation that 
common CNVs are well tagged by SNPs.  
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2.9 Linkage disequilibrium 
The non-random association of alleles at two or more loci in the genome is known as 
linkage disequilibrium (LD), i.e. that the occurrences of some combinations of alleles 
at two or more loci are more or less frequent than expected based on their individual 
allele frequencies. For example, suppose allele A1 at SNP A and allele B1 at SNP B 
have frequencies p1 and q1 respectively. If the two SNPs are independent, then we 
expect to see the A1B1 haplotype at a frequency of p1q1; any departure from this 
expected frequency means that the two SNPs are in LD. Most commonly used 
statistics to quantify the extent of LD between two loci are the r
2 
and D’ statistics 
(Lewontin et al., 1960). Both statistics are based on the extent of departure of the 
observed haplotype frequency from the expected. Let x11 be the observed AB 
haplotype frequency. Then, D = x11 – p1q1. Now, let the other two alleles of SNP A 
and SNP B have frequencies p2 and q2 respectively.  
   
  
        
  and      
 
    
  where       {
   (         )         
   (         )         
 
Both measures have a minimum value of 0, which indicates independence between 
the two loci, and maximum value of 1, which indicates complete dependence between 
the two loci.  
2.10 Quantification of positive selection 
Positive selection is the phenomenon where certain variants rise to a frequency at a 
faster rate than would be expected, i.e., the favouring of variants that increase survival 
and reproduction. Under neutral evolution, new variants need a long time to reach 
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high frequency, resulting in common variants usually having short range LD because 
recombination would have occurred to disrupt the haplotypes (Sabeti et al., 2002).    
Hence, one „clue‟ or signature that provides evidence of positive selection is an 
unusually long and common haplotype which indicates an allele which rose to high 
frequency rapidly before recombination occurs (Bersaglieri et al., 2004). 
One statistic used to quantify positive selection is the integrated haplotype score (iHS) 
(Voight et al., 2006). Briefly, this score measures how unusual the haplotypes around 
a core SNP are, relative to the rest of the genome. The iHS first utilizes the extended 
haplotype homozygosity (EHH) statistic (Sabeti et al., 2002); the EHH measures the 
decay of haplotype identity as a function of distance. For each SNP, haplotype 
homozygosity starts at 1 and decays to zero with increasing distance. Alleles under 
selection tend to have high haplotype homozygosity that extends much further, 
resulting in a large area under the EHH curve. The iHS is a standardized measure of 
the integrated EHH. Clusters of SNPs with large positive or large negative iHS are 
evidence of position selection in the region.   
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Chapter 3 – AIMS 
Overall, the general aim of this thesis is to use and develop statistical and 
bioinformatics methods to improve detection and analyses of structural variants. The 
thesis is divided into four studies as follows:  
I. We develop a method and accompanying software to identify common CNV 
regions in multiple individuals. The identified common regions can be used 
for downstream analyses such as group comparisons in association studies. 
II. We develop a method and software to identify CNVs by using data from 
multiple platforms simultaneously. We also propose an objective criterion for 
discrete segmentation required for downstream analyses. For each identified 
segment, the software reports a p-value to indicate the likelihood of the 
segment being a true CNV. 
III. We investigate the population characteristics of ROHs in three Singapore 
populations (Chinese, Malays and Indians), and access the relationship 
between the occurrence of ROHs and haplotype frequency, regional LD and 
positive selection.  
IV. We highlight problems and issues encountered when analysing NGS data for 
CNVs, in particular, those pertaining to DOC methods. We use real data from 
the 1000 Genomes Project to highlight and investigate challenges associated 
with (1) GC-content, (2) quality score of reads, and (3) identifying CNVs in 
repeated regions.   
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Chapter 4 - PAPER SUMMARIES 
4.1 Study I: Identification of recurrent regions of copy-number variation across 
multiple individuals.  
4.1.1 Motivation 
Most algorithms for CNV-detection detect CNVs sample-by-sample with individual 
specific breakpoints. However, common CNV regions (CNVRs) are likely to occur at 
the same genomic locations across multiple individuals.  
4.1.2 Methods overview 
The main novelty of our algorithm is that we exploited the region specific confidence 
score statistic provided by commonly used segmentation programs, PennCNV and 
QuantiSNP. This statistic indicates how likely the detected CNV for a particular 
individual is true. By not incorporating the use of individual specific confidence 
scores, it means that all regions contribute equally to the statistic used to identify the 
common regions, but some regions are more likely to be true positives than others. 
Our method utilizes both the confidence score statistic, as well as the frequency of 
occurrence, to identify CNVRs. Intuitively, we have less confidence in a CNV that 
occurs in one individual than one that occurs in many individuals. However, a single 
occurrence of CNV might still be a true discovery if it is associated with a high 
confidence score, i.e., it is based on a strong signal. Since individual CNVs span 
different probes, the number of individual regions that overlap each probe varies. 
However, common CNV regions tend to occur at almost the same genomic locations 
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across multiple individuals. Hence, we expect the common regions to be identified by 
consecutive probes where a „significant‟ number of individuals have an overlapping 
CNV. Furthermore, we also expect the confidence score of the individual regions to 
be relatively high.  
Method 1: Cumulative Overlap Using Very Reliable Regions (COVER) 
To calculate the COVER statistic for a probe, we sum the number of high-confidence 
individual regions that overlap that probe. The common region is then defined as 
consecutive probes for which the COVER statistic is greater than or equal to a 
specified threshold, u. Users provide two parameters here: the confidence score 
threshold, c, to determine high-confidence regions and u, the threshold for the 
COVER statistic.  
Method 2: Cumulative Composite Confidence Scores (COMPOSITE) 
In COVER, we may miss regions that are detected with lower confidence scores but 
nonetheless detected consistently across a large number of individuals. For the 
COMPOSITE statistic, we sum all individual regions that overlap the probe, weighted 
by their confidence score.  
Method 3: Clustering of Individual CNV regions within a Common Region  
The CLUSTER method uses a clustering algorithm that further refines the regions 
identified by either method 1 or method 2. This method is motivated by the 
observation of a complex mixture of sub-regions within a CNVR identified by 




Figure 4.1:  An example of a CNVR identified by COVER. We observe that despite 
being identified as a common region, the individual regions still portray a mixture 
phenomenon of several distinct sub-regions (from Teo et al., 2010).  
4.1.3 Results 
Comparison with sequenced regions 
To assess the performance of our methods, we use 112 HapMap samples and vary the 
threshold parameters in our methods. For each threshold, we calculate discordance 
rates with sequencing-based results (Kidd et al., 2008) and rates of departure from 
HWE. The discordance rates as well as the rates of departure from HWE decrease 
when we select CNVs with higher confidence scores, showing the importance of 
further processing of the CNVs (for COVER results, see Figure 4.2). Similar results 
were observed for COMPOSITE method (Figure not shown). Concordance rates 




Figure 4.2: (a) Discordance rates for COVER method decreases as the confidence 
score thresholds increase. (b) Rates of departure from HWE decreases as the 
confidence score thresholds increase (from Teo et al., 2010).  
Comparison to other algorithms 
We compare our methods to two previously published methods, STAC (Diskin et al., 
2006) and GISTIC (Beroukhim et al., 2007). We find that our methods are better at 
identifying low-frequency but high-confidence CNV regions.  
Implementation 
The methods are implemented in an R package, cnvpack. The main input is a list of 
detected individual CNV regions with the following information: Sample name, 
chromosome number, detected integer copy number, start and end genomic locations 




4.2 Study II: Multi-platform segmentation for joint detection of copy number 
variants. 
4.2.1 Motivation 
At the time this research was carried out, SNP genotyping platforms from major 
commercial companies, such as Illumina and Affymetrix, were rapidly evolving, and 
it is not uncommon for research groups to have data from different platforms for the 
same individuals. For CNV detection, marker density is one important factor. 
Different platforms have different sets of marker panels and combining data from 
multiple platforms would undoubtedly give higher marker density. It has the potential 
to yield more precise and accurate detection of CNVs and its breakpoints. However, 
combining such data is not straightforward as different platforms show different 
degrees of attenuation of the true copy-number, noise characteristics and marker 
panels (Zhang et al., 2010). There is still a relative lack of formal procedures for 
combining information from different platforms for copy-number calling. Most 
studies with data from multiple platforms interrogating the same samples usually 
process the data independently for each platform, after which the identified segments 
are combined in an ad-hoc manner. This approach does not fully utilize information 
from the different platforms, and when the segmented results from the different 
platforms differ, it is difficult for researchers to come to a consensus in a statistically 
rigorous manner. 
In this study, we develop a new method for identifying CNVs by using data from 
multiple platforms simultaneously. As we are often interested in discrete segments of 
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CNVs for downstream analyses, we also develop an objective method to obtain 
discrete segments, and provide a p-value associated with each segment; the p-value 
would indicate how likely the segment is a CNV, and can be used to filter false 
positives. 
4.2.2 Methods overview  
The method, multi-platform smooth segmentation (MPSS) is an extension of Huang 
et al. (2007)‟s single-platform smoothseg algorithm which is based on the Cauchy 
random-effect model that allows jumps in the underlying copy-number patterns. 
MPSS uses normalized log2-intensity ratios from two or more platforms and estimates 
the underlying copy number pattern for an individual. For each individual, we denote 
{x1, …, xn} as the union of the probe locations from the different platforms, with x1 < 
x2 < … < xn. Denote {yx1j, …, yxnj} as the set of log2-intensity ratios from platform j. 
We write our model as  
      (   )       , 
where f is a random effects parameter that is common to all platforms, meaning that 
each platform is assumed to measure the same underlying copy-number pattern; as 
such, background normalization is recommended so that data from the different 
platforms become comparable. The error term exij is platform-specific to take into 
account different noise characteristics of the different platforms. The platform 
specific error structure was chosen to be t-distributed to incorporate a heavy tailed 
structure that can deal with outliers in the observations. The smoothness of f can be 
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  are 
independent and identically distributed with some distribution. We specify *ia  
to 
follow the Cauchy distribution to allow for jumps in the segments. To estimate the 
random-effects parameter f, we derive an iterative weighted least squares algorithm 
by maximizing the likelihood of the Cauchy random-effects model.  
4.2.3 Results  
We compare MPSS against the single-platform smoothseg algorithm, an existing 
multiplatform method, called MPCBS (Zhang et al., 2010), and its associated single 
platform method, CBS (Olshen et al., 2004). We use nine HapMap samples, which 
were previously genotyped by both the Illumina 1M and Affymetrix 6.0 SNP arrays 
by our collaborators at the Genome Institute of Singapore, Agency for Science, 
Technology and Research. For the same samples, we have the integer copy-numbers 
from Conrad et al. (2010)‟s study, which we use as a reference list.    
When signals from the different platforms are consistent, we get increased power to 
detect the CNVs when we combine information from different platforms, especially 
in areas where a single platform has low density of probes (Figure 4.3a) or complete 
lack of probes (Figure 4.3b). To compare against other methods, we perform 
individual-specific comparisons with the reference list and report the number of 
overlapping bases as a proportion of the total length of CNVs identified by the 
method and as a proportion of the total length of CNVs in the reference list. In Figure 
4.4, we show that MPSS CNVs have greater amount of overlap with the reference, 




The algorithm is implemented in an R package MPSS that can be freely downloaded 
from http://www.meb.ki.se/∼yudpaw. The main inputs are vectors of genomic 
positions, chromosome numbers and log2-intensity ratios from each platform. 
 
Figure 4.3: Examples of segments detected by the multiplatform methods. (a) A 
deletion in Chromosome 8. Single platform smoothseg on Illumina platform was 
unable to identify the deletion due to lack of probes in the region. Single platform 
smoothseg on Affymetrix platform was unable to identify the deletion due to 
insufficient signal. (b) A deletion in Chromosome 16. Single platform smoothseg on 
Affymetrix platform was unable to identify the deletion due to complete lack of 




Figure 4.4: The number of overlapping bases as a proportion of Conrad's CNVs and 
as a proportion of each method's CNVs; the different points for each method 
correspond to the different thresholds. A higher proportion of overlap indicates better 
performance (from Teo et al., 2011).  
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4.3 Study III: Regions of homozygosity (ROHs) in three Southeast Asian 
populations 
4.3.1 Motivation 
The genomes of outbred populations were first shown in 2006 to contain an 
abundance of long stretches > 500kb without heterozygosity (Gibson et al., 2006; Li 
et al., 2006). Since then, there have been several studies that investigate the 
population characteristics of ROHs in healthy individuals (McQuillan et al., 2008; 
Nothnagel et al., 2010; O‟Dushlaine et al., 2010), and also several studies that 
perform association analyses to identify ROHs that are associated with complex 
diseases (Yang et al., 2010; Lencz et al., 2007; Nalls et al., 2009). However, the 
majority of these studies are conducted on European populations, and there is a lack 
of knowledge of ROHs in Asian populations. Thus, the first aim is to characterize 
ROHs in the three main Singapore populations, namely the Chinese, Malays and 
Indians. 
Furthermore, it was observed that the location of ROHs is markedly non-random, 
where unrelated individuals may share similar region boundaries. Some loci are 
caused by a single common haplotypes, whereas others are a consequence of several 
common haplotypes that could be markedly disparate (Curtis et al., 2008). The 
second aim of this study is to investigate the relationship between the occurrence of 




The genomic DNA samples used in this study were part of the Singapore Genome 
Variation Project
1
, whose aim was to characterize the extent of common genetic 
polymorphisms and the haplotypes in each of the three ethnic groups in Singapore 
(Teo et al., 2009). Peripheral blood DNA was extracted from a total of 292 
individuals and genotyped using the Illumina Human 1M Beadchip and the 
Affymetrix Genome-wide Human SNP Array 6.0.  
4.3.3 Results 
We identified an average of 207, 179 and 126 ROHs per individual for Chinese, 
Malays and Indians respectively. Indians have lower numbers as well as lower total 
length of ROHs as compared to Chinese and Malays. About 83% of the ROHs are 
within the 500 kb to 1 Mb size range while 17% of them are greater than 1 Mb.  
Using the individual regions to form common regions (using the software from Study 
I), we obtain 1256 common ROH loci in the three populations. We study the 
relationship of the common ROHs with haplotype frequency, LD and positive 
selection. For each locus, we test for differences among the 3 populations in terms of 
ROH frequencies and haplotype frequencies, and 47 loci (<4%) differ significantly in 
frequencies while 899 loci (69%) differ significantly in haplotype frequencies among 
the populations. One interesting example is a 700 kb region in Chromosome 16 that 
overlaps with the Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene, 
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where genetic polymorphisms within this gene has been found to correlate with 
differences in warfarin dosage and response (Aquilante et al., 2006; Harrington et al., 
2005). In the Singapore populations, the Indians were observed to display warfarin 
resistance, thus requiring a higher dose as compared to the Chinese and Malays (Zhu 
et al., 2007). The ROH frequencies of this region are 21%, 13% and 20% for the 
Chinese, Malays and Indians respectively (no significant difference in frequencies). 
However, the haplotypes frequencies of this region among the three populations differ 
drastically (Table 4.1), especially between the Indians and the other two populations.   
 Haplotype A Haplotype B 
Chinese 0.31 0.0052 
Malay 0.28 0.045 
Indian  0.0060 0.34 
Table 4.1: Haplotype frequencies of three populations in an ROH that overlaps 
VKORC1 gene (from Teo et al., 2012). 
With regards to haplotype frequency and regional LD, we find that the frequency of 
an ROH is positively associated with the total frequency of the top three haplotypes 
as well as with regional LD. The majority of regions detected for recent positive 
selection and regions with differential LD between populations overlap with the ROH 
loci. When we consider both the location of the ROHs and the allelic form of the 
ROHs, we are able to separate the populations by principal component analysis 
(PCA), demonstrating that ROHs contain information on population structure and the 
demographic history of a population.  
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4.4 Study IV: Statistical challenges associated with detecting CNVs using next-
generation sequencing (NGS) technology.  
4.4.1 Motivation 
Whole genome re-sequencing for the identification of CNVs has gained popularity 
with the recent development of NGS platforms that allow massive parallel sequencing. 
These techniques have the potential to discover smaller CNVs that were not 
previously discovered and detect balanced rearrangements such as inversions and 
translocations. However, analysing NGS data for CNVs is a new and challenging 
field, with no standard protocols or quality control measures. Also, due to the 
complexity of the genome and the short read lengths from NGS technology, there are 
still many challenges associated with the analysis of NGS data for CNVs, no matter 
which method or algorithm is used.   
4.4.2 Results 
We describe and discuss areas of potential biases in CNV detection using NGS data, 
focusing on issues pertaining to (1) mappability, (2) GC-content bias, (3) quality-
control measures of reads, and (4) difficulties in identifying duplications. To gain 
insights to some of the issues discussed, we download real data from the 1000 
Genomes Project and analyse its depth of coverage (DOC) data. We show examples 
of how reads in repeated regions can affect CNV detection, demonstrate current GC 
correction algorithms, investigate sensitivity of DOC algorithm before and after 
quality-control of reads and discuss reasons for which duplications are harder to 
detect than deletions.  
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Chapter 5 - DISCUSSION 
5.1 What makes a good CNV detection method? 
The quality of a CNV detection method (including the technology and algorithm) can 
be broadly attributed to three aspects: (1) location (2) breakpoints (3) genotype. The 
location and breakpoints of a CNV are closely related, where the breakpoints are 
given by the start and end positions of a CNV, and the location is the entire region 
that spans from the start position to the end position. Most studies use the location 
and breakpoints to determine sensitivity and specificity of a method. However, with 
SNP/aCGH arrays, the start and end positions are technically not the true start/end 
positions of a CNV, but rather the start and end probes of the array that was used. 
Hence, breakpoint precision is highly affected by the resolution of the array. An array 
with denser probes at and near the location of the CNV will be able to detect the 
start/end of the CNV with higher precision.  
Another less-frequently used criteria for evaluating CNV detection methods is the 
ability to discern the actual copy number of the region, for example 0 copy versus 1 
copy for deletions and 3 or more copies for duplications. This is also known as 
„genotyping‟ of the CNV. Many algorithms use a clustering procedure, assuming that 
most individuals have normal „2 copies‟.  
5.2 Concordances among CNV detection methods      
From experience of several peer reviews we got during our submission of the 
manuscripts, many reviewers are often concerned about the low concordance between 
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the CNVs generated by our methods as compared to the reference list we use. 
However, this low concordance is often not a very good indicator of bad algorithm 
performance per se, but rather a more general problem in CNV detection. For 
example, in McCarroll et al. (2008)‟s study, they employed a set of very strict criteria 
on duplicate experiments in SNP arrays to define common CNV regions in eight 
HapMap samples. Despite that, (on average) 76% of the regions do not overlap with 
the list of regions found using sequencing. Even when applied to the same raw data, 
Pinto et al. (2011) found that different analytic tools typically yield CNV calls with 
<50% concordance. The low concordance can be attributed to several factors such as 
(1) lack of a true gold standard, (2) noisy data resulting in many false identifications 
and (3) imprecision of the breakpoints identified.  
Indeed, the first step of determining the sensitivity of a method is to obtain a „true 
positive‟ dataset. Hence, the first problem with CNV analysis: we do not know the 
„true positives‟! The closest bet is to use published results from studies that are well-
validated as a reference panel, and that is often only possible if you have the same 
samples as that in the reference panel. HapMap samples are commonly used in 
methodology research, usually for two main reasons: the raw data are readily 
available and there are several studies which have characterized the CNV profiles for 
these individuals and often used as the „gold standard‟ (Kidd et al., 2008; McCarroll 
et al., 2008; Conrad et al., 2010). When this is not possible, simulation is another way 
to estimate the sensitivity of the method.  
After we have chosen our „gold standard‟ dataset, the second difficulty in accessing 
sensitivity is in answering the question “Is CNV1 and CNV2 the same variant?” In 
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Figure 5.1a, when the breakpoints of the two variants match perfectly, there is no 
doubt in calling them the same variant. In Figure 5.1b, the breakpoints are different 
but the two variant have a good amount of overlap and are of roughly the same length. 
What about in Figure 5.1c where one breakpoint coincides but the length of the 
variant differs by a lot? Some studies use a relaxed criterion of calling two variants 
the same as long as there is a single base overlap, while other studies may be as 
stringent as requiring at least an 80% reciprocal overlap. A 50% reciprocal overlap 
seems to be adopted by the majority of studies in recent years. To avoid the need to 
choose this arbitral percentage, some studies define sensitivity as the proportion of 
bases that overlap. 
 
 Figure 5.1: Diagram illustrating the non-triviality of determining if two CNVs are the 
„same‟ variant.  In (a), CNV1 and CNV2 overlap completely. In this case, we are 
confident that the two CNVs are the same. In (b), the start and end positions of CNV1 
and CNV2 differs, but there is substantial overlap between the two. In (c), CNV1 is 
completely within the range of CNV2 but the two CNVs differ vastly in lengths. In 
most research papers, scientists are comfortable with using a 50% reciprocal overlap 
to determine if two CNVs are concordant.  
5.3 Problems caused by repetitive DNA 
Repetitive DNA poses challenges in CNV detection regardless whether SNP arrays or 
sequencing methods are used. For SNP arrays, the density of SNP probes in 


















implementation (Winchester et al., 2009) resulting in a bias against detecting CNVs 
in segmental duplicated regions using SNP arrays.  
For sequencing, reads that fall in repetitive DNA cause problems in alignment and 
assembly algorithms (Treangen et al., 2012). This problem is exacerbated in NGS (as 
compared to Sanger sequencing) because the sequenced reads from NGS are 
relatively short (35-150bp). Furthermore, mutations or sequencing errors in one or 
two locations may also cause reads to be mapped wrongly (Li et al., 2008). In the 
1000 Genomes trios Project, about 20% of the reference genome was considered 
inaccessible (defined as regions with many ambiguously placed reads or unexpectedly 
high or low numbers of aligned reads). The resulting low sensitivity in detecting 
CNVs in repeated/segmental-duplicated regions is a serious problem, because there is 
an observed enrichment of CNVs in segmental duplicated regions and many 
breakpoints lie in duplicated regions (Medvedev et al., 2009).  
For assembly-based methods, repeat regions create challenges because if the read 
length is shorter than the repeat region, it is not straightforward to decipher the 
original sequence since overlap between the reads or contigs will be ambiguous 
(Knudsen et al., 2010). For other methods that require mapping to a reference, there 
are different alignment strategies for dealing with multi-reads, such as (1) discarding 
the reads, (2) choosing a position at random out of all equally good match positions, 
and (3) reporting all possible positions. In Study IV, we have shown why these 
strategies are inadequate for dealing with multi-reads.  
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Recently, there are several algorithms that claim to be able to resolve specific types of 
CNVs in repeat regions. For example, He et al. (2011) developed an algorithm for 
tandem copy number variation reconstruction in repeat-rich regions, which considers 
all locations of possible mappings and uses information on read-pair and DOC. Alkan 
et al. (2009) developed a new alignment method, mrFAST. The aligner maps short 
sequence reads to a repeat-masked reference genome, meaning that all loci with 
known high-copy common repeats were first masked before alignment, and reports all 
mapping locations for multi-reads. It also keeps track of mutation in multi-reads. This 
method has been shown to be able to predict absolute copy number and multicopy 
differences. Sudmant et al. (2010) also uses a similar approach to identify and 
genotype CNVs within segmental duplications. However, these approaches seem to 
work only for deeply sequenced data (>20X), and more has to be done to extend these 
methods for lower coverage data (Chiang et al, 2009).   
Longer read lengths from third generation sequencing may partially solve the 
problems with repeats, but even with a read length of 1kb, there still remains about 
1.5% of the human genome sequence that is non-unique (Schatz et al., 2010). 
5.4 A peek into third generation sequencing (TGS) 
Third generation sequencing (TGS) or also known as single molecule sequencing 
(SMS) promises to improve sequencing rates, throughput and read lengths as 
compared to NGS. Since it does not require repeated stepwise „washing and scanning‟ 
procedures like in NGS, TGS may increase the sequencing cycle by four orders of 
magnitude (Eid et al., 2009). The first commercially available SMS instrument is the 
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HeliScope Single Molecular Sequencer by Helicos Biosciences; however, the read 
lengths are still short at ~32 bases long (Schadt et al., 2010). Since PCR amplification 
is not required in TGS, bias observed in NGS in depth of coverage due to PCR may 
be resolved. The longer read lengths of TGS will also improve challenges caused by 
the short read lengths of NGS. Time will reveal if TGS can fulfil its promises for 





CHAPTER 6 - CONCLUSIONS 
 Copy number variations, ROHs and other structural variations are an 
important source of variation in the human genome, and have been associated 
with many complex diseases. 
 Due to the multi-base and multi-allelic nature of these variants, detecting them 
with high sensitivity and specificity is still a challenge. Hence, new statistical 
methods and user-friendly bioinformatics tools are needed for the analyses of 
these variants. 
 In Study I, we develop a method that allows users to detect common CNV 
regions. 
 In Study II, we develop a method that allows users to detect CNVs using 
information from multiple platforms simultaneously.  
 There is a lack of studies investigating regions of homozygosity in Asian 
populations. There is also a lack of understanding of the relationships between 
ROHs and haplotype frequency, linkage disequilibrium and positive selection. 
These are addressed in Study III.  
 Next-generation sequencing has the potential to detect CNVs beyond the 
resolution of SNP arrays and aCGH, as well as detect copy neutral SVs such 
as inversions and translocations. 
 Analytical methods and algorithms for CNV detection using NGS are not yet 
mature and there are still many challenges. In Study IV, we describe and 
discuss challenges faced in CNV detection using NGS data.   
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Chapter 7 – FUTURE DIRECTIONS AND PERSPECTIVES  
The field of genetics and genomics has progressed a long way since the first human 
genome was sequenced in 2000. By now, there are thousands of genes and loci 
discovered that are associated with simple and complex human diseases, and many of 
the discoveries were made via GWAS of SNPs. SVs, on the other hand, were much 
less considered in association studies, particularly attributed to technical difficulties in 
characterizing SVs with high resolution. Recent development of high-throughput 
sequencing presents new opportunities for identifying SVs, especially the smaller 
CNVs that were beyond the resolution of old techniques, as well as copy-neutral 
events such as inversions and translocations. However, there are still many problems 
associated with identifying SVs using NGS technology, as discussed in Study IV. As 
the technology and analytical methods continue to improve, some of these problems 
may resolve. However, it is of my personal opinion that the following cannot be 
neglected:  
1. Collaborations among various research centres. Even as the cost for whole 
genome high-throughput sequencing continues to drop, routine sequencing of 
a large number of individuals will still remain too pricy for the majority of 
research centres. Collaborations will push the research at a faster pace, 
overcoming cost and manpower issues. Take for example the 1000 Genomes 
Project (www.1000genomes.org), which aims to sequence 2500 individuals, 
and have thus far completed the sequencing of more than 1000 individuals. 
Such an effort was the result of collaborations of more than 70 research 
groups and would definitely not have been possible by a single research centre.  
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2. Well-studied and standardized analysis pipelines and quality-control (QC) 
metrics. One of the major difficulties in comparing SVs among different 
studies is that all studies use different algorithms and QC metrics. With NGS 
technology, there are already numerous algorithms to choose from, but yet no 
consensus on the appropriate analysis pipeline.   
3. Educating a whole new discipline of „big data biology‟. As more and more 
genomics data are collected, the growing need for storage, processing and 
analysis of the data becomes more and more apparent. Already, there is a great 
demand for information technology infrastructure and bioinformatics team to 
analyse the massive amount of data, with speculations that the costs associated 
with down-handling, storing and analysis of the data could be more than the 
production of the data. Hence, we need to train new scientists to handle these 
upcoming challenges.  
4. Beyond discovery studies. Many early works on population wide SVs are 
„discovery‟ studies where SVs in a population are characterized. As our 
understanding of SVs continues to increase, we should look beyond 
„discovery‟, but aim to collect phenotype data for association studies.  
5. Integrated knowledge with RNAseq, transcriptome, proteomics etc. We still 
do not have a good understanding of the function of SVs in the context of 
human phenotypes. The integrated knowledge of SVs with transcriptome and 
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Abstract
Background: Algorithms and software for CNV detection have been developed, but they detect the CNV regions
sample-by-sample with individual-specific breakpoints, while common CNV regions are likely to occur at the same
genomic locations across different individuals in a homogenous population. Current algorithms to detect common
CNV regions do not account for the varying reliability of the individual CNVs, typically reported as confidence
scores by SNP-based CNV detection algorithms. General methodologies for identifying these recurrent regions,
especially those directed at SNP arrays, are still needed.
Results: In this paper, we describe two new approaches for identifying common CNV regions based on (i) the
frequency of occurrence of reliable CNVs, where reliability is determined by high confidence scores, and (ii) a
weighted frequency of occurrence of CNVs, where the weights are determined by the confidence scores. In
addition, motivated by the fact that we often observe partially overlapping CNV regions as a mixture of two or
more distinct subregions, regions identified using the two approaches can be fine-tuned to smaller sub-regions
using a clustering algorithm. We compared the performance of the methods with sequencing-based results in
terms of discordance rates, rates of departure from Hardy-Weinberg equilibrium (HWE) and average frequency and
size of the identified regions. The discordance rates as well as the rates of departure from HWE decrease when we
select CNVs with higher confidence scores. We also performed comparisons with two previously published
methods, STAC and GISTIC, and showed that the methods we consider are better at identifying low-frequency but
high-confidence CNV regions.
Conclusions: The proposed methods for identifying common CNV regions in multiple individuals perform well
compared to existing methods. The identified common regions can be used for downstream analyses such as
group comparisons in association studies.
Background
Copy-number variants (CNVs) are genomic regions that
contain an abnormal number of copies. In humans, we
normally expect two copies of each autosomal region,
but in CNV regions we may observe copy gains or
losses. Current common technology used for CNV
detection are high-density single nucleotide polymorph-
ism (SNP) arrays or array comparative genomic hybridi-
zation (aCGH) arrays. Detection of CNVs from aCGH
arrays is mostly based on locating change-points in
intensity-ratio patterns that would partition each chro-
mosome into several discrete segments [1-5]. On the
other hand, the hidden Markov model (HMM) is
particularly popular for detection of CNVs from SNP
arrays, where the hidden states provide a natural way of
combining information from the total signal intensity
and the allele frequency values (see for example, [6,7]).
These approaches detect CNVs sample-by-sample, and
because of the high noise level in the intensity values,
especially for SNP array data, the boundaries of the
detected CNVs tend to vary among individuals. How-
ever, in a homogenous population, common CNV
regions are likely to occur at the same genomic loca-
tions across different individuals. Our focus in this
paper is to identify common CNV regions in multiple
individuals from a given population.
Common CNV detection algorithms for SNP arrays
report the log Bayes factor as a confidence score for
each identified region; this provides a measure of the
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reliability of a detected CNV within an individual. Pre-
vious methods developed to identify recurrent CNV
regions (see [8] for a review) were primarily developed
for aCGH data and hence did not incorporate confi-
dence scores. For example, a previously published
method, STAC [9], uses two statistics to identify recur-
rent CNV regions. These statistics are based on the
frequency of occurrence of the regions and the align-
ment of the regions. However, since the method does
not incorporate confidence scores, every individual
region contributes equally to the statistic, whereas in
fact, inter-sample variability is bound to exist, where
some regions are more likely to be true/false positives.
Furthermore, STAC requires each chromosome to be
split into non-overlapping windows of a user-defined
fixed size. The algorithm then searches for evidence of
common CNV regions within each window. The weak-
ness of this is that the output from such an approach
will only provide evidence of whether each window
harbours a common CNV, but will not indicate the
breakpoints of the CNV. Although we may decrease
the window size to improve the resolution, in practice,
doing so will incur an enormous computational
burden.
In this paper, we investigated two different methods
to detect common CNV regions. The methods take
segmented data as the input. The first method esti-
mates a statistic based on the frequency of occurrence
of reliable CNVs, where reliability is determined by a
high confidence score. The second method is based on
a weighted frequency of occurrence of CNVs, where
the weights are determined by the confidence scores.
Figure 1 illustrates a common CNV region in chromo-
some 22, identified using the first method, and shows
evidence of several distinct subregions within the iden-
tified common region. Hence, in addition to these
methods, we also investigated the use of a clustering
algorithm to split the common regions into smaller
subregions.
To assess the performance of the methods, we ran
the algorithms on 112 HapMap samples from the Illu-
mina iControl database, composed of individuals from
three populations (Yoruba, Caucasian and Asian). We
compared the regions we identified to the regions
identified using sequencing [10]. In general, the discor-
dance rates with sequencing-based CNV regions as
well as the rates of departure from HWE decreased
when we filtered the individuals with a stricter confi-
dence score threshold. To benchmark the proposed
methods to currently available methods, we performed
comparisons with STAC [9] and GISTIC [11] and
found that the proposed methods outperformed both




We assume that the raw intensity data have been pro-
cessed by a CNV detection algorithm. Denote by Ri =
{Ri1, Ri2..., R R R Ri i i i i { , , , }1 2   } the collection of
CNV regions detected in individual i, for i = 1,...,n. A
region is defined by its start and end probe locations,
and its CNV type (duplication or deletion). For each
region, we assume we have a confidence score statistic
that measures the likelihood that the detected region is
real. An example of this statistic is the log Bayes Factor
(see [6]). For region j detected in individual i, we denote
this statistic as Cij.
Cumulative Overlap Using Very Reliable Regions (COVER)
Our confidence in a CNV region depends on the within-
and between-subject information; our methods shall uti-
lize both information. The within-subject information
comes from the strength of the signal within an indivi-
dual CNV region, and this is measured by the confi-
dence score. The between-subject information comes
from the consistency of the CNVs across different indi-
viduals. Intuitively, we have less confidence in a CNV
that occurs in one individual than one that occurs in
many individuals. However, a single occurrence of CNV
might still be a true discovery if it is associated with a
high confidence score, i.e., it is based on a strong signal.
Since individual CNV regions span different probes,
the number of individual regions that overlap each
probe varies. However, common CNV regions tend to
occur at almost the same genomic locations across mul-
tiple individuals. Hence, we expect the common regions
to be identified by consecutive probes where a ‘signifi-
cant’ number of individuals have an overlapping CNV
region. Furthermore, we also expect the confidence
score of the individual region to be relatively high.
Let Zijk be the indicator that region j detected in indi-
vidual i overlaps with probe k. For each probe k, we cal-
culate the Cumulative Overlap using Very Reliable
Regions (COVER) statistic yk, defined as










where IC cij  is the indicator function for regions
detected with a confidence score above a certain thresh-
old c. The common CNV regions are then defined by
R         l l y u m mm m k k, , , , ,
representing sets of consecutive probes for which yk is
consistently greater than or equal to a specified
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threshold u. lm is the genomic position of probe m and
it is implicitly understood that the cardinal position of
the probe reflects its relative position in the chromo-
some so that when there are M probes in a chromo-
some, l1 <l2 <...<lM.
Using COVER, we can identify multiple common
CNV regions within a chromosome. Furthermore, differ-
ent subsets of individuals may contribute to different
common regions, hence allowing COVER to identify
regions that are common to only a subset of individuals.
By only considering individual regions that are detected
with high reliability, we also incorporate the uncertainty
associated with each individual region in the identifica-
tion of common regions. If this is not taken into
account, then all regions would be treated equally
despite the fact that some are more likely to be true
than the others. Figure S4 in the [Additional File 1]
gives an illustration of how COVER works.
Cumulative Composite Confidence Scores (COMPOSITE)
In COVER, regions with low confidence are given zero
weights and they do not contribute to the COVER sta-
tistic. The within-subject confidence is not fully
exploited when computing the COVER statistic: regions
Figure 1 An example of a common CNV region found based on COVER method with threshold u = 2 and c = 60. This figure illustrates a
common CNV region in part of chromosome 22, found using the COVER method with threshold u = 2 and confidence cutoff at 60th percentile.
41 out of 112 individuals have CNVs that overlap with this common region, indicated by the horizontal lines. We can see that despite being
identified as a common region, the individual regions still portray a mixture phenomenon of several distinct subregions.
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that are detected with low confidence but nonetheless
detected consistently across a large number of subjects
might be missed.
This limitation is addressed in the second method. For
probe k the composite confidence score (COMPOSITE)
statistic is defined as,








This formula is in fact similar to COVER statistic,
where instead of using the indicator function IC cij  as
weights, now all detected individual regions contribute
to the COMPOSITE statistic, with the amount of their
contribution proportional to their confidence scores.
Using COMPOSITE, the common CNV regions are
then defined as
R         l l s v m mm m k k, , , , ,
representing sets of consecutive probes for which sk is
consistently greater than or equal to a specified thresh-
old v. Figure S4 in [Additional file 1] gives an illustra-
tion of how COMPOSITE works.
Clustering of Individual CNV Regions within a Common
Region (CLUSTER)
Cluster analysis has been used in the analysis of gene
expression and aCGH data (see for example, [12-14]).
Here, the motivation for CLUSTER stems from the
observation that within a common CNV region identi-
fied by COVER or COMPOSITE, a complex mixture
phenomenon can still be observed (see Figure 1).
Figure 2 depicts the hypothetical situation where a
common region of length L bases has been identified by
COVER or COMPOSITE. Four individual regions over-
lap with the common region and from the figure, it is
clear that the first two regions are clustered to the left
while the last two are clustered to the right. The two
groups may form two distinct subregions and these
Figure 2 Hypothetical example of a identified common CNV region with 2 distinct clusters. Hypothetical situation where an identified
common CNV region is common to four individuals. From the figure, it is clear that the common region consists of two partially overlapping
regions. The first two individual regions are clustered together to the left of the common region, while the last two individual regions are
clustered to the right.
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subregions could differ biologically. In reality, the situa-
tion is more complex than the hypothetical example
here (see for example Figure 1).
To find the subregions inside this common region, we
first perform pairwise comparisons of the individual
regions that overlap with the common region. For
example, the comparison of two regions A and B can be
summarized into 4 values (a, b, c, d), where a is the
number of bases for which both A and B overlap with
the common region, b is the number of bases where A
overlaps with the common region but B does not, c is
the number of bases where B overlaps with the common
region but A does not, and d = L - a - b - c.
The (dis)similarity index can be computed using a
variety of distance metrics appropriate for binary data
such as the Manhattan, Canberra or Jaccard distance
[15]. The Jaccard distance is particularly attractive for
our case; it is defined by a/(a + b + c) and can be inter-
preted as the percentage of common overlap of the two
regions relative to the union of the overlaps of the two
regions with the common region. We then construct a
dissimilarity matrix as input to a hierarchical clustering
algorithm. The number of clusters will be determined
by the amount of within-cluster similarity we require.
The boundaries of each subregion will be the minimum
and maximum positions of all individual regions that
belong in that cluster. If these bounds overshoot the
boundaries of the initially identified region, then the





We studied the performance of the proposed procedures
by varying the corresponding threshold parameters in
each approach. 112 HapMap samples, comprising 46
Caucasian (CEU), 29 Beijing Chinese and Tokyo Japa-
nese (CHBJPT) and 37 Yoruban (YRI) individuals were
used in the analysis. These samples are part of the Illu-
mina iControl Database. Each sample was genotyped
using the Illumina 1M chip, and PennCNV [6] was used
to detect the individual CNV regions.
Comparison with Sequenced Regions
We compared the common regions we identified to a
list of reference CNVs identified in eight HapMap sam-
ples using sequencing data [10]. For each of the eight
samples, we calculated the discordance rates by record-
ing the proportion of common CNV regions (found
using our methods) for that sample that were not con-
cordant with the sample-specific reference CNVs. To be
‘concordant’ with a reference CNV, a region has to be
either contained within the reference CNV or it has to
overlap with at least 50% of the reference region. It is
important to note however that it is difficult to get a
gold standard for common CNV boundaries; even the
sequencing-based CNV regions cannot be expected to
have 100% sensitivity and specificity in genotype calling
and certainly not in boundary calls for common CNVs.
Comparison with other Array-based Regions
We compared the regions found using our methods to
the regions found by two other groups using array-
based methods. We compared with McCarroll et al.
[16], where the regions were identified using the Affy-
metrix SNP 6.0 arrays on 270 HapMap samples. To
minimize false discoveries, they ran two independent
experiments and require a CNV to be observed in both
experiments. We also compared our regions to the
regions found by Conrad et al. [17]. These regions were
identified using tiling oligonucleotide microarrays, com-
prising of 42 million probes, on 41 HapMap samples. A
total of 11,700 CNVs were identified, and 8,599 were
validated using a set of stringent criteria including (i)
additional measurements by Agilent 105K CGH arrays,
(ii) overlap with previous studies and (iii) other quality-
control filters. For our comparisons, we used only the
8,343 validated CNVs in the autosomal regions.
Comparison to other approaches
We compared our approaches to previous common
CNV detection methods, STAC: Significance Testing for
Aberrant Copy number [9] and GISTIC: Genomic Iden-
tification of Significant Targets in Cancer [11].
Briefly, STAC takes segmented data as input and esti-
mates two statistics: 1. A frequency statistic, which esti-
mates the frequency of aberration at each location
across all individuals. 2. A footprint statistic, which uses
a subset search methodology and counts the number of
locations c such that c is contained in a set of intervals
(see [9] for more details). It then uses a permutation
test to assess the significance of the observed region.
STAC requires each chromosome to be split into non-
overlapping regions of a user-defined fixed size. The
algorithm looks for evidence of common CNV regions
within each window, and reports the associated fre-
quency and footprint p-values.
GISTIC first calculates a ‘G score’ that is associated
with both the frequency of occurrence as well as the
amplitude of the aberration. Then, it calculates the
probability (q-value) of the observed region occurring by
chance via a permutation test. One can either input the
log intensity ratios, where the GLAD algorithm [18] will
be used to segment the data, or input pre-segmented
data using other algorithms.
We had also planned to make comparison to another
method called MSA [19], but failed because the soft-
ware, which is part of the GenePattern module, did not
work properly. MSA can be viewed as an improvement
over STAC, where it extends the notions of frequency
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and footprint statistics using original intensity ratio data
instead of segmented data [8]. We also tried a compari-
son to RJaCGH [2], which uses a non-homogenous Hid-
den Markov Model fitted via the Reversible-Jump
Markov Chain Monte Carlo method to estimate the
probability that a region has copy number alterations;
the method also allows the identification of minimal
common regions of copy number changes among multi-
ple individuals.
Unfortunately, with our samples, the algorithm did not
converge, so we could not proceed with the comparison.
Testing Hardy-Weinberg Equilibrium
It has been observed that the majority of common
CNV regions are inherited [20]. Hence, for a popula-
tion of normal (healthy) individuals, we expect, for
most of the common regions, the integer copy num-
bers to be in Hardy-Weinberg equilibrium (HWE).
The small number of regions that depart from HWE
can be attributed to factors such as recent mutations.
For example, McCarroll et al. [16] found that about
98% of common diallelic CNV regions do not show
significant departure from HWE. In principle, HWE
applies to both diallelic CNVs (where only loss or gain
of copy numbers are present in addition to normal
copies) and multi-allelic CNV regions (where both loss
and gain of copies are present).
For diallelic CNVs with only loss and normal-copy
numbers (copy-number = 0,1,2), the HWE test can be
conducted by treating ‘0’ copies as minor allele homozy-
gous, ‘1’ copy as heterozygous and ‘2’ copies as reference
homozygous. Similarly, for CNVs with only gain and
normal-copy numbers (copy-number = 2,3,4), we treat
‘2’ copies as reference homozygous, ‘3’ copies as hetero-
zygous and ‘4’ copies as minor-allele homozygous. For
multi-allelic CNVs, a model with three or more alleles is
needed. However, the HWE test cannot be performed
directly on the unphased copy-number because there is
an issue with different combinations of alleles producing
the same copy-number. For example, in a 3-allele
model, a copy-number of 2 can be produced by a com-
bination of ‘0’ and ‘2’ copies or two ‘1’ copy alleles.
When dealing with samples from healthy individuals,
we propose to use the outcome of the HWE tests to
select ‘optimal’ parameter thresholds (e.g., c in COVER
and v in COMPOSITE). If we observe a large number
of common CNV regions with significant departure
from HWE (after accounting for population stratifica-
tion), it could mean that the parameters we choose are
not optimal. When dealing with a mixture of healthy
and diseased individuals such as in association studies,
it is expected that the CNVs among the diseased indi-
viduals will show some degree of departure from HWE
as some of the CNVs could be due to recent abbera-
tions. We propose performing HWE tests only among




Figure 3 shows the results for COVER. The discordance
rates with Kidd et al.’s [10] reference CNVs (see Com-
parison with Sequencing Results) can be as high as 80%
when we include all CNV calls in identifying the com-
mon regions. The discordance rates decrease when we
exclude CNVs whose confidence scores are below a cer-
tain percentile; more severe filtering generally reduces
the discordance rates. The lowest discordance rates of
about 55% were achieved when we excluded individual
regions whose confidence scores were below the 80th
percentile. Surprisingly, increasing the required mini-
mum number of individuals inside a region (u) does not
seem to have an effect on the discordance rates.
However, the required minimum number of indivi-
duals (u) does affect the rates of HWE violation (calcu-
lated as the percentage of diallelic CNVs whose p-value
from the HWE test is < 0.01 in at least one of the three
ethnic groups). (Some HapMap individuals were related;
the HWE test in each ethnic group was carried out on
unrelated individuals only.) There is an overall increas-
ing trend for the proportion of common CNV regions
that violate HWE when we increase the minimum num-
ber of individuals (Figure 3(b)). This is partly due to the
fact that with increasing number of individuals, we
detect CNV regions with larger minor allele frequencies
(see Figure 3(c)), hence the test for HWE will be more
powerful. Generally, the rates of departure from HWE
are less than 10% and can be lowered by filtering out
individuals with lower quality regions. A steeper reduc-
tion in the rates of departure from HWE can be
observed when only individual regions whose confidence
scores are above the 60th percentile are considered (Fig-
ure 3(b)).
The sizes of the identified common regions generally
increase when we filter lower quality individual regions
(Figure 3(d)), reflecting the fact that smaller regions
with fewer overlapping probes would tend to have lower
confidence scores. By choosing confidence score thresh-
olds (c) anywhere up to the 60th percentile, the average
size of the common regions are approximately the same
or slightly smaller than the average size that Kidd et al.
[10] obtained using sequencing methods (solid horizon-
tal line in Figure 3(d)). The dashed horizontal line in
Figure 3(d) shows that the median size of CNV regions
identified using the 500K EA chip [21] is much larger
than what we observe using our methods.
For this dataset, setting the confidence score threshold
to the 60th percentile seems to be the optimum choice.
With this setting, the discordance rates are around 60%
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and the proportion of diallelic CNVs that violate HWE
is kept at around 8%. The choice of u is more subjec-
tive, as it depends on our definition of ‘common’
regions. For example, if we require each common region
to overlap with at least three individual regions and set
c to the 60th percentile, we will identify 443 common
CNV regions (see [Additional file 2]).
COMPOSITE results
A total of 89% of the probes does not contain any indi-
vidual CNV regions and thus their composite scores are
zero. So, if we set the threshold v at the 89th percentile
of the composite scores, we do not filter out any indivi-
dual regions and this approach is essentially the same as
using u = 1 and c = 0 in COVER.
Figures 4(a) and 4(b) show that, as we increase the
threshold, the discordance rates as well as the rates of
HWE violation decrease steadily. Unlike the COVER
approach, where increasing the confidence score thresh-
old does not result in lower ability to detect rarer
CNVs, increasing the composite score threshold does
result in fewer rare CNVs being detected (Figure 4(c)).
This is because the composite score is a function of
both the confidence score and the number of individuals
within a common region. By increasing the threshold,
we are implicitly requiring more individuals within a
common region.
The increasing trend of mean minor allele frequency
(MAF) is consistently seen when the threshold is
increased to the 96th percentile. Beyond this, the mean
MAF decreases because large regions with higher MAF
may be split into several subregions with smaller MAF.
This observation is consistent with the pattern of med-
ian size of CNV regions (Figure 4(d)). Generally, we are
losing the smaller regions with low composite scores as
we increase the threshold. However, beyond the 96th
Figure 3 Results of COVER method. (a) Discordant Rates, (b) Proportion of diallelic CNVs that failed HWE, (c) mean minor allele frequency (MAF) of
diallelic CNVs and (d) Mean CNVs size (kilo-bases) as a function of confidence scores cut-off points and minimum number of individuals.
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percentile, the median region size decreases again due to
the splitting of the large regions.
The optimal setting is to set the threshold to the 94th
percentile, where the proportion of regions that failed
HWE is around 5% (Figure 4(c)). Using this setting, we are
able to detect 491 CNV regions (see [Additional file 3])
with median CNV size slightly larger then the median size
found by Kidd et al. [10]. The discordance rates among
the eight HapMap samples are approximately 70%, higher
than what can be achieved by COVER. Hence, although
COMPOSITE can pick up more regions, a higher percen-
tage of these regions is likely to be false discoveries.
CLUSTER results
The common regions identified using either COVER or
COMPOSITE can be further refined into distinct subre-
gions using CLUSTER. Here, we present the results of
applying CLUSTER to the common regions identified by
COVER. We choose the CLUSTER parameters so that
regions will be clustered together if they are at least 60%
similar. Complete linkage is used so that the distance
between any pair of clusters is defined as the maximum
distance between a pair of members drawn one from
each cluster. Single or average linkage can also be used.
Since single linkage defines the distance between any
pair of clusters as the minimum between a pair of mem-
bers from the clusters, it generally tends to produce
clusters that are more similar to each other, and when
the same similarity cut-off point is used, it tends to pro-
duce fewer clusters than complete linkage. Meanwhile,
using average linkage gives more clusters than single
linkage, but fewer than complete linkage. In the [Addi-
tional file 1], we compare the three linkage measures for
a sample region.
Figure 4 Results of COMPOSITE method. (a) Discordant Rates, (b) Proportion of diallelic CNVs that failed HWE, (c) mean minor allele frequency
(MAF) of diallelic CNVs and (d) Median size of CNV regions (kb) as a function of composite confidence scores cut-off points. Solid line is median
CNV size found by Kidd et al.
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Figure 5(a) shows that the number of clusters
decreases when we increase the confidence score thresh-
old. But even when we consider CNVs with confidence
scores above the median, the clustering effect is still evi-
dent with 1.3 to 1.7 clusters found for each common
region, depending on which threshold value u is used.
For the optimum parameters u = 3 and c = 60, on aver-
age, 1.5 clusters are found per common region. The
rates of departure from HWE (Figure 5(b)) are approxi-
mately the same as in Figure 3(b) and increasing the
confidence-score threshold lowers the rates.
Once the common regions are identified, it is straight-
forward to perform a number of downstream analyses.
For example, a principal component analysis (PCA) can
done based on subjects’ integer copy-number calls at
these regions (see Section ‘Principal Component Analy-
sis of CNV Profiles’ for more details). In the HapMap
dataset, CLUSTER clearly improves the separation
between the Yoruba and the other two populations
based on the subjects’ common CNV region profiles
(compare Figure 5(c) vs 5(d)). This result suggests that
different ethnic groups have more subtle differences in
the breakpoints of CNV regions.
Comparisons
McCarroll et al.’s versus Kidd et al.’s Results Using
the Affymetrix 6.0 arrays, McCarroll et al. [16]
employed a set of strict criteria based on duplicate
experiments to identify the CNV regions. For each of
the eight samples sequenced by Kidd et al. [10], we cal-
culated the discordance rates with McCarroll et al.’s
CNVs and they range from 71% for sample NA12878 to
84% for sample NA18517. On average, across the eight
samples, 76% of the regions found by McCarroll et al.
are discordant with the regions found by Kidd et al.
Figure 5 Results of applying CLUSTER to common regions identified by COVER method. (a) Average number of clusters, (b) rates of
departure from HWE, (c) First and second components of PCA based on subjects’ integer copy-number calls at common regions found using
COVER (with u = 3 and c = 60), (d) First and second components of PCA based on subjects’ integer copy-number calls at common regions
found using complete-linkage CLUSTER (with cluster.limit = 0.6).
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[10]. In comparison, using COVER, the discordance
rates are around 60% (see Section “COVER Results”).
Thus, the methods described in this paper, using only
data from a non-duplicated experiment, actually perform
better in terms of discordance rates against sequencing
data.
McCarroll et al.’s versus COVER/COMPOSITE
Results We also compared the regions identified by our
approaches to the list of common CNV regions identi-
fied by McCarroll et al. [16]. Figure 6(a) shows that by
using COVER, the discordance rates can be lowered by
either increasing the confidence-score threshold, placing
a higher limit on the minimum number of individuals
(u), or both. For the best scenario, the discordance rate
is about 15%. Using COMPOSITE, the discordance rates
can be reduced by increasing the composite-score
threshold, but even for the best scenario, the discor-
dance rate is around 25% (see Figure 6(b)).
Comparison to Conrad et al.’s regions Treating the set
of 8,343 validated autosomal CNVs found by Conrad
et al. [17] as reference CNVs, we calculate the discor-
dance rates against this reference list. Using the optimal
parameters for COVER/COMPOSITE for this dataset,
we obtain discordance rates of 42% and 31% for COVER
and COMPOSITE respectively. By refining the regions
using CLUSTER, the discordance rate for COVER
decreases to 34% and that for COMPOSITE remains
about the same, at 33%. These are better than McCarroll
et al.’s [16] regions, which have a discordance rate of
44%.
Comparison to GISTIC As input to GISTIC, we used
CNV calls from PennCNV for the same Hapmap
samples as described in the Datasets Section. Using the
default parameters of GISTIC, with the q-value thresh-
old set at 0.25, we obtained 342 significant common
regions with a mean frequency of 0.106 and a median
confidence score of 15.7. For comparison with COVER
and COMPOSITE, we chose threshold parameters to
give the closest number of common regions to that
detected by GISTIC. For COVER, this corresponded to
the choice of u = 3 and c = 70th percentile, which
yielded 329 regions with a mean frequency of 0.065 and
median confidence of 32.3. For COMPOSITE, the
threshold was chosen to be the 94.5th percentile, and
this yielded 360 regions with a mean frequency of 0.121
and median confidence of 27.6.
For each region identified by COVER, we checked if it
was concordant with any region identified by GISTIC.
Concordance is defined in the same way as in the Sec-
tion ‘Comparison with Sequencing Results’. The
COVER-identified regions can hence be divided into
two groups: those that are concordant with at least one
GISTIC region and those that are not. For each group,
we computed the mean frequency and median confi-
dence score, as well as the discordance rates with Kidd
et al.’s regions. We did the same for each region identi-
fied by GISTIC, checking if the region was concordant
with any region identified by COVER. Similar analysis
was done comparing COMPOSITE and GISTIC.
Table 1, for COVER, shows that regions that are con-
cordant with GISTIC regions have higher frequencies
but moderate confidence scores, while those that are
not concordant with GISTIC regions have lower fre-
quencies but higher confidence scores. The concordant
Figure 6 Comparison to McCarroll’s CNVs. (a) Discordance rates when comparing regions found using COVER and those found by McCarroll
et al., plotted against confidence score thresholds for different values of u. (b) Discordance rates when comparing regions found using
COMPOSITE and those found by McCarroll et al., plotted against composite score thresholds.
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regions have lower discordance rates with sequenced-
based results. Similar patterns in frequencies, confidence
scores and discordance rates are also seen for the
regions found by COMPOSITE. We deduce that GIS-
TIC misses regions that are of low frequencies but high
confidence scores. Hence, it seems that COVER/COM-
POSITE can identify the low-frequency CNVs better. In
addition, of the regions found by GISTIC, those that are
concordant with COVER or COMPOSITE have high
frequencies and moderate confidence scores while those
that are not concordant have low frequencies and low
confidence scores. Again, the concordant regions have
lower discordance rates with sequenced-based results.
From this, we deduce that the regions identified by GIS-
TIC but missed by our methods are those with low fre-
quencies and low confidence scores, and hence more
likely to be false positives.
Comparison to STAC For the purpose of analysis using
STAC, we split each chromosome into 1450-1500 fixed-
size windows with the size of the windows varying from
165 kb for chromosome 1 down to 24 kb for chromo-
some 22, resulting in a total of 32780 windows across
chromosome 1-22. (We tried a smaller window size but
the computational burden became too large, where even
after 48 hours the algorithm was still running in a 3
GHz windows PC with 4 Gb RAM). We used 0.05 as a
cut-off to declare windows with significant frequency or
footprint p-values, and obtained 868 significant windows
with a mean frequency of 0.155. Each significant fixed-
size window will be taken as a significant region.
To compare the regions found by STAC to the
regions found using COVER and COMPOSITE, we
chose threshold parameters to give a number of com-
mon regions closest to that detected by STAC. For
COVER, this corresponded to the choice of u = 2 and
c = 60th percentile, and for COMPOSITE, the 93th per-
centile. We obtained 777 and 805 common regions
respectively. We performed similar analysis as in the
comparison to GISTIC.
A summary of this comparison is shown in Table 2a.
We observe similar results as in the comparison to GIS-
TIC: regions that were identified by STAC but that were
missed by COVER/COMPOSITE have low frequencies
and low confidence scores, but regions identified by
COVER/COMPOSITE that were missed by STAC have
low frequencies but high confidence scores, and were
thus more likely to be true positives.
We also investigated if the relative performance of
STAC would improve if we manually filtered out indivi-
dual regions with lower confidence scores. We decided
to use only individual regions whose confidence scores
were above the median confidence score of all reported
regions. Using this filtered input, STAC identified 654
significant windows. Using u = 2 and c = 70th percen-
tile for COVER and the 93.5th percentile for COMPO-
SITE, we identified a similar number of common
regions (615 for COVER and 610 for COMPOSITE).
Table 2b summarizes the results of this comparison and
our conclusions are similar to those with the unfiltered
input data.
We conclude that COVER and COMPOSITE are able
to detect the majority of the regions found by STAC,
and in addition they also detect common high-confi-
dence CNV regions that occur in a smaller number of
subjects that were missed by STAC.
Implementation
The methods are implemented in an R package
cnvpack. The main input is a list of detected indivi-
dual CNV regions with the following information: Sam-
ple name, chromosome number, detected integer copy
number, start and end genomic locations and a confi-
dence score. The package can be downloaded from
http://www.meb.ki.se/~yudpaw.
Table 1 Comparison with GISTIC.
regions found by overlap? no. of regions mean freq median conf discordance**
COVER ✓ GISTIC 139 0.10 30 62%
✗ GISTIC 190 0.037 37.5 87%
COMPOSITE ✓ GISTIC 162 0.21 20.0 64%
✗ GISTIC 198 0.048 72.8 75%
GISTIC ✓ COVER 153 0.15 22.3 56%
✗ COVER 189 0.072 8.8 84%
✓ COMPOSITE 173 0.15 20.6 61%
✗ COMPOSITE 169 0.058 8.8 82%
✓ - overlap
✗ - no overlap
** discordance rates with Kidd’s sequencing results.
This table shows a summary of the results obtained from comparing COVER/COMPOSITE to GISTIC.
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Downstream analyses
CNV-association analysis
One important use of the identified common CNV
regions is for group comparisons in association stu-
dies. For each region we test whether certain CNVs
are over-represented in one group compared to the
others. Typically, the Fisher’s exact test or chi-squared
test for contingency tables can be used. The test can
be carried out for all identified common CNV regions
and the issue of multiple testing can be dealt with
using the false discovery rate (FDR) assessment. (See
[Additional file 1] on how to use the package for such
analyses.)
As an illustration we performed an association ana-
lysis on the common regions identified in the 112
control subjects using the optimal parameters for
COVER and COMPOSITE. The subjects were grouped
by ethnicity (YRI, CHBJPT and CEU). Both methods
showed that there were a number of highly-significant
CNV regions with p-value < 1e-06. Two of these
regions were detected by both methods. The first one
is a 16.2 kb deletion in chromosome 2 (genomic posi-
tions 203,004,035 to 203,020,242). This region occurs
exclusively in the Yoruba population (17/37) and over-
laps with the BMPR2 gene that has been linked to pri-
mary pulmonary hypertension [22]. The second region
is a 4.6 kb deletion in chromosome 4 (genomic posi-
tions 20,982,707 to 20,987,259) that occurs among
Yoruban (19/37) and CHBJPT (4/29). This region
overlaps with the KCNIP4 gene that is known to
interact with presenilin, a protein that has been
reported to be involved in early-onset Alzheimer’s dis-
ease [23].
Principal component analysis of CNV profiles
We also perform principal component analyses (PCA) to
obtain informative plots of population differentiation in
the CNV profiles (see [Additional file 1] for more infor-
mation). For the HapMap samples, the first two compo-
nents obtained using the optimal COVER parameters
separate the Yoruba population (YRI) from the Cauca-
sian(CEU) and Asian(CHBJPT) populations, but the
other two populations are not very well separated (Fig-
ure S1 in the [Additional file 1]). A better separation
between the CEU and CHBJPT populations is achieved
using the third and fourth components(see Figure 7(a))
and the separation is further improved when we use
CLUSTER to refine the CNV regions identified by
COVER (Figure 7(b)).
Conclusions
We have described and compared two different methods
for identifying common CNV regions. Using 112 Hap-
Map samples, we have shown that these methods pro-
duce common CNV regions that mostly follow Hardy-
Weinberg equilibrium (HWE). For the eight HapMap
samples where we compared the regions we identified
to the reference CNV regions found by sequencing [10],
the discordance rates can be as high as 80%, but this
can be reduced to 60% by considering CNVs with higher
confidence scores, thus showing the importance of
Table 2 Comparison with STAC.
STAC input: all data regions found by overlap? no. of regions mean(freq) median(conf)
COVER ✓ STAC 301 0.084 25.6
✗ STAC 476 0.021 31.2
COMPOSITE ✓ STAC 372 0.14 18.6
✗ STAC 433 0.023 52.5
STAC ✓ COVER 609 0.15 23
✗ COVER 259 0.11 8.1
✓ COMPOSITE 727 0.15 20.5
✗ COMPOSITE 141 0.07 7.21
STAC input: filtered data regions found by overlap? no. of regions mean(freq) median(conf)
COVER ✓ STAC 294 0.068 30.2
✗ STAC 321 0.020 37.6
COMPOSITE ✓ STAC 297 0.14 23.1
✗ STAC 313 0.045 65.2
STAC ✓ COVER 585 0.14 28.1
✗ COVER 69 0.07 16.1
✓ COMPOSITE 595 0.14 26.8
✗ COMPOSITE 59 0.06 20.2
✓ - overlap
✗ - no overlap
This table shows a summary of the results obtained from comparing COVER/COMPOSITE to GISTIC.
Mei et al. BMC Bioinformatics 2010, 11:147
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further processing of the CNVs. The high level of dis-
cordance itself might be due to an inherent limitation in
the SNP array as the platform for CNV detection, but
perhaps also due to imperfection in the sequencing-
based results. Further works are needed to explain the
discordance level.
When we compared our methods to previously pub-
lished methods, STAC and GISTIC, we found that our
methods are better at identifying low-frequency CNVs.
Moreover, STAC is rather rigid and insensitive to the
actual breakpoints of a CNV region, because if two con-
secutive windows are reported as significant, we do not
know if there is one large CNV which spans both win-
dows, or two separate and distinct CNVs. Although we
can decrease the window size to increase the resolution,
in practice, decreasing the window size beyond a certain
point will incur too much computational burden.
Another limitation of previous methods is the lack of
consideration of individual-specific confidence scores.
This means that all samples contribute equally to the
calculation of the statistic used to identify the common
regions, while in fact, there is bound to be inter-sample
variability, where some CNVs are more likely to be true
positives than others.
The results of COVER and COMPOSITE are similar
in terms of discordance rates and HWE violation rates,
but COMPOSITE appears to be better at identifying
rare regions. The HWE violation rates are useful in
determining the choice of parameter values for COVER
and COMPOSITE. For this particular data set, we
observed a steeper reduction in HWE violation rates
when we used COVER with a confidence score thresh-
old set above the median or higher. For COMPOSITE, a
more noticeable reduction in HWE violation rates was
observed when we set v to the 94th percentile. For a
new dataset, we encourage users to choose the confi-
dence score and COMPOSITE score parameter thresh-
olds for which steeper reduction in HWE violation rates
can be observed.
When using COVER, the minimum number of indi-
viduals inside a common region (u) needs to be speci-
fied as well. If we are interested in rare variants
in addition to the common variants, then it makes
sense to set u = 1. Otherwise, u ≥ 2 should be used.
A higher u will result in the identification of fewer,
but more highly-recurrent CNV regions. In our experi-
ence with the HapMap samples, clustering results pro-
duce better separation of the ethnic groups than
indicated by the initial common CNV regions. In com-
parison with the highly-validated CNVs from Conrad
et al. [17], the concordance rate of COVER also
improves after refinement with CLUSTER. So, in sum-
mary, we recommend users to further refine the identi-
fied common CNV regions using CLUSTER.
Additional file 1: The supplementary report documents details on
how to use the R package cnvpack for the various analyses
described in this paper.
Additional file 2: This table shows details of the regions found by
COVER.
Additional file 3: This table shows details of the regions found by
COMPOSITE.
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Supplementary information for 
Identification of common copy-number variation (CNV) regions using high-density 
SNP array 
Teo Shu Mei, Agus Salim, Stefano Calza, Ku Chee Seng, Chia Kee Seng, and Yudi 
Pawitan 
The following R commands show how users can use the cnvpack package to identify 
common copy-number regions among 112 HapMap samples that are part of the Illumina 
iControl Database. The input files are PennCNV outputs based on Illumina 1M beadchip. 
We will only analyze common CNV regions (CNVR) detected in chromosome 1 to 22. 
 
Download and install the cnvpack from http://www.meb.ki.se/~yudpaw 
 




The main functions in the package are summarized here: 
1. read.cnv – reads in outputs from any CNV-detection software. 
 
2. setreg – sets up common CNV regions using one of the three proposed 
methods, using user-specified parameters. The output will contain a list of 
common CNV regions and for each individual, a list of individual-specific 
common CNV regions and the discrete copy number calls. 
 
3. plot – displays clusters of regions within each common region: only available 
when CLUSTER method is used.  
 
4. hwe.cnv – tests Hardy-Weinberg Equilibrium (HWE) of diallelic CNV 
regions. 
 
5. summary – prints descriptive statistics of size and frequencies of common 
CNV regions, conducts CNV-association analysis. The output is a list of common 
CNV regions with their frequency distribution and p-values from the association 
analysis, adjusted for multiple testing. 
 
We read in the PennCNV output (input="penncnv") which contains the list of 
detected individual CNVs for the 112 HapMap samples. This file contains confidence 
score values for the individual CNVs (conf = TRUE), as well as the list of genes 
within the individual CNVs (annotated=TRUE). The read.cnv function will then 




Note that if the output is from PennCNV or QuantiSNP, there must be a column 
indicating confidence scores.  
Outputs from other software can also be read in, provided it contains the following 
information in tab delimited columns: (1) chr: chromosome where CNV region is located,  
(2) sample: sample name, (3) cn: the detected integer copy-number with cn=2 indicating 
normal copy number, (4) startsnp: SNP or copy-number probe where the region starts and 
(5) endsnp: SNP or copy-number probe where the region ends and (6) confidence 
(optional): a score that reflects how confident the CNV-detection algorithm is in calling 
the integer copy number. The magnitude of the score reflects the level of confidence. If 
confidence scores are not available, set conf=FALSE. 
 
Next, we load the Illumina IM beadchip annotation file and the phenotype data for our 
samples. The annotation file contains a list with components “Name”, “Position", 
"Chromosome" and "Chr.num"; “Name” contains the name of the SNP or CNV marker, 
“Position” contains the position of the markers in the genome , “Chromosome” specifies 
the Chromosome the marker is in (1,2,3,…,22, X, Y, XY, (M)itochondrial) and 
“Chr.num” is the numeric form of “Chromosome”, where “X” is coded as “23”, “Y” is 
coded as “24”, “XY” is coded as “25” and “M” is coded as “26”. The phenotype data is a 
data frame with columns “sample”, “gender” and “ethnic” (other covariates may be 





[1] rs12354060 rs2691310  rs2531266  rs4477212  rs4124251  rs8179466  
1072820 Levels: cnv10000p1 cnv10003p1 cnv10003p5 cnv10004p1 ... SNP98 
 
head(ann$Position) 
[1]  10004  46844  59415  72017  97215 224176 
 
head(ann$Chromosome) 
[1] 1 1 1 1 1 1 
26 Levels: 1 10 11 12 13 14 15 16 17 18 19 2 20 21 22 3 4 5 6 7 8 9 M X ... Y 
 
head(ann$Chr.num) 
[1] 1 1 1 1 1 1 
 
Next, we load the data frame containing gender and ethnicity information of the 112 
samples.  
load ('112hapmap_pheno.Rdata')  
head(pheno) 
   sample gender ethnic 
1 NA06985  FALSE    CEU 
2 NA06991  FALSE    CEU 
3 NA06994   TRUE    CEU 
4 NA07000  FALSE    CEU 
5 NA07029   TRUE    CEU 
6 NA07345  FALSE    CEU 
 
We now use the setreg function to set up the common CNV regions for these 112 
individuals. The Cumulative Overlap Using Very Reliable Regions (COVER) method 
was used (method="COVER").The minimum acceptable confidence score is set to be 
equal to the 60
th
 percentile of all reported confidence scores(high.conf=60). Inside 
a genomic location in a common CNV region, there must be at least 3 individuals whose 
individual CNVs overlap with that genomic location (LIM=2), with the deletion 
and duplication regions considered simultaneously (cnv.abnormality= 
"both"). If confidence scores are not available, set high.conf = NA.   
 
cnvr<-setreg(out,anno.list = ann,pheno.data= 
pheno,high.conf = 60,LIM = 2,method = "COVER", 
cnv.abnormality = "both") 
 
The cnvr$reg$loc object containing the list of all identified common CNV regions 




         st      en st.chr regmin 
1         5      47      1    -15 
2       205     248      1     -7 
3       269     283      1     -4 
4      2681    2695      1     -4 
5      4201    4208      1     -3 
6      4367    4381      1     -5 
7      5380    5392      1     -4 




443 1029556 1029574     22     -8 
 
 
The cnvr$reg$regID is a list. For each individual, it contains the CNVR ID 
(corresponding the ID in cnvr$reg$loc) for which that individual has copy-number 
variation. The corresponding integer copy-number call is given in cnvr$reg$call. 
The ordering of the individual in cnvr$reg$regID corresponds to the way they are 
ordered in  cnvr$pheno, so that cnvr$reg$regID[[1]] contains the CNVR for 
individual on the first row of cnvr$pheno; cnvr$reg$regID[[2]] contains the 
CNVR for individual on the second row of cnvr$pheno and so on. 
 
Test for Hardy-Weinberg Equilibrium 
We can test for Hardy-Weinberg Equilibrium of common diallelic CNV regions when 
cnv.abnormality= "both" in setreg. 
   
cnvr.hwe = hwe.cnv(cnvr) 
 
The main component of interest in cnvr.hwe would be cnvr.hwe$group1$fdr 
which gives the pvalue from testing HWE on each CNVR in cnvr$reg$loc, corrected 




[1] 0.2992617 0.6346215 0.7874008 0.8400692 0.8400692 
0.7874008 
 
The ordering of the adjusted pvalues in cnvr.hwe$group1$fdr corresponds to the 




[1] 1 2 3 4 5 6 
 
Downstream Analyses 
Comparing between-group CNV frequency 
We can obtain a summary of the number of CNVs and distribution of CNV length for 
each level of group variable. Using test= TRUE, we can compare between-group 
CNV frequency. A output of the list of common CNVs with their profiles and frequency 
distribution as well as p-values and false discovery rates will be saved in LIST of CNV 
regions.xls (see Supplementary Table I) .Here, we are comparing between ethnicity, 
where the ethnicity information was located in the third column of our phenotype data 
(group= 3).  
 
summary(cnvr,anno.list= ann,test= TRUE,group= 3) 
 
A group-by-group summary of the CNV regions will be displayed as follows: 
 CNV Region group-by-group summary:  
 
 group=CEU  
Number of unique CNV regions across individuals = 322  
Average length of CNV regions 71039.51  
Median length of CNV regions 19175  
Distribution of length  
 
    (0,1e+03] (1e+03,1e+04] (1e+04,5e+04] (5e+04,1e+06]  
            6            90           148            73  
 
 CNV Region group-by-group summary:  
 group=CHJP  
Number of unique CNV regions across individuals = 175  
Average length of CNV regions 106601.0  
Median length of CNV regions 23551  
Distribution of length  
 
    (0,1e+03] (1e+03,1e+04] (1e+04,5e+04] (5e+04,1e+06]  
            5            56            54            55  
 
 CNV Region group-by-group summary:  
 
 group=YRI  
Number of unique CNV regions across individuals = 362  
Average length of CNV regions 63749.46  
Median length of CNV regions 18185  
Distribution of length  
 
    (0,1e+03] (1e+03,1e+04] (1e+04,5e+04] (5e+04,1e+06]  
            5           102           176            74  
Correlation of CNV Regions Frequency  
           group=CEU group=CHJP group=YRI 
group=CEU  1.0000000  0.5093919 0.1071928 
group=CHJP 0.5093919  1.0000000 0.2491267 
group=YRI  0.1071928  0.2491267 1.0000000 
 
Principal Component Analysis (PCA) of CNV profiles  
To perform PCA on the CNV profiles, we need to create A , a pn  matrix of absence-
presence, where n  is the number of individuals and p  is the number of CNV regions. 
The j
th 
element of the i
th
 row will be equal to 1 if the i
th
 subject has CNV in the j
th
 region 
and 0 otherwise. We can extract this information from the regID component of reg list, 




matrix of scatterplots of the first five principal component loadings is shown in Figure 
S1.  For a clearer picture, we also plot loading 3 versus loading 2 in Figure S2. We can 
see that the three ethnic groups are well separated. A summary of the proportion of data 
explained by the different components can be obtained by using summary ( ). There are 
in total 112 principal component loadings, and the first 5 components explain about 27% 
of the variance in the data. 
 
# The following commands perform PCA on integer copy-number 
n = 112 #number of individuals 
ncol = max(unlist(cnvr$reg$regID)) #get the largest CNVR ID  
reg = unique(unlist(cnvr$reg$regID)) #get a vector of 
unique CNV region ID 
x = matrix(2,nrow=n,ncol=ncol) 
for(i in 1:n){   #for each individual 
   x[i,unlist(cnvr$reg$regID[[i]])] = 
unlist(cnvr$reg$call[[i]])} 
out = princomp(t(x))      
#Figure S1 
pairs(out$load[,1:5],main="First five principal component 
loadings", 
col=as.numeric(factor(cnvr$pheno$ethnic)),pch=substring(cnv








Importance of components: 
                          Comp.1     Comp.2     Comp.3     Comp.4     Comp.5 
Standard deviation     0.8847292 0.66110492 0.58680472 0.44996690 0.40621197 
Proportion of Variance 0.1160093 0.06477583 0.05103398 0.03000775 0.02445556 
Cumulative Proportion  0.1160093 0.18078518 0.23181916 0.26182690 0.28628247 
                           Comp.6     Comp.7     Comp.8     Comp.9    Comp.10 
Standard deviation     0.39876638 0.39198306 0.37636555 0.37189963 0.36877064 
Proportion of Variance 0.02356727 0.02277230 0.02099384 0.02049858 0.02015510 




                          Comp.11    Comp.12    Comp.13    Comp.14    Comp.15 
                           Comp.108     Comp.109     Comp.110     Comp.111 
Standard deviation     0.0758989870 0.0740548526 0.0701807397 0.0681210169 
Proportion of Variance 0.0008537765 0.0008127917 0.0007299752 0.0006877561 
Cumulative Proportion  0.9972214494 0.9980342411 0.9987642163 0.9994519725 
                           Comp.112 
Standard deviation     0.0608086094 
Proportion of Variance 0.0005480275 
Cumulative Proportion  1.0000000000 
 
 
Figure S1. The first five principal component loadings based on the CNV profiles of the 
European population CEU (black), the Yoruba population (green) and the Asian 




COVER with CLUSTER 
 
We refine the CNV regions identified by COVER above and look for clustering of 
individual regions (see Figure S3 for evidence of clustering). Here, we use hierarchical 
clustering with complete linkage and require that within-cluster similarity to be at least 
60% (see Table S1 for effects on linkages and cut-off on number of clusters). 
 
cnvr <-setreg(out,anno.list= ann,pheno.data= 




We perform principal component analysis (PCA) based on the common CNV region 
profiles identified by this configuration of threshold parameters.  
 
 
Figure S2. The first five principal component loadings based on the CNV profiles of the 
European population CEU (black), the Yoruba population (green) and the Asian 
population (red) based on CNV region profiles identified using COVER with u=3 and 




p = dim(cnvr$reg$loc[[1]])[1]     
n = length(cnvr$reg$regID)   #no. of individuals 
x = matrix (2, nrow = n, ncol = p) 




x[i,sort(index) ] = unlist(cnvr$reg$call[[i]]) 
} 
out  = princomp(t(x)) 
 
## Figure S2 
pairs(out$load[,1:5],main="First five principal component 
loadings", 
col=eth,pch=eth,cex = 0.6) 
 
 
Figure S3. (a) A common CNV region identified using COVER with u=3 and c=60, 
exhibiting clusters of individual regions and (b) identified clusters of individual regions 




Dissimilarity cut-off Number of Clusters 
 Single Linkage Average Linkage Complete Linkage 
0.01 1 2 9 
0.05 2 5 9 
0.10 2 6 10 
0.20 2 9 12 
0.30 4 12 14 
0.50 11 17 21 
0.60 16 21 23 
0.70 24 27 28 
Table S1. The number of clusters identified in CNV region in Figure S3 as a function of 
dissimilarity (1-similarity) cut-off point and linkage. 
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ABSTRACT
Motivation: With the expansion of whole-genome studies, there
is rapid evolution of genotyping platforms. This leads to practical
issues such as upgrading of genotyping equipment which often
results in research groups having data from different platforms for
the same samples. While having more data can potentially yield
more accurate copy-number estimates, combining such data is
not straightforward as different platforms show different degrees of
attenuation of the true copy-number or different noise characteristics
andmarker panels. Currently, there is still a relative lack of procedures
for combining information from different platforms.
Results: We develop a method, called MPSS, based on a correlated
random-effect model for the unobserved patterns and extend the
robust smooth segmentation approach to the multiple-platform
scenario. We also propose an objective criterion for discrete
segmentation required for downstream analyses. For each identiﬁed
segment, the software reports a P-value to indicate the likelihood
of the segment being a true CNV. From the analyses of real
and simulated data, we show that MPSS has better operating
characteristics when compared to single-platform methods, and
have substantially higher sensitivity compared to an existing
multiplatform method.
Availability: The methods are implemented in an R package MPSS,
and the source is available from http://www.meb.ki.se/∼yudpaw.
Contact: agus_salim@nuhs.edu.sg
Supplementary Information: Supplementary data are available at
Bioinformatics online.
Received on December 17, 2010; revised on March 8, 2011;
accepted on March 26, 2011
1 INTRODUCTION
Copy-number variants (CNVs) are defined as duplications or
deletions in the number of copies of a DNA segment (larger than
1 kb in length) when compared to a reference genome. Currently,
common technologies used to detect CNVs include high-density
∗To whom correspondence should be addressed.
single nucleotide polymorphism (SNP) arrays and comparative-
genomic hybridization (CGH) arrays. In recent years, whole-genome
studies using commercial genotyping arrays to detect CNVs have
been rapidly expanding. With decreasing cost of commercially
available platforms and the fast evolution of these platforms, it is not
unusual for research groups to have data from multiple platforms
for each sample. For example, The Cancer Genome Atlas Research
Network, a joint effort of the National Cancer Institute (NCI)
and the National Human Genome Research Institute (NHGRI) to
explore genomic changes involved in human cancers, used Agilent
244K, Affymetrix SNP 6.0 and Illumina 550K platforms to measure
copy number alterations in its pilot study. Our own collaborators,
and perhaps many other researchers, collected genotype data using
both Illumina HumanHap300 and HumanHap240S arrays for each
sample in order to get higher genome coverage.
Marker density is an important factor for comprehensive and
accurate detection of CNVs and their breakpoints, and different
platforms have different probe coverage and density; see Curtis
et al.(2009) for a summary of probe coverage of the different
platforms in the different chromosomes. Combining data from
different platforms can potentially yield more precise and accurate
detection of CNVs and its breakpoints. However, combining such
data is not straightforward because it is known that estimates from
different platforms show different degrees of attenuation of the true
copy-number changes (Bengtsson et al., 2009) as well as different
noise characteristics. Furthermore, different platforms have different
marker panels and molecular assay methods (Zhang et al., 2010).
Currently, there is still a relative lack of formal procedures for
combining information from different platforms for copy-number
calling. Most studies with multiple platforms interrogating the same
samples process the data from the different platforms independently,
then combine the segments in an ad hoc manner. This approach
does not fully utilize information from the different platforms, and
when the segmented results from the different platforms differ, it
is difficult for researchers to come to a consensus in a statistically
rigorous manner.
One published method, multiple platform circular binary
segmentation (MPCBS) (Zhang et al., 2010), is able to jointly
use information from different platforms for CNV calling. The
MPCBS method extends the circular binary segmentation (CBS)
algorithm (Olshen et al., 2004) by detecting coupled changes
in multiple sequences. Briefly, it uses a weighted sum of t-statistics
© The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 1555
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from a generalized log-likelihood ratio of a multiplatform model and
pools statistical evidence across platforms during segmentation.
The proposed multiplatform smooth segmentation (MPSS)
method extends Huang et al. (2007)’s smoothseg algorithm, which
is based on the Cauchy random-effect model that allows jumps
in the underlying copy-number patterns to the multiple platforms
scenario. The algorithm computes the estimated random-effect
estimates that capture the underlying copy-number patterns, and
is applicable to both germ-line and tumor DNA as long as the
data has been appropriately normalized. As we are often interested
in discrete segments of deletions, normal copies and duplications
for downstream analysis such as CNV association studies, we also
develop an objective method to obtain the discrete segmentation.
From analyses of real and simulated data, MPSS performs well
compared to single-platform methods, and shows substantially
higher sensitivity compared with MPCBS.
2 METHODS
We first describe the correlated random-effect model for the unobserved
pattern. For each individual, denote X ≡{x1,...,xn} as the union of the
genomic locations of probes from the different platforms, with x1 <x2 <...<
xn. Denote Yj ≡{yx1j ,...,yxnj } as the set of log2-intensity ratios from platform
j, nj is the number of probes in platform j. Let N =∑nj . We consider the
model:
yxij = fj(xij)+exij (1)
where fj is the unknown platform-specific random-effects; the platform-
specific errors are independent and identically t-distributed with location
parameter 0, unknown dispersion parameter σj and k degrees of freedom.
We assume the errors and the random-effects to be independent. The error
structure was chosen to be t-distributed to incorporate a heavy-tailed structure
that can deal with outliers in the observations. We simplify (1) to
yxij = f (xij)+exij (2)
such that f (.) is a random effect parameter common to all platforms.
This simplification is justified when data from the different platforms are
well normalized, because the different platforms are measuring the same
underlying copy-number pattern. If not, a normalization procedure has to
be applied first. Note that the error term is still platform-specific. In matrix
form, we write (2) as
Y ≡Zf +ε
where Z is the model matrix determined by the observed x’s and the choice
of basis functions. We use the observed x’s as knots and choose the zero-
order B-splines. Hence, Z is the N by n model design matrix that indicates
the genomic locations of the probes from the different platforms, meaning
that the row of Z associated with the original data yij has value one at the
i-th location and zero otherwise. The smoothness of f can be expressed by
assuming that the scaled second-order differences a∗i ≡ 
2fi
(xi)2 are i.i.d. with
some distribution. Since f is mostly smooth, the size of ai ≡2fi = (xi)2a∗i
is very small relative to the local noise. So, there will be little difference
whether we specify the model on a∗i or ai. For convenience, we shall use the
latter. We choose the Cauchy distribution with location 0 and scale factor σ2f .
The Cauchy distribution has been used to deal with jumps in the underlying
patterns, with desirable results (see Huang et al., 2007, 2009).
2.1 Estimation of f via maximum likelihood
We derive an iterative weighted least squares algorithm by maximizing
the likelihood of the Cauchy random-effects model (see Huang et al.,
2007 and Pawitan, 2001, pp. 464–466). The log-likelihood based on y and




logL(f ,σ2f ,σ2j )= logp(y|f )+logp(f ). The first term comes from the t-density
with k degrees of freedom: For all (i,j) where platform j has a probe at
location i,












where c is a constant. The second term comes from the Cauchy model with
location 0 and scale factor σf :











Differentiating (3) with respect to f , we get:
∂logp(y|f )
∂f =Z
′WY −Z ′WZf (5)
where W is a N by N diagonal matrix with diagonal elements wij =
k+1
kσ2j +(yij−fi)2
, associated with the corresponding original data yij . In scalar
form, the i-th element of (5) can be written as∑j wij(yij − fi). Differentiating
(4), we obtain:
l′(a)=−D−1a (6)
where a = 2f , denoted by 2 the (n−2) by n matrix that represents the
second-order difference operator and
D−1 =diag [2/(σ2f +a2i )]
Combining (5) and (6), we obtain the score function, the first derivative of
logL(f ,σ2f ,σ2j ) as:
S(f )= (Z ′WY −Z ′WZf )−(2)′D−1(2)f
Setting S(f )=0, we get
[Z ′WZ +(2)′D−1(2)]f =Z ′WY (7)
We estimate f from (7) by exploiting the band-limited property of [Z ′WZ +
(2)′D−1(2)] and use well-tested fortran subroutines available in Linpack
(see Huang et al., 2007 and Dongarra et al., 1979).
2.2 Estimation of σ j
Given fˆ , at each probe position i, the deviance is defined as
di = (k+1)log
{




This can be approximated by the gamma distribution with mean µi and
dispersion φ. To estimate µi, we use a generalized linear model with a log-
link function, so h(µ)= log(µ) and h(µi)=xtiα, where the dimension of xi
and α is equal to the number of platforms. We solve using IWLS with robust
weights:
(1) Start with an initial α0. We estimate φ once using φˆ= var(di)d¯i2 .
(2) We write
Y∗ =Xα+e∗ (8)




(di −µ0i )+xtiα0 (9)
e∗i = ∂h∂µ ei and var(e∗i )= ( ∂h∂µ )2φµ2i =φ










where cj = 1.345σj . As an initial estimate, we use a robust measure
of spread, σˆj = median(|e∗j |)/0.6745. Then α can be solved using the
usual weight least squares solution:
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(4) We iterate between steps (2) and (3) until convergence. Then we obtain
σˆ2j =eαˆj . In subsequent sections, if there is a need for a single σ
estimate, we use the average of the σjs.
2.3 Choosing optimal λ
The degrees of freedom associated with f is given by (Pawitan, 2001, p. 448)
df = trace{(Z ′WZ +(2)′D−1(2))−1Z ′WZ}
where W and D are computed using fˆ . This expression is hard to obtain






where w¯ and d¯ are the average diagonals of Z ′WZ and D, and
vk =2[1−cos{π(k−1)/n}]
is the j-th eigenvalue of the second derivative matrix 2. We choose λ that




2.4 Summary of MPSS algorithm




, we employ the following algorithm:
(a) Start with an initial value for f0 and σ2j ’s.




(c) Compute Z ′WZ and D−1 and update f using (7).
(d) Update σ2j ’s as described in Section 2.2 .
(e) Repeat (b)–(d) until convergence.
2.5 P-values for segments
The Fisher information for f is the negative of the second derivative of the
log-likelihood.
I(f )=Z ′WZ +(2)′D−1(2)
At convergence, the estimated variance matrix is
V = I−1( f )
If we have a segment S, defined for instance by setting a threshold, then
fS is a vector which contains the estimated values in the segment and zero
everywhere else,
fS,i =
{ fˆi if i is in S
0 otherwise
}
The significance of the segment can be assessed using the statistic
χ2 = f ′SV−1fS (12)
To compute (12) without explicitly obtaining the inverse of a matrix with
extremely large dimension, we write (12) as





where aS,i contains the second-order differences of fS and d contains the
diagonal elements of D−1. We compare this statistic to the chi-squared
distribution with q degrees of freedom, where q is the number of probes
in S. To adjust for multiple hypothesis testing involving a large number of
segments, we compute the false discovery rate (FDR) for each segment.
2.6 Objective threshold segmentation
A segment whose random-effects parameter f consistently and significantly
deviates from zero is evident of a deletion/duplication. We obtain potential
copy-number segments by setting thresholds for fˆ , where duplications are
sets of consecutive probes for which fˆ is consistently greater than or equal to
a specified threshold, and deletions are sets of consecutive probes for which
fˆ is consistently smaller than or equal to a specified threshold. For automatic
threshold selection, users can pick the threshold that maximizes the total χ2
values (scaled by its associated degrees of freedom).
To avoid oversegmentation, we merge the segments if the distance
between adjacent segments is less than 5 kb. For each segment, we compute
its associated P-value/FDR as described in the previous section. We further
filter the segments by its length (those that are less than 1 kb are omitted),
FDR and number of probes (minimum number of probes within segment
is 10). A segment will also be omitted if the adjacent distance between 2
consecutive probes is larger than 100 times the median interprobe distance.
All filtering parameters can be changed by the user. Users can also filter the
segments by probe density (Number of probes/length of segment).
2.7 Removal of discrepant segments
For each segment identified by the MPSS algorithm, we test if the mean
intensity from the different platforms differ using a t-test (corrected for
autocorrelation, assuming the data has a first-order autoregressive structure)
if there are two platforms and ANOVA if there is more than two platforms.
We remove the segments where the FDR for the test is <0.01. We call these
segments ‘discrepant segments’. Discrepant segments are removed because
the multiplatform algorithm assumes the signals from the different platforms
are consistent with each other, hence signals from ‘discrepant’ segments are
likely to be unreliable.
2.8 Comparisons using simulated data
We conduct a simulation study to evaluate the performance of MPSS as well
as to compare against the MPCBS method. To get a realistic noise pattern,
we use the empirical CNV profile of chromosome 1 of the Hapmap sample
NA10851. We use data from both Affymetrix 6.0 and Illumina 1M platforms
(see Section 3.1) and apply the MPSS algorithm with segmentation threshold
of 0.05 and FDR threshold of 10−5. We remove segments with <4 probes as
extremely short segments are more likely to be false positives due to noise.
We label the different segments of the chromosome as CNV or ‘NULL’. In
total, there are 12 CNV segments and 13 ‘NULL’ segments. We perform
the simulation study at three different noise levels; the input values are the
smoothed intensities plus 0.5, 1, and 2 times the residuals from the respective
platforms. Note that the smoothed intensities plus 1 times the residuals is
exactly the original input intensities. We sample the 25 segments randomly
with replacement and use their corresponding intensity values as input to the
MPSS and MPCBS algorithms. We calculate the percentage of CNV probes
that were correctly identified (sensitivity) and the percentage of ‘NULL’
probes that were correctly identified (specificity). We repeat the process 100
times by bootstrapping from the residuals.
Labeling the CNV segments using segments originally identified by the
MPSS method may bias the analysis in favor of MPSS. Hence, we also repeat
the whole process, labeling the CNV segments using segments identified by
MPCBS, with a segmentation threshold of 0.05. After removing those with
less than 4 probes, we are left with 6 CNV segments and 7 ‘NULL’ segments.
2.9 Comparisons using real data
We compare MPSS against the single-platform smoothseg as well as MPCBS
in a real data setting. We use the integer copy-numbers for a total of 5037
CNV loci from Conrad et al.(2010)’s study as well as McCarrol et al.(2008)’s
study as a reference list. A set of 20 NimbleGen arrays, each comprising
2.1-million long oligonucleotide probes were used to first generate a new
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comprising of 105 000 long oligonucleotide probes was used to detect the
loci and the genotypes were estimated for 450 HapMap samples using a
Bayesian algorithm with stringent selection for optimal normalization and
cluster locations for every locus [See Supplementary Material in Conrad
et al. (2010) for more details]. We remove segments in the reference if the
number of probes from the combined probe list from the two platforms we
are using is less than 10 or if the segment size is less than 1 kb. There is a
median of 163 CNV segments per individual.
It should be noted, however, that this reference list cannot really be
considered the gold standard, as even sequencing data do not have 100%
sensitivity and specificity in CNV detection (Xie et al., 2009). For each
method, we perform individual-specific comparisons with Conrad’s CNVs
and compute the number of bases that are called as CNV both by the
method and by Conrad et al. We report the number of overlapping bases
as a proportion to the total length of CNVs identified by the method and
as a proportion of total length of Conrad’s CNVs. While these may not be
considered a ‘true discovery rate’ and ‘sensitivity´, since Conrad’s CNVs
are well-validated, a higher proportion of overlap is an indication of better
performance.
2.10 Implementation and computing time
The methods are implemented in an R package MPSS. The main
inputs are vectors of genomic positions, chromosome numbers and
log2-intensity ratios from each platform. It is recommended that users
check if data from the different platforms are well-normalized. If not,
background correction should be performed first; the package rsmooth
from http://www.meb.ki.se/∼yudpaw can be used for background correction.
All computations for this article was done on a 3 GHz Intel Core 2 Duo
processor. For 1 individual, with more than 2.5 million combined probes from
Affymetrix 6.0 and Illumina 1M, and for a user-specified λ, the algorithm
takes <1 min. It takes <6 min if the AIC criteria is used to find the optimal λ.
3 RESULTS
3.1 Datasets and background correction
We use nine HapMap samples (International HapMap Consortium,
2005 and see Supplementary Materials for sample ID and
population). These samples were previously genotyped by two SNP
arrays (Illumina 1M and Affymetrix 6.0) in our research lab. We
first perform background correction on the log2-intensity ratios from
each platform using a robust smoother in the rsmooth package from
http://www.meb.ki.se/∼yudpaw. This normalization assumes that
the majority of the genome does not contain CNVs, which is the
case for germline samples.
To investigate if the input intensities are well-normalized, we
randomly sample a non-CNV segment of 100 consecutive probes
and test if the mean intensity for the Affymetrix platform is equal to
the mean intensity of the Illumina platform (using t-test corrected for
autocorrelation). We repeat the process 1000 times and record the
percentage of P-values that are less than 0.01. The normalization
results look reasonable for all individuals with the percentage of
P-values less than 0.01 ranging from 0.0043 to 0.02.
3.2 Estimated parameters
For each chromosome, we use the λ that minimizes theAIC criterion.
A large variation in the optimal λ is observed across the genome,
indicating the need for the selection of different λs for different
chromosomes. For example, for individual NA19139, the optimal
λ ranges from about 47 for Chromosome 15 to about 4900 for
Chromosome 19; see Figure 1.


























Fig. 1. AIC as a function of λ for data from chromosome 15 and 19 for
individual NA19139.







































Fig. 2. Scaled total χ2 as a function of segmentation thresholds (in absolute
values) for individual NA19139.
3.3 Choice of thresholds
For each individual, we choose the deletion and duplication
thresholds that give the largest total scaled chi-squared value. For
individual NA19139, the deletion and duplication thresholds was
chosen to be 0.13 (Fig. 2). At the chosen threshold values, after
removing the discrepant segments (see Section 2.7), the algorithm
identifies a median of 137, 129, 117 and 110 segments that passed
the FDR threshold of 10−6, 10−7, 10−8 and 10−9, respectively.
The median length of the segments are 15.6, 16.1, 16.7 and 17.3
respectively.
At the same segmentation and FDR thresholds, the single platform
algorithm identifies a median of 68, 63, 58 and 56 segments (median
length of 39.6, 41.4, 43.3 and 42.8 kb) for the Illumina platform and
81, 77, 69 and 66 segments (median length of 40.8, 41.6, 44.5 and
45.1kb) for the Affymetrix platform.
We apply the MPCBS method on the signals, post-background
correction, and use the modified Bayesian information criterion
(BIC) approach as suggested by the authors to estimate the number of
segments. The maximum number of change points per chromosome
is set to 30. MPCBS outputs the breakpoints of the segments as
well as the estimated response from each platform. We calculate
the estimated response for each segment as the average of the
responses from the two platforms. For each individual, we vary the
segmentation thresholds such that the total length of CNVs identified
by MPCBS is similar to MPSS. Similar results are obtained if we
control the number of CNVs, so the results are not shown here. We
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Table 1. Sensitivity and specificity of MPSS and MPCBS using simulation
data
Sensitivity Specificity
Data input MPSS MPCBS MPSS MPCBS
MPSS segments
1*residuals 0.779 0.098 >0.999 > 0.999
0.5*residuals 0.804 0.281 0.918 > 0.999
2*residuals 0.127 0.025 > 0.999 > 0.999
MPCBS segments
1*residuals 0.527 0.192 0.999 >0.999
0.5*residuals 0.627 0.414 0.914 >0.999
2*residuals 0.177 0.098 >0.999 0.989
length of 1 kb and a maximum length of 1.1 Mb. The median length
of the segments at these thresholds are 21.8, 21.8, 21.7 and 21.7 kb,
respectively.
We also ran the single platform CBS algorithm. With α=0.01 and
segmentation threshold of ± 0.01, 0.02, 0.03 and 0.04, we obtain a
median of 30, 28, 26 and 26 segments (median length of 21.9, 19,
16.1 and 14.8 kb) for the Illumina platform and a median of 75, 73,
71 and 69 segments (median length of 37.8, 34.8, 34.3 and 31.5 kb)
for the Affymetrix platform.
3.4 Comparison: simulated data
The average sensitivity and specificity across 100 bootstrap samples
are summarized in Table 1. For most scenarios, both MPSS and
MPCBS have high specificity (greater than 99%), though MPSS
has slightly lower specificity when noise level is decreased. For both
algorithms, sensitivity increases with decreased noise level and vice
versa. In all cases, MPSS has substantially higher sensitivity than
MPCBS. Mean sensitivity for MPSS can be as high as 80% when
the noise level is decreased, whereas MPCBS only attains a mean
sensitivity of about 41%. When noise level is high, both algorithms
perform poorly—MPSS with a mean sensitivity of about 18% and
MPCBS with a mean sensitivity of about 10%. However, note that
with twice the magnitude of the residuals, the platform variability is
increased to four times the original variability. With such high level
of noise, unless the CNV signal is very strong, no algorithm is likely
to identify the CNV.
3.5 Comparison: real data
When signals from the different platforms are consistent, we
get increased power to detect the CNVs when we combine the
information from the different platforms, especially in areas where
a single platform has low density of probes. Figure 3a shows that
the Illumina platform has a single probe in the deletion region,
and while this probe exhibits strong evidence of a decreased
intensity (log2-intensity ratio less than −3), the single platform
approach was unable to identify the deletion. On the other hand,
the Affymetrix platform has several probes in the region with
moderately decreased log2-intensity ratio values, and the single
platform approach detects a slight dip but the evidence is not strong.
With the multiplatform approach, we see strong evidence of a
deletion in that area. The gray shaded area indicates the CNV region




Fig. 3. Examples of segments detected by the multiplatform methods.
(a) A deletion in Chromosome 8 of individual NA19139. Single platform
smoothseg on Illumina platform was unable to identify the deletion due
to lack of probes in the region. Single platform smoothseg on Affymetrix
platform was unable to identify the deletion due to insufficient signal. (b)
A deletion in Chromosome 16 of individual NA19139. Single platform
smoothseg on Affymetrix platform was unable to identify the deletion due
to complete lack of probes in the region. (c) A deletion in Chromosome 22
of individual NA19139.
ftp://ftp.ncbi.nlm.nih.gov/hapmap/cnv_data/hm3_cnv_submission.txt
on 20 July 2010); this particular individual NA19139 was found
to have a homozygous deletion in this region. In some cases, a
single platform is unable to detect the CNV due to complete lack
of probes in that region (Fig. 3b).
When signals from different platforms are inconsistent, it is
difficult for the multiplatform method to detect the CNV. Even if the
CNV segments are identified, they are likely to be false positives.
For example, at the FDR threshold of 1e-6, the true discovery rate
for the non-discrepant segments is 15.5% but it is 5.1% for the
discrepant segments. On average, we remove 22 discrepant segments
per individual.
Figure 4 plots the proportion of bases that overlap with Conrad’s
CNVs as a function of total length of CNVs for MPSS and MPCBS.
MPSS has a higher proportion of base overlap with Conrad’s CNVs
as compared to MPCBS. Figure 5, which plots the amount of
overlapping bases as a proportion of Conrad’s CNVs versus the
amount of overlapping bases as a proportion of each method’s
CNVs, also shows the better performance of MPSS as compared
to all the other methods.
3.6 Application: breast cancer data
To demonstrate the applicability of the method for large studies, we
apply the method to samples from the Cancer Hormone Replacement
Epidemiology in Sweden (CAHRES) study, a population-based
study which includes women aged 50–74 years, born in Sweden and
resident there between October 1, 1993 and March 31, 1995 (Li et al.,
2008). A subset of 804 subjects were selected for genotyping on the
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Fig. 4. Proportion of bases that overlap with Conrad’s CNVs as a function
of of the total length of CNVs identified by the method. A higher proportion
of overlap indicates better performance.




































Fig. 5. The number of overlapping bases as a proportion of Conrad’s CNVs
and as a proportion of each method’s CNVs; the different points for each
method correspond to the different thresholds. A higher proportion of overlap
indicates better performance.
made available to us includes lymph node status, tumor size and
histologic grade. Prior to combining data from the two platforms, we
use rsmooth package(http://www.meb.ki.se/∼yudpaw) to perform
background correction with the smoothing parameter set to λ=105.
The background-corrected intensity data is then used as inputs
to MPSS algorithm. We choose the optimal smoothing parameter,
λ based on the AIC criterion. For convenience, the segmentation
threshold is fixed at the 5th and 95th percentile of the intensities
for deletions and duplications, respectively. These are similar to
objectively chosen values in the previous examples. We further filter
out segments with FDR more than 0.01, number of probes less than
10, length of segments less than 1 kb and segments with discrepant
signals from the two platforms.
An average of 14 deletions and 4.5 duplications are identified per
individual. The median length of deletions is 113 kb and that for
duplications is 140 kb. We use the method in Teo et al. (2010) to
form common CNV segments, defined as segments with consecutive
probes where there is at least 0.5% of the subjects (∼4 subjects)
whose individual segments overlap with the probes. We identified
942 common segments (median length of 114.5 kb).
We test each segment for association with tumor size (n=540
with size <2 cm versus n=60 with size >3 cm), lymph node
status (n=242 lymph-node positive versus n=561 negative) and
tumor grade (n=118 grade-1, n=377 grade-2 and n=308 grade-3).
Fisher’s exact test is used to compute the P-values. There are no
significant associations with tumor size. For lymph-node status,
6 segments have P<0.01 (see Supplementary Table T2). Of
notable interest is segment 159 in Chromosome 3 which overlaps
with the protein tyrosine phosphatase, receptor type, G (PTPRG)
gene; overexpression of PTPRG was found to inhibit anchorage-
independent growth and proliferation of breast cancer cells (Shu
et al., 2010). Another interesting segment is segment 845 in
Chromosome 17, which overlaps with the ITGB4 gene, where
studies have shown its expression to be correlated with tumor size
and nuclear grade (Diaz et al., 2005) and significantly association
with basal-like breast cancer (Lu et al., 2008).
Ten segments are associated with tumor grade (see Supplementary
Table T3). Segment 548 in Chromosome 9 overlaps with TPM2
gene, where its protein products were found to be differentially
expressed between tumor and non-tumor forming breast cancer cell
lines (Harris et al., 2002). Segment 691 in Chromosome 11 overlaps
with the PKNOX2 gene, previously shown to be deleted in breast
cancer (Issei et al., 2001).
The 240K array was designed to supplement the 300K array, hence
the probes on the two arrays are non-overlapping. The validation of
the method in the earlier sections was performed on Affymetrix 6.0
and Illumina 1M arrays which have overlapping probes. Here, we
are interested to know if the algorithm works for non-overlapping
platforms. However, we do not have a ‘gold standard’ for CNVs
of these individuals to make comparisons with. Instead, we take
a random sample of non-overlapping 240 000 and 300 000 probes
from the Illumina 1M platform for the 9 HapMap samples and make
comparisons with the reference CNVs in the same way as before. The
true discovery rate and sensitivity for the multiplatform approach is
higher than that of the single platform approach: true discovery rate
of 0.29 for the multiplatform approach, 0.24 for the 300K array and
0.22 for the 240K array. Sensitivity of 0.027 for the multiplatform
approach, 0.027 for the 300K array and 0.017 for the 240K array.
4 DISCUSSION
We have described a new method for identifying CNVs by using
data from multiple platforms simultaneously. This method allows
researchers to come to a formal consensus result when data from
different platforms but for the same individuals are available.
The model assumes a random-effects parameter that is common
to all platforms, meaning that each platform is assumed to have
the same underlying copy-number pattern. We also develop an
objective method to segment the estimated random effects parameter
(which describes the underlying copy-number pattern) into discrete
segments. In addition, we provide a method for calculating a P-value
associated with a segment of interest. The P-value would indicate
how likely that the segment is a deletion/duplication, and is useful
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Background correction is needed to make the data from the
different platforms comparable; we use a robust smoother that
assumes the majority of each chromosome has normal copy-number.
While this assumption is likely to be true for germ-line samples,
it may not hold for cancer/tumor samples. Recently, Bengtsson
et al. (2009) developed a normalization method to bring data from
different platforms to the same scale. The method uses a technique
based on principal curves to estimate the normalization functions.
This method was tested on data from The Cancer Genome Atlas
Research Network and seems to work well on tumor samples where
there is sufficient deletions and duplications in the genome, but
we found that it did not work well with the germ-line samples we
use. When we performed Bengtsson et al.(2009)’s normalization on
our samples, the correlation in the copy-number estimates between
the platforms increased only very slightly after normalization (see
Supplementary Fig. S1 and Table T3). This could be due to
insufficient CNVs in the data for the principal curves to be identified.
We illustrate the performance of MPSS using real and simulated
data sets. In the comparisons using real datasets, we show that MPSS
CNVs has greater amount of overlap with the reference as compared
to the other methods. In the comparisons using simulated datasets,
we show that the proposed method can achieve high sensitivity and
specificity at reasonable noise levels.
In general, for all methods, the proportion of overlapping bases
with the highly comprehensive CNV map published by Conrad
et al. (2010) is low. However, we believe it is due to the limitation
of the SNP arrays rather than the inadequacy of the algorithms.
This was also noted by Zhang et al.(2010) where the authors
investigated and found that in the regions where the reference CNVs
lie, both Affymetrix and Illumina platforms do not have a shift
in the intensities and hence the algorithm would not pick out the
region as a CNV. Moreover, we do not know if the reference list
we have used can be considered the gold standard, since it is not
likely to have 100% sensitivity and specificity. Even sequencing
methods only show between 72.2% and 96.5% specificity (Xie et al.,
2009). The arrival of higher density arrays, for example, the Illumina
HumanOmni2.5 and HumanOmni5 arrays will likely improve the
sensitivity of CNV identification.
Another kind of multiplatform problem arises when there is some
stratification of cohorts by chips; for example, if the cases and
controls were typed on different chips. Differential sensitivity or
false positive rates between the platforms will lead to confounding
bias in the case–control comparisons. The method presented here
assumes that the data from the different platforms are available
for each individual, hence the algorithm could not address this
problem. This is an important and valid concern and warrants further
investigations.
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Table T1: HapMap sample ID and population 








NA19138  YRI 
NA19139  YRI 
Table T2: Regions associated with lymph-node status 
RegID  Chr   Start    End      Length(kb)   CNV type 
134    2   241588064   241694279    106.2       del 
159    3   61836554    61935672     99.1       del 
160    3   71621386    71691966     70.6       del 
348    6   14684833    14729332     44.5       del 
393    6   137998026   138029601    31.6       del 
845    17   71257965    71418529     160.6       del 
 
 
Table T3: Regions associated with tumor status 
RegID  Chr   Start    End      Length(kb)   CNV type 
96    2    64511726   64541950     30.2       del 
368    6    65179566   65463971     284.4        del+dup 
535    9    11609839   12185026     575.2        del+dup 
548    9    35504653   35813009     308.4        del+dup 
615    10    92237989   92460757     222.8        del 
626   10    132460162   132505487    45.3         del 
691    11    124523950   124615799    91.9         del 
713    12    26211854   26258097     46.2         del 
770    15    86475519   86569433     93.9         del+dup 
812    16    88813    152362     63.6         del+dup 
Figure S1: Log R Ratio from Illumina 1M versus Log R Ratio from 
Affymetrix 6.0 before and after normalization for individual NA19139. 
 
Table T3: Correlation* of the log R ratios from the Affymetrix 6.0 and 
Illumina 1M before and after normalization**.  
Subject ID       Before normalization      After normalization 
NA19139          0.051                     0.072 
NA15510          0.027                     0.030 
NA18632          0.020                     0.055 
NA19137          0.028                     0.044 
NA12057          0.021                     0.022 
NA18971          0.033                     0.042 
NA10851          0.045                     0.047 
NA19138          0.021                     0.024 
NA12044          0.016                    -0.018 
NA12056         -0.008                    -0.009 
* The correlation is calculated based on the probes that are 
common to both Illumina1M and Affymetrix 6.0. 
** Normalization done using Bengtsson, H. et al.(2009) 
CORRIGENDUM
Regions of homozygosity in three Southeast Asian
populations
Shu-Mei Teo, Chee-Seng Ku, Agus Salim, Nasheen Naidoo, Kee-Seng Chia and Yudi Pawitan
Journal of Human Genetics (2012) 57, 400; doi:10.1038/jhg.2012.51
Correction to: Journal of Human Genetics (2012) 57, 101–108;
doi:10.1038/jhg.2011.132; published online 1 December 2011
The authors of the above article noted an error in publication of this
paper in Figure 1. The correct figure is shown below.
The authors would like to apologize for the error. This correction
does not affect the rest of the results and their interpretation as





















Figure 1 Number of ROH versus total length of ROHs in each individual.
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ORIGINAL ARTICLE
Regions of homozygosity in three Southeast Asian
populations
Shu-Mei Teo1,2,3,4,5, Chee-Seng Ku1,2,5, Agus Salim2, Nasheen Naidoo1, Kee-Seng Chia1,2,4 and Yudi Pawitan4
The genomes of outbred populations were first shown in 2006 to contain regions of homozygosity (ROHs) of several megabases.
Further studies have also investigated the characteristics of ROHs in healthy individuals in various populations but there are no
studies on Singapore populations to date. This study aims to identify and investigate the characteristics of ROHs in three
Singapore populations. A total of 268 samples (96 Chinese, 89 Malays and 83 Indians) are genotyped on Illumina Human 1M
Beadchip and Affymetrix Genome-Wide Human SNP Array 6.0. We use the PennCNV algorithm to detect ROHs. We report an
abundance of ROHs (X500kb), with an average of more than one hundred regions per individual. On average, the Indian
population has the lowest number of ROHs and smallest total length of ROHs per individual compared with the Chinese and
Malay populations. We further investigate the relationship between the occurrence of ROHs and haplotype frequency, regional
linkage disequilibrium (LD) and positive selection. Based on the results of this data set, we find that the frequency of
occurrence of ROHs is positively associated with haplotype frequency and regional LD. The majority of regions detected for
recent positive selection and regions with differential LD between populations overlap with the ROH loci. When we consider both
the location of the ROHs and the allelic form of the ROHs, we are able to separate the populations by principal component
analysis, demonstrating that ROHs contain information on population structure and the demographic history of a population.
Journal of Human Genetics (2012) 57, 101–108; doi:10.1038/jhg.2011.132; published online 1 December 2011
Keywords: PennCNV; regions of homozygosity; Singapore; Southeast Asian populations
INTRODUCTION
A region of homozygosity (ROH) is defined as a continuous stretch of
DNA sequence without heterozygosity in the diploid state. All genetic
variations such as single-nucleotide polymorphisms (SNPs) or micro-
satellites within the homologous DNA segments have two identical
alleles that create homozygosity.1 Currently, there is no consensus or
standardized criteria to define an ROH. Previous studies focused on
ROHs larger than 1Mb which could have led to an underestimation of
the true extent of homozygosity in the human genome,2,3 whereas more
recent studies define an ROH at a minimum length of 500 kb,4 with
the intention of avoiding this underestimation. This is of relevance as
shorter ROHs are now also thought to be associated with complex
phenotypes.4
The genomes of outbred populations were first shown in 2006 to
contain ROHs of several megabases.2,3,5 Their location is markedly
nonrandom, where different individuals share similar region bound-
aries. Some loci are caused by a single common haplotype, whereas
others are a consequence of several common haplotypes that could be
markedly disparate.6 Several mechanisms for the occurrence of ROHs
have been suggested, including uniparental isodisomy (a chromoso-
mal abnormality where a child inherits two identical copies of a
chromosome from one parent and none from the other) and auto-
zygosity (where a child inherits the same common ancestral haplotype
chromosomal segment from both parents). Studies have found no
significant violation of Mendelian transmission in these areas and
concluded autozygosity as the most likely cause for the majority of
ROHs observed.7,8
Previous studies have also investigated the population character-
istics of ROHs in healthy individuals9–11 and performed association
analyses to identify ROHs that are associated with complex diseases
and traits using a case–control study design.4,12,13 However, the
majority of these studies are conducted on European populations,
and only a few on Asian populations. This study aims to identify and
characterize ROHs in three Singapore populations, and to investigate
their relationship to linkage disequilibrium (LD), haplotype frequency
and positive selection.
Received 21 April 2011; revised 30 September 2011; accepted 24 October 2011; published online 1 December 2011
1Centre for Molecular Epidemiology, National University of Singapore, Singapore; 2Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National
University of Singapore, Singapore; 3NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore and 4Department of Medical
Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
5These authors contributed equally to this work.
Correspondence: S-M Teo, NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore.
E-mail: g0801862@nus.edu.sg
or Dr Y Pawitan, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, 17177 Stockholm, Sweden.
E-mail: Yudi.Pawitan@ki.se
Journal of Human Genetics (2012) 57, 101–108




We use data from the Singapore Genome Variation Project (SGVP),14 where a
total of 292 DNA samples (consisting of 99 Chinese, 98 Malays and 95 Indians)
are genotyped using the Illumina Human 1M Beadchip and the Affymetrix
Genome-Wide Human SNP Array 6.0. The characteristics of copy number
variations of these populations have been investigated and reported.15 The
Chinese, Indians and Malays in Singapore descended from immigrants from
neighboring countries such as China (mainly from southern provinces such as
Fujian and Guangdong), India (majority from south-eastern India), Indonesia
and Malaysia. The detailed information on the sources of DNA samples,
demographic data of the samples, sample selection, and the origin and
migration history of the three Singapore populations have been described in
previous publications.14,15 A total of 268 samples (consisting of 96 Chinese, 89
Malays and 83 Indians) are used in the subsequent analysis after removing
samples on the basis of high rates of SNP missingness (greater than 2%),
excessive heterozygosity or cryptic relatedness by excessive identity-by-states.
Population membership is ascertained on the basis that all four grandparents
belong to the same population, and samples that display either evidence of
admixture or clear evidence of discordance between self-reported and geneti-
cally inferred population membership are excluded.
SNP genotypes are obtained from the SGVP website (http://www.
nus-cme.org.sg/sgvp/). These SNPs have undergone a series of quality control
measures,14 including removing SNPs with SNP missingnessX5% and P-value
o0.001 for a test of departure of Hardy–Weinberg Equilibrium (HWE),
resulting in B1.58 million SNPs per population remaining. Quality control
measures were conducted seperately for each of the populations.
Identification of individual-specific ROHs
Individual-specific ROHs are identified using the PennCNValgorithm16 for the
Illumina and Affymetrix arrays based on the log R ratio and B allele frequency
for each sample. The ROHs identified by PennCNV are copy neutral events,
meaning that one-copy deletions are excluded. We exclude regionso500 kb. To
further filter regions that may be called erroneously by PennCNV, we check the
SNPs genotypes for the number of heterozygous genotypes within the region.
Ideally, we would expect no heterozygous genotypes in the region, but we allow
for some heterozygosity that may be due to genotyping errors or other causes.
We investigate the effect of allowing some heterozygosity on the relationship
between ROH and LD. From a simulation (see Supplementary Methods,
‘Simulation’ section), we observe that ROH detection is very sensitive to
heterozygosity present either due to mutation or genotyping errors, whereas
the LD in the region is largely preserved despite the mutations introduced. By
not allowing any heterozygosity, we miss detecting older ROHs in many
individuals and this affects the formation of the common regions. So, to
capture the LD/haplotype structure using ROHs, it is important to allow a
small percentage of heterozygosity.
We use a binomial probability upper bound to calculate a confidence score
for each region (see Supplementary Methods, ‘Confidence scores
calculation’ section). The confidence score takes into account the amount of
heterozygosity, as well as the SNP density, and is an indication of how confident
we are that the ROH is true. In general, the confidence scores for regions
detected by the Affymetrix platform are lower than that detected by the
Illumina platform (see Supplementary Methods Figure S1). We decide to use
the Illumina platform with more than 1 million SNPs for ROHs detection but
still use the combined genotypes from 1.58 million SNPs from both platforms
in the calculation of confidence scores. Several summary statistics are computed
to describe and compare the characteristics of ROHs in the three Singapore
populations.
Identification of common ROHs
We identify common ROH loci using a previously published method.17
We define common loci as regions with consecutive probes where at least
5% of the subjects (that is, 13 subjects) have individual regions that overlap
with the probes. Occasionally, individual regions within a common locus can
show considerable variations in their boundaries, resulting in a heterogeneous
region. To refine the identified common loci, we form clusters of regions by
requiring all individual regions within a cluster to overlap by at least 80%. For
each common locus, individual regions are said to be concordant if it overlaps
with at least 80% of the length of the locus. Common loci witho2 concordant
individuals or o500 kb or having a SNP density o0.2 (SNP per kb) are
discarded. The common loci are further refined as the intersection of the
concordant regions. We perform population comparisons and test of departure
of HWE for each locus. For each set of tests, we account for multiple
comparisons using the false discovery rate,18 with results or discoveries
considered interesting at false discovery rate of o0.01.
Quantification of regional LD
The two most widely used measures to quantify the amount of LD
between two markers are the D¢ and r2 statistics.19 Here, instead of LD
between two markers, we are interested in the amount of LD in a region.
For all SNPs in a region, we calculate the pairwise D¢ (and r2). We perform
eigenvalue decomposition on the D¢ (r2) matrix and calculate the
percentage explained by the first eigenvalue (y). This percentage will take
values between 100/n and 100, where n is the number of (polymorphic) SNPs
in the region. To make the percentages comparable across regions with different
number of SNPs, we scale it such that the value varies between 0 and 1. So,
y*¼(y–100/n)/(100–100/n). The higher the value of y*, the stronger the LD in
the region.
Haplotypes in ROH loci
For each common locus, we use phased genotypes (using the program
fastPHASE version 1.3, see Supplementary Methods in Teo et al.14 for details
on the choice of parameters for phasing) to determine the different haplotypes
present in the three populations. To reduce the dimension of the data, we
consider only the top three most frequent haplotypes and combine the
others as ‘other haplotypes’, that is, we categorize each region into four alleles
(top three most common haplotypes and ‘other’ haplotypes). Each individual
has two alleles for each region. For convenience, we will refer to the alleles as A,
B, C and D.
Identification of regions with differential LD between populations
We use a previously published method, varLD,20,21 to identify regions with
differential LD between populations. Briefly, the method tests for equality
between two LD matrices for a user-defined window size, shifting each
window one SNP at a time. We calculate the varLD score for a window size
of 50 SNPs for the signed r2 matrices.21 For each pair of populations, a region is
considered to have differential LD if consecutive positions are above the 95th
percentile of the genome-wide varLD score. We restrict to regions4500 kb for
comparison with ROHs. We exclude the region if it overlaps by 450% with
copy number variations previously reported for the same set of individuals,14 as
LD measures for regions that encapsulate copy number variations may not be
reliable.21
RESULTS
Summary statistics of individual ROHs
We discard regions whose confidence scores are below the 25th
percentile of the confidence scores. Table 1 summarizes the character-
istics of ROHs. On average, the Indian population has lower number
of ROHs compared with the Chinese and Malay populations. There is
wide inter-individual difference in the number of ROHs, which ranges
from 98 (sample 334_01 and 461_01) to 241 (sample 81_01). More
than 80% of the ROHs areo1Mb in length. The largest ROH spans a
length ofB68.5Mb, and is detected in one Indian individual (sample
408_01) in Chromosome 3. A total of 32 ROHs larger than 10Mb are
detected (Table 2). Interestingly, three Indian samples (397_01, 290_01
and 408_01) have five or more of these ‘extremely long’ ROHs.
Figure 1 plots the number of ROHs versus the total length of ROHs
in each individual. We see clusters of the three populations, indicating
that number and length of ROHs differ among populations. This
result was also observed by Kirin et al.22
ROHs in three Southeast Asian populations
S-M Teo et al
102
Journal of Human Genetics
Summary statistics of common ROHs
We identify 1256 common ROH loci in all three populations (Sup-
plementary Table 1), where 90% of the loci overlap with UCSC genes
(http://genome.ucsc.edu/), and 292 (23%) overlap with genes listed in
the Online Mendalian Inheritance in Man Morbid Map (ftp://
ftp.ncbi.nih.gov/repository/OMIM/ARCHIVE/morbidmap). For each
locus, we test for differences among the three populations in terms of
ROH frequencies and haplotype frequencies, and 47 loci (o4%) differ
significantly in frequencies while 899 loci (69%) differ significantly in
haplotype frequencies among the populations. Approximately 52% of
the loci are detected in 45% (more common ROH loci) of indivi-
duals (Figure 2). Figure 3 shows the length distribution of the ROH
loci; B78% of the ROH loci are p1Mb, and majority of the long
ROH loci (41Mb) are in the range of 1–2Mb. The proportion of the
genome that is in the different ROH length categories differs among
the three populations (Figure 4). The Chinese and Malays have more
ROHs of shorter lengths compared with the Indians, while the Indians
have more ROHs in the longer length categories (44Mb).
We compare the common loci we found to that published in
previous studies.10,23 Two regions are defined to overlap if the regions
have a reciprocal overlap of at least 50%. Nothnagel et al.’s study10
surveys ROHs in Europeans; we found that all 10 regions listed as
‘ROH islands’ (meaning they have a high population frequency) in
their study overlap with an ROH loci found in this study, suggesting
Table 1 Characteristics of ROHs in three Singapore populations
(using 1029591 SNPs from the Illumina 1M platform)
Characteristics Chinese (n¼96) Malay (n¼89) Indian (n¼83)
Number of ROHs per individual
Mean 207 179 126
Median 206 178 127
Minimum 157 123 98
Maximum 241 228 173
Length of ROHs (in kb)
Mean 800.9 806.1 879.6
Median 670.5 672.8 666.3
Maximum 23230 21850 68500
Total length of ROHs per individual (in Mb)
Mean 166.1 144.6 111.2
Median 165.7 143.4 100.5
Minimum 115.4 90.49 73.91
Maximum 195.4 191.9 315.6
Size distribution of ROHs (proportion, %)
500kb–1 Mb 83.0 82.5 83.5
X1 Mb 17.0 17.5 16.5
Abbreviations: ROHs, regions of homozygosity; SNPs, single-nucleotide polymorphisms.
Table 2 ROHs larger than 10Mb
Chromosome Start End Length Sample Ethnicity
1 120 837 663 143 420 875 22583 213 108_01 Chinese
6 3 217 193 26449 280 23232 088 17_01 Chinese
16 34 034 376 45968 704 11934 329 131_01 Chinese
1 120 837 663 143 420 875 22583 213 218_01 Chinese
8 41 842 707 52102 021 1 025 9315 465_01 Malay
1 94 915 135 108 531 282 13616 148 174_01 Malay
11 19 924 676 41772 573 21847 898 174_01 Malay
1 67 073 684 90862 713 23789 030 290_01 Indian
3 175 758 479 190 839 635 15081 157 290_01 Indian
4 41 334 756 55223 410 13888 655 290_01 Indian
6 112 768 454 147 227 544 34459 091 290_01 Indian
11 86 911 515 131 748 067 44836 553 290_01 Indian
14 71 970 357 88634 741 16664 385 290_01 Indian
17 152 362 10559 477 10407 116 290_01 Indian
3 102 253 981 170 758 820 68504 840 408_01 Indian
6 79 661 14549 208 14469 548 408_01 Indian
6 121 892 269 132 743 942 10851 674 408_01 Indian
13 52 267 631 77893 750 25626 120 408_01 Indian
13 78 497 109 94452 168 15955 060 408_01 Indian
22 37 722 142 49582 267 11860 126 408_01 Indian
13 74 778 668 100 318 094 25539 427 367_01 Indian
3 158 294 635 169 108 914 10814 280 361_01 Indian
6 90 065 419 106 409 967 16344 549 397_01 Indian
7 28 668 234 43132 968 14464 735 397_01 Indian
7 80 118 053 105 839 742 25721 690 397_01 Indian
8 590 729 10908 015 10317 287 397_01 Indian
9 33 415 385 45059 163 11643 779 397_01 Indian
9 66 448 030 100 731 809 34283 780 397_01 Indian
10 121 636 24722 946 24601 311 397_01 Indian
15 63 308 076 73720 143 10412 068 397_01 Indian
7 9 983 924 21830 396 11846 473 76_01 Indian
13 47 337 000 72862 520 25525 521 76_01 Indian
Abbreviations: ROHs, regions of homozygosity.
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that these regions are not specific to Europeans (see Supplementary
Methods Table S1). The population frequencies of these ROHs in our
populations differ from that reported in Nothnagel et al.’s study,10 but
formal testing is inappropriate as the methods used to calculate the
frequencies are different.
Auton et al.’s study23 surveys ROHs in Mexicans, Europeans, East
Asians and South Asians; we found that out of 34 high-frequency
ROHs (defined as being found in at least 10% of individuals within
a population) 11 overlap with an ROH locus found in our study
(see Supplementary Methods Table S2). All the regions that overlap
are found in the East Asian population, except for one region in
Chromosome 4, which is present in all populations. The frequencies of
these ROHs are, however, quite low in our population (1–4%).
Association with haplotype frequency and regional LD
Figure 5 shows that the frequency of an ROH is positively associated
with the total frequency of the top three haplotypes (correlation of
0.69), and Figure 6 shows that as the frequency of an ROH increases,
so does yD¢ and yr2 (figure is shown for the Malay population,
similar figures for the Chinese and Indians are shown in Supplemen-
tary Methods Figures S2 and S3). If we assume random mating, the
homozygosity of any region will be high when there are few haplotypes
present at high frequency, thus it reinforces autozygosity as the
mechanism for the occurrence of an ROH. These empirical results
suggest that there is positive correlation between the frequency of an
ROH and the frequency of the common haplotypes, and also between
the frequency of an ROH and LD in the region.
Frequency of ROHs and frequency of haplotypes within ROHs
To assess if there is a difference in the location and frequency of ROHs
among the populations, we perform principal component analysis




















Figure 1 Number of ROH versus total length of ROHs in each individual.
A full color version of this figure is available at the Journal of Human
Genetics journal online.


























































Figure 3 Percentage of ROH loci in the respective length classes.
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Figure 4 Percentage of ROH loci in the respective length classes. A full
color version of this figure is available at the Journal of Human Genetics
journal online.
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(PCA) using absence/presence of the common ROH loci. For each
individual, we check if that individual has an ROH that is concordant
with the common ROH. We can view the matrix input for the PCA
analysis as a matrix of 1’s and 0’s where each row corresponds to an
individual and each column corresponds to a common loci, so that
the (i, j) entry indicates whether individual i has a concordant ROH at
locus j. From Figure 7, we see that the Indians are quite well separated
from the Chinese and Malays, and that there is some separation
between the Chinese and Malays. This implies that the location and
frequency of occurrence of ROHs differ among populations.
However, interestingly, populations can share the same (or similar)
ROH location, but the common haplotypes driving the ROH can be
markedly disparate. One example is a 700-kb ROH in Chromosome
16 (location 30,438,046–31,137,964) that overlaps with the Vitamin K
epoxide reductase complex subunit 1 (VKORC1) gene (location
31,009,956–31,013,551). Genetic polymorphisms within the gene
have been found to correlate with differences in warfarin dosage
and response in many studies.24–26 In the Singapore populations,
the Indians were observed to display warfarin resistance, thus requir-
ing a higher dose as compared with the Chinese and Malays.26–29
There is no significant difference in ROH frequencies among the
populations (ROH frequencies of 21, 13 and 20% for the Chinese,
Malays and Indians, respectively). However, if we examine the
haplotypes in this region, there is significant difference. Fisher’s
exact test performed on the frequencies of the top three most frequent
haplotypes results in a P-value o10–6. In particular, the difference in
haplotype frequencies of the Indians differs markedly from the
Chinese and Malays. This is highlighted in Table 3, where haplotype
A dominates in the Chinese and Malays but is almost absent in the
Indians, while haplotype B dominates in the Indians but is almost
absent in the Chinese and Malays. Haplotypes A and B differ at 104
locations out of the 158 SNPs in this region.
We also perform PCA on the allele counts of the haplotypes as
described in the section ‘Haplotypes in ROH loci’. The first two
components separates the Indians from the Chinese and Malays while
the third component further separates the Chinese from the Malays
(see Figure 8). This suggests that ROH loci contain much genetic
ancestral haplotype information of a population.
Testing departure from HWE
Using the estimated frequencies of the top three haplotypes, we are
able to calculate the expected frequencies of the corresponding
genotypes. For the observed frequencies, we use the unphased geno-
types. For each individual, we can identify the haplotypes without
phase information when all the SNPs in the region are homozygous
(removing SNPs where we had allowed heterozygosity in the detection
















Figure 5 Frequency of ROH loci versus total frequency of top three
haplotypes.









































Figure 6 Regional LD versus frequency of ROH based on (a) D¢ matrix and (b) r2 matrix. These results are based on the Malay population.






















Figure 7 Principal component 2 versus principal component 1 using
absence/presence of 1256 common ROHs. A full color version of this figure
is available at the Journal of Human Genetics journal online.
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of ROH). With that, we are able to obtain observed frequencies for the
(A, A), (B, B) and (C, C) genotypes. We use the w2 test with three
degrees of freedom to test if there is departure of the observed from
the expected. A large majority of ROH loci (492%) adhere to HWE,
suggesting that assumptions of autozygosity and random mating are
true for most ROH loci. Of the regions that show departure from
HWE (false discovery rateo0.01), majority show excess homozygos-
ity than would be expected. The reasons for departure from HWE are
not immediately clear, and could be due to various reasons such as
positive selection (see section ‘Comparison with regions associated
with positive selection’) or nonrandom mating.
Comparison with varLD
As described in the section ‘Identification of regions with differential
LD between populations’, we identify 16, 10 and 13 regions with
differential LD variation between the Chinese and Indian populations,
Malay and Indian populations, and Chinese and Malay populations,
respectively. Of the 16 regions, 14 overlap with a common ROH and
10 out of 14 show significant differences in haplotype frequency
between the Chinese and Indian populations. Of the 10 regions, 7
overlap with a common ROH and 7 out of 7 show significant
differences in haplotype frequency between the Malay and Indian
populations. Of the 13 regions, 8 overlap with a common ROH and 8
out of 8 show significant differences in haplotype frequency between
the Chinese and Malay populations.
We observe that the majority of regions (74%) that show LD
differences between populations correspond to regions where ROHs
are observed, and furthermore, the haplotype frequencies in these
regions differ between the populations. These results indicate that
ROH patterns explain a large proportion of LD variations.
Comparison with regions associated with positive selection
We investigate if the regions detected for recent positive natural
selection overlap with ROHs. We consider the top 10 candidate
regions for recent positive selection in each of the populations, as
published in a previous study.14 These regions were detected based on
the clustering of SNPs with high integrated haplotype score.30 Out of
the 30 regions considered, 28 regions overlap with a common ROH
defined in this study, with 20 regions completely within an ROH and
the other 8 regions with a high percentage of overlap (at least 60%).
This suggests the occurrence of ROHs as a possible consequence of
positive selection, where the positively selected haplotypes rise to a
high frequency, resulting in a high possibility of ROHs due to
autozygosity.
Out of the 28 regions, 10 of them overlap with an ROH that failed
HWE. Performing Fisher’s exact test on a 2 by 2 table with indicators
for departure from HWE and indicators for positive selected regions
as rows and columns, we obtain an odds ratio of 1.89 (P-value¼0.05).
The departure from HWE may be a consequence of positive selection.
An ROH that has a higher frequency than would be expected for its
length may also be an evidence of positive selection (see Supplemen-
tary Methods Figure S8).
Effect of heterozygosity on the relationship between ROH and LD
When we filter the individual regions using a stricter confidence
threshold of the 75th percentile (that is, allowing less heterozygosity),
we identify 414 common regions, but the relationship of these regions
with haplotype frequency, regional LD and positive selection is weak
(see Supplementary Methods Figures S4 and S5 and section Compar-
ison with VarLD (results based on these 414 common regions)). We
also see poorer separation of the populations by PCA, but this is likely
due to the fewer number of common regions identified. At the 25th
percentile threshold, the percentage of heterozygosity is still kept low
at o5% for a large majority of the regions (See Supplementary
Methods Figure S9). With an overly strict confidence score threshold,
many regions are omitted and this decreases the number of common
regions formed from 1256 to 414. Allowing for some heterozygosity
within the regions allows detection of older ROH loci (heterozygosity
caused by recent recombination or mutation), which have a stronger
relationship with LD and positive selection (see Simulation section in
Supplementary Methods).
DISCUSSION
In summary, this study identifies and investigates the population
characteristics of ROHs in three Singapore populations, Chinese,
Malay and Indian. We report an abundance of ROHs, with an average
of 4100 ROHs per individual. On average, the Indians have lower
numbers and total length of ROHs per individual than the Chinese
and Malays, possibly indicative of a larger founder population.
However, there are several Indians with multiple large ROHs, suggest-
ing that they may be offsprings of parents who are close relatives. In
India, consanguineous marriages are more prevalent in the South,
especially in Tamil Nadu, from where many Singapore Indians
descended. From the Consanguinity/Endogamy Resource (http://
www.consang.net/index.php/Main_Page), data from a 1982 study
have shown the prevalence of consanguineous marriages among
Singapore Indians to be 4% compared with only 0.3% in Singapore
Chinese. Published data have shown that the number of ROHs of
several megabases increase markedly in the offsprings of consangui-
neous marriages,3,24 with an average of 6.25% homozygosity expected
in the genome of the offsprings of first cousin marriages.7 Li et al.3
have shown that in a family with four children from first cousin
Table 3 Haplotype frequencies of three populations in a ROH in
Chromosome 16 that overlaps with VKORC1
Haplotype A Haplotype B Haplotype C
Chinese 0.31 0.0052 0.099
Malay 0.28 0.045 0.10
Indian 0.0060 0.34 0
Abbreviation: ROH, region of homozygosity.













Figure 8 Results of PCA on haplotype frequencies of ROH regions. A full
color version of this figure is available at the Journal of Human Genetics
journal online.
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marriages, multiple ROHs ranging from 3.06 to 53.17Mb were
observed in all the children. Woods et al.24 have also shown a marked
increase in homozygosity levels in individuals with a recessive disease
whose parents were first cousins, where, on average, 11% of their
genomes were homozygous.
In addition, we identify 1256 common ROH loci, and investigate
the occurrence of ROHs and haplotype frequency, regional LD and
positive selection. Based on the results for this data set, we find that
the frequency of occurrence of ROHs is positively associated with
haplotype frequency and regional LD. The preferential occurrence of
ROHs in regions of high LD and low recombination has also been
observed in other studies.10 The majority of regions detected for recent
positive selection and regions with differential LD between popula-
tions overlap with ROH loci. By considering both the location of the
ROH and the allelic form of the ROH, we are able to separate the
populations by PCA, demonstrating that ROHs contain information
on population structure and the evolutionary and demographic
history of a population.
The ability of genome-wide SNP markers for population structure
analysis has been widely acknowledged. Here, we are not proposing
the superiority of ROHs in population structure analysis. It is expected
that using genome-wide SNP data allows very good separation of
populations through PCA because of the amount of information it
contains (see 14 for PCA analysis using SNPs on the same population
samples). In this paper, we have shown that it is possible to distinguish
populations using just B1000 segments of the genome. Compara-
tively, if we were to choose 1000 random segments of the genome and
perform a similar analysis, we would not obtain as good a separation
as with ROHs (see Supplementary methods Figure S7). The unique
characteristics of ROHs allow us to study common haplotypes
conveniently; it is complementary to SNP-based analysis. In SNP-
based analysis, we simply compare SNP-level frequencies between
populations but in ROH-based analysis, we are able to capture
differences in LD or haplotype structures.
Majority of the ROH loci overlap with known genes but their
association with complex phenotypes is still rudimentary. This war-
rants further characterization of ROHs in different populations,
investigation of their roles in the genetics of complex phenotypes
and further studies of population evolutionary genetics. These future
studies will be of importance given the abundance of ROHs in the
human genome and the differences of ROHs between populations.
A sufficiently large number of SNPs is required to accurately detect
ROHs.1,2 To this end, we have used two highly dense SNP arrays
(Illumina 1M and Affymetrix 6.0) with 41.58 million unique SNPs.
Using a confidence score metric that takes into account percentage of
heterozygosity as well as the number of SNPs in the region, we discard
individual regions whose confidence scores are below the 25th
percentile of the confidence scores. We use the PennCNV algorithm
that relies on signal intensity data to detect putative ROHs. We then
filter out false positives by checking SNP genotypes within the ROH.
To our knowledge, most studies on ROHs use only SNP genotypes,
but this approach may produce false positives caused by hemizygous
deletions. On the other hand, due to the noise in signal intensity data,
the regions called by PennCNV could also result in false-positive
regions. We feel it is important to use a combination of the methods
(that is, signal intensity data and genotype data) to minimize false-
positive rates.
We also use PLINK, a widely used software for ROH detection, on
genotypes from both platforms using the following parameters: 500 kb
window with two heterozygous SNPs allowed, minimum length of
500 kb, 50 SNPs as minimum number of SNPs and minimum density
of 1 SNP per 10kb. We find that 75% of the regions found by
PennCNV are detected by PLINK, suggesting that the results of the
analysis will likely give similar conclusions using PLINK. A formal and
systematic comparison of multiple algorithms for ROH detection will
be interesting.
Potential biases in the detection of ROHs include false-negative
regions due to ascertainment bias in SNP selection for the SNP
arrays and false-positive regions due to the lack of minor allele
frequency (MAF) criterion applied before the identification of
ROHs. With regards to the former, SNPs from genotyping platforms
are mostly tagged SNPs from the HapMap project, so populations
that were not analyzed in the HapMap project will have less chance
of their population-specific SNPs being included in the array.
However, both the Illumina 1M and Affymetrix 6.0 arrays have a
high marker density and uniformity. With regards to the later, we
do not expect our results to be affected considerably by not filtering
SNPs with low MAF, for several reasons. First, we have very dense
SNP genotyping data of 41.58 million SNPs, and as an ROH is
defined as a region of consecutive homozygosity of 4500 kb, it is
unlikely that there exists a large number of consecutive low-MAF
SNPs that cause a false-positive identification. In any case, these
monomorphic/near monomorphic SNPs are uninformative and
would not affect the haplotype analyses. It is of concern if the region
is detected because the monomorphic/low-MAF SNPs are genotyped,
whereas other SNPs present in the region are missed (due to
ascertainment bias). However, as ROH detection is not reliant on a
single SNP, but on many consecutive homozygous SNPs in a 500 kb
region, we do not expect either issue to be of serious concern.
Some studies23 have adopted the strategy of removing SNPs in high
LD before defining an ROH (that is, thinning the data set but
requiring a lower number of SNPs for the definition of ROH).
However, we found poor correlation between the frequency of the
ROHs we identified and the mean or median pairwise D¢ or r2
statistics (for SNPs within the ROH, up to 250 kb apart, see Supple-
mentary Methods Figure S6), meaning that a SNP being in high LD in
the vicinity is not sufficient for its inclusion in an ROH, and a SNP in
low LD is not sufficient for its exclusion in an ROH.
In conclusion, our study is one of the first to describe the
population characteristics of ROHs in the three Singapore populations
(Chinese, Malay and Indian). Our results are in support that
ROHs contain population demographic and ancestral haplotype
information.
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Supplementary Methods for 
Regions of homozygosity in three Southeast Asian populations 
Shu-Mei Teo, Chee-Seng Ku, AgusSalim, NasheenNaidoo, Kee-Seng Chia, YudiPawitan 
Simulation 
We perform a simulation study to investigate the effect of allowing/ not allowing heterozygosity 
in defining ROHs. We pick a 70 SNP ROH locus with 29 haplotypes whose observed 
frequencies are 31%, 23%, 16%, 10%, 6% and so on. We randomly sample a pair of haplotypes 
for each of 1000 individuals from the 29 haplotypes with the above mentioned frequencies. We 
repeat the process 100 times. Using the same definition of regional LD (based on D’, see main 
manuscript), we obtain an average ROH frequency of 19% and an average regional LD of 
81.9%.  
Next, we introduce three mutations per haplotype such that the total number of haplotypes is now 
58. The new haplotypes have frequencies that are 10% of their ‘parent’ haplotype from which 
they mutated from. Thus, the frequencies of the parent haplotypes decrease to 90% of their 
original frequencies. With this set of new haplotypes, we get an average ROH frequency of 16% 
and an average regional LD of 80.8%. When we repeat the procedure but increase the new 
haplotype frequencies to 20% of their ‘parent’ haplotype, ROH frequency dropped to 13% while 
regional LD remains high at 79%. From this simulation, we observe that ROH detection is very 
sensitive to heterozygosity present either due to mutation or genotyping errors, whereas the LD 
in the region is largely preserved despite the mutations introduced. By not allowing any 
heterozygosity, we miss detecting older ROH in many individuals and this affects the formation 
of the common regions. So, to capture the LD/haplotype structure using ROHs, it is important to 
allow a small percentage of heterozygosity.  
 
Confidence scores calculation 
For each individual ROH region identified by PennCNV, let n be the number of SNPs within the 
region. Let x  be the number of heterozygous calls among the SNPs within the region, and 
assume ~ ( ; )x Binomial n p , where p is the unknown probability of observing a heterozygous 
SNP genotype within an ROH region. Then, the upper bound for p at 0.1   can be calculated 
by solving the equation: 
 
0
( ) ( ) (1 ) 0.05
x
n i n i
i
i
P X x p p 

   
 We use log( )c p  as a confidence score; the higher c  is, the more likely the called ROH 
region is a true ROH.  
From Figure S1, we see that in general, regions identified on the Affymetrix platform have lower 
confidence scores as compared to those identified on Illumina platform. Taking only regions 
whose confidence scores are above the 25
th
 percentile of the confidence scores, Affymetrix 
platform detects 71522 ROHs of which 57% are also detected on Illumina platform. Illumina 
detects 46402 ROHs of which 89% are detected on Affymetrix platform. When we increase the 
confidence cut off to the 75
th
 percentile, Affymetrix detects 7289 ROHs, of which 97% are also 
detected on Illumina platform. Illumina detects 15432 individual ROHs of which more than half 
are not detected on Affymetrix platform. This means that majority of Illumina regions at low 
confidence cut off are detected by Affymetrix, and at high confidence cut off, Illumina platform 
detects almost all of what Affymetrix platform can detect and about 7000 more ROHs that 
Affymetrix platform is unable to detect.  
Regions not detected by Affymetrix platform may be due to low SNP density in the Affymetrix 
array in those regions or due to higher noise levels in the intensity data resulting in lower 
sensitivity in detection. We decide to use Illumina as our platform for detection but still use the 
combined genotypes from both platforms in the calculation of confidence scores.  
 
 
Figure S1: Boxplots of confidence scores of individual ROH regions detected by Affymetrix and Illumina platforms. 
Plots of regional LD versus frequency of ROH for Chinese and Indian populations 


































































Figure S2: Regional LD vs. frequency of ROH based on a) D’ matrix b) R2 matrix for Chinese population 
 
































































Figure S3: Regional LD vs. frequency of ROH based on a) D’ matrix b) R2 matrix for Indian population 
 
Results based on 414 common regions (when individual regions are filtered at the 75
th
 
percentile confidence score cut off) 
















































Figure S4: Principal component 2 vs. principal component 1 using absence/presence of 414 common ROHs. 
 





































Figure S5: Frequency of ROH loci vs. total frequency of top 3 haplotypes for 414 common ROH loci 
 
Comparison with VarLD (results based on 414 common regions) 
Out of 39 regions with differential LD, 11 overlap with a ROH locus, as compared to 29 regions 
which overlap with a ROH loci when we used a less stringent confidence cut off to identify 
common ROH regions (see main manuscript).  
Comparison with regions associated with positive selection (results based on 414 common 
regions) 
Out of 30 positively selected regions, 10 overlap with a ROH locus, as compared to 28 regions 
which overlap with a ROH loci when we used a less stringent confidence cut off to identify 
common ROH regions (see main manuscript). 
 
Table S1: Regions which overlap with ‘ROH islands’ found in Europeans (from 
Nothnagelet al., 2010’s study) 
Regions from Nothnagel Regions from thisstudy 
Chr Start End Start End Numberof Total (%) 
Indians Chinese Malays 
14 65754607 66956534 65758913 66794163 20 23 18 21.3 
4 33305316 34167260 33400308 34604048 4 7 7 6,3 
3 50382348 51835857 50936680 51979357 10 11 8 10.1 
12 110249612 111461573 110613553 111448453 21 45 26 32.1 
1 35023369 36505444 35201015 36357664 17 2 1 7.0 
5 129845818 131423014 129573162 130581277 7 10 5 7.7 
11 47998479 49391209 46931701 48858129 3 3 2 2.8 
16 65360598 66845475 65280236 66985827 7 16 7 10.5 
16 46391563 46826430 46509288 47291485 2 16 4 7.7 
10 74211870 75086795 74460386 74990059 22 29 23 25.8 
 




Regions from thisstudy 




Indians Chinese Malays 
1 15380 17401 E.Asia 15960 17101 1 1 2 1.4 
2 176872 177858 E.Asia 177149 178254 0 3 1 1.4 
3 43179 45125 E.Asia 44110 45092 1 8 3 4.2 
4 32251 34658 Europe 32994 34443 3 4 3 3.5 
4 32251 34826 Mexico 32994 34443 3 4 3 3.5 
4 32528 34431 S.Asia 32994 34443 3 4 3 3.5 
4 32555 34431 E.Asia 32994 34443 3 4 3 3.5 
4 158335 160168 E.Asia 158098 159384 1 1 1 1.0 
10 21520 23314 E.Asia 21679 23079 4 2 2 2.8 
15 61190 64122 E.Asia 61487 63420 0 1 2 1.0 










Table S3: ROH loci with above 30% population frequency 
Chr Start End Length No. of indiv. (%) 
3 48656057 49679991 1023935 140 (52.2) 
3 49384708 50133778 749071 115 (42.9) 
17 55785079 56526387 741309 105 (39.2) 
1 28443393 29001138 557746 103 (38.4) 
15 62134999 62858424 723426 97 (36.2) 
12 98743338 99292958 549621 93 (34.7) 
12 110613553 111448453 834901 92 (34.3) 
1 8341341 8813712 472372 89 (33.2) 
1 50538569 51263192 724624 88 (32.8) 

















 Mean and median pairwise D’/R2 for SNPs within each ROH region 





















































































Figure S6: Mean and median pairwise D’/R2 for SNPs within each ROH region (D’/R2 calculated up to a distance of 
250kb from each SNP). Results shown here are for the Chinese population.  Every SNP with minor allele frequency 
≥v5% has a chance to bedefined as the focal SNP and for each focal SNP, we compute the LD between the focal 
SNP and all otherSNPs with MAF ≥N5% that are found within 250kb upstream and downstream of the focal SNP. 
 
PCA using random non ROH regions 





















Figure S7: Results of PCA on haplotype frequencies of ROH regions (Based on 1256 random non-ROH regions) 
Positive selection 





























Figure S8: An ROH that has higher frequency than would be expected for its length may also be evidence of 
positive selection. For example, if we draw an arbitrary line on the plot of frequency of ROH vs. length of ROH, 
such that points above the line are suggestive of possible candidates of positive selection. 54/544(10%) of the points 
above the line overlaps with a region found to be positively selected, while only 15/712(2%) of the points below the 
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ABSTRACT 
Motivation: Analysing next-generation sequencing (NGS) data for 
copy number variations (CNVs) detection is a relatively new and 
challenging field, with no accepted standard protocols or quality- 
control measures so far. There are by now several algorithms de-
veloped for each of the four broad methods for CNV detection using 
NGS, namely the depth of coverage (DOC), read-pair (RP), split-
read (SR) and assembly-based (AS) methods. However, due to the 
complexity of the genome and the short read lengths from NGS 
technology, there are still many challenges associated with the 
analysis of NGS data for CNVs, no matter which method or algo-
rithm is used.   
Results: In this review, we describe and discuss areas of potential 
biases in CNV detection for each of the four methods. In particular, 
we focus on issues pertaining to (1) mappability, (2) GC-content 
bias, (3) quality-control measures of reads, and (4) difficulty in identi-
fying duplications. To gain insights to some of the issues discussed, 
we also download real data from the 1000 Genomes Project and 
analyse its DOC data. We show examples of how reads in repeated 
regions can affect CNV detection, demonstrate current GC correc-
tion algorithms, investigate sensitivity of DOC algorithm before and 
after quality-control of reads and discuss reasons for which duplica-
tions are harder to detect than deletions.  
  
Contact: g0801862@nus.edu.sg, agus_salim@nuhs.edu.sg  
1 INTRODUCTION  
Copy number variations (CNVs) are an important and abundant 
source of variation in the human genome, encompassing a greater 
proportion of the genome as compared to single nucleotide poly-
morphisms (SNPs); an estimated 1.2% of a single genome differs 
from the reference human genome when considering CNVs, as 
compared to 0.1% by SNPs (Pang et al., 2010). In the last several 
years, SNP arrays and array comparative hybridization (aCGH) are 
commonly used for detection of CNVs, albeit with relatively low 
resolution especially in terms of breakpoint determination. Sanger 
sequencing of paired reads, often seen as the gold standard for 
CNV detection, is able to detect CNVs with higher accuracy and 
resolution, to detect balanced rearrangements such as inversions 
and translocations, as well as to detect CNVs in regions where 
  
*To whom correspondence should be addressed.  
probe density of other platforms, such as SNP arrays, is low. How-
ever, the technique is not feasible for a large number of genomes 
due to time and budget constraints. Next-generation sequencing 
(NGS) or also known as high-throughput sequencing (HTS) at-
tempts to combine the benefits of array technology and sequenc-
ing. The biggest advantage of NGS over traditional Sanger se-
quencing is the ability to sequence millions of reads in a single run 
at a comparatively inexpensive cost (Metzker, 2010). However, 
due to the complexity of the genome and the short read lengths 
(usually 35-400bp) from NGS technology, there are still many 
challenges associated with the analysis of NGS data for CNVs, no 
matter which method or algorithm is used.  
The growing popularity and success of NGS is evident from 
large scale projects such as the 1000 Genomes Project 
(http://www.1000genomes.org/), which aims to sequence at least 
1000 individuals from different populations around the world in 
order to construct a detailed map of genetic variations in the hu-
man genome (The 1000 Genomes Project Consortium, 2010). Thus 
far, in its pilot phase, the project has identified approximately 15 
million SNPs, 1 million short indels and more than 20,000 struc-
tural variations (SVs), most of which were previously unreported 
(about 61% of deletions and 89% of duplications are novel). The 
average SV size detected by the study was 8 kb, approximately 
four times smaller than a recent SV detection study using tiling 
CGH array (Conrad et al., 2010). SVs include dosage-alterating 
variants such as CNVs (usually defined as deletions and insertions 
larger than 1Kb) and shorter indels, as well as dosage-neutral 
variants such as inversions and translocations. 
Nevertheless, current analytical methodologies to analyse NGS 
data for CNVs are not yet mature and there are no well-established 
pipelines/protocols/quality-control measures. Broadly, there are 
four methods for CNV detection using NGS data, namely (1) depth 
of coverage (DOC, or also known as read-depth (RD) methods), 
(2) paired-end mapping (PEM, or also known as read pair (RP) 
methods), (3) split-read (SR) and (4) assembly-based (AS) meth-
ods (Alkan et al., 2011). The different methods are usually com-
plementary to one another as the underlying concepts excel at 
detecting certain types of variants, and a large proportion of dis-
covered variants remain unique to a particular approach (Alkan et 
al., 2011). For example, in the 1000 Genomes Project CNV analy-
sis, the group applied various variations of the four methods with a 
2 
 
total of 36 call sets with vastly varying degrees of false discovery 
rates (FDR <10% - 89%), as well as notable differences in terms of 
genomic regions ascertained, CNV size range and breakpoint 
precision among the different methods (Mills et al., 2011). This 
review paper highlights and investigates challenges encountered 
when analysing NGS data for CNVs. In particular, we focus on 
issues pertaining to (1) mappability, (2) GC-content bias, (3) quali-
ty-control measures of reads, and (4) difficulty in identifying du-
plications. Since the characteristics of CNVs in germline and 
tumour cells are different, we caution that this review focuses 
largely on CNVs in the germline, and issues unique to tumour 
CNVs (also known as copy number alterations or CNAs) are not 
discussed.  
2 THE FOUR CLASSES OF METHODS FOR CNV 
DETECTION USING NGS  
We describe each of the four methods for CNV detection using 
NGS data, namely (1) depth of coverage (DOC), (2) paired-end 
mapping (PEM), (3) split-read (SR) and (4) assembly-based (AS) 
methods. Except for the latter, the other three classes of methods 
require first mapping the sequenced reads to a known reference 
genome. We summarize a list of commonly used software for 
CNV detection using NGS data in Table 1. Readers may refer to 
seqanswers website: http://seqanswers.com/wiki/Software for a 
more comprehensive list. 
The underlying concept of identifying CNVs using DOC is 
similar to that of using intensity data: a lower than expected 
DOC/intensity indicates deletion and a higher than expected 
DOC/intensity indicates duplication. Most DOC methods count the 
number of reads that fall in each pre-specified window of a certain 
size (Abyzov et al., 2011; Xie et al., 2009; Yoon et al., 2009). The 
algorithm relies heavily on the assumption that the sequencing 
process is uniform, i.e. the number of reads mapped to a region is 
assumed to follow a Poisson distribution and is proportional to the 
number of copies. However, certain biases such as GC-content and 
mappability cause this assumption to be unrealistic. Regions of the 
genome may be over or under-sampled regardless of the copy 
number of the region, often resulting in spurious signals. Most 
DOC algorithms correct for GC-content bias before detecting 
CNVs (Abyzov et al., 2011; Yoon et al., 2009) while there are 
others that use ratios between reads from the target and reference 
genome and claims to mitigate the need for GC-correction if the 
two datasets are prepared in the same way (Xie et al., 2009). Other 
algorithms also exploit SNP heterozygosity information or also 
known as „B allele frequency‟ to call CNVs and loss of heterozy-
gosity (LOH) regions (Boeva et al., 2012; Sathirapongsasuti et al., 
2011). DOC algorithms usually detect large CNVs and are unable 
to detect copy neutral events such as inversions and translocations. 
Single end or paired end data may be used for this analysis.  
PEM methods require the reads to be paired (Chen et al., 2009; 
Hormozdiari et al., 2009; Korbel et al., 2009). The concept is that 
the fragments of DNA from which the reads are to be sequenced 
have a fragment length (or also known as insert size) of a certain 
distribution. When the sequenced ends of the fragment map to the 
reference at a distance longer than expected, it is indicative of a 
deletion in the studied genome. Vice versa, when the sequenced 
ends of the fragment map to the reference at a distance shorter than 
expected, it is indicative of an insertion in the studied genome. 
Based on the patterns from which the paired reads are mapped to 
the reference, PEM can also detect inversions and translocations 
(see Xi et al., 2011 for a review of the different SV signatures in 
PEM). For example, if the two ends of a fragment are mapped with 
a wrong orientation, it could be an indication of an inversion 
(Feuk, 2010). The size of CNVs detected using PEM is limited by 
the insert size and as a result, PEM often detects smaller CNVs.  
Split read (SR) methods focus on pairs of reads where one read 
is mapped uniquely to the reference while the other read failed to 
be aligned (Ye et al., 2009). The idea is that the location of the 
unmapped read may span the breakpoint of the CNV. The mapped 
read is used as an anchor to narrow down the search space for the 
split read alignment of the unmapped read. SR analysis has the 
advantage of being able to pinpoint the location of the breakpoints.  
Assembly-based (AS) methods, on the other hand, do not align 
the reads to a known reference but construct the genome piece-by-
piece; this is also known as de novo sequencing. Some AS methods 
still use the reference genome as a guide to resolve repeats. This is 
known as comparative assembly (Pop et al., 2004). AS methods 
can discover new non-reference sequence insertions. AS methods 
work best for small genomes such as bacterial genomes and are 
less widely used in NGS sequencing of humans because the short 
reads from NGS makes assembly in repeat regions difficult (Ye et 
al., 2009). Most AS algorithms for NGS data are extensions of the 
method described by Pevzner et al., 2001 which uses de Bruijn 
graphs. It is difficult to judge which method is superior although 
the methods developed more recently such as SOAPdenovo (Li et 
al., 2010) claims faster computation time and longer contig size 
and assembly accuracy when compared to earlier methods such as 
ABySS (Simpson et al., 2009) and velvet (Zerbino et al., 2008). 
Cortex (Iqbal et al., 2011) is capable of assembling multiple ge-
nomes simultaneously.   
Some algorithms use a combination of methods for more accu-
rate detection of CNVs. For example, CNVer (Medvedev et al., 
2010), HYDRA (Quinlan et al., 2010) and SVDetect (Zeitouni et 
al., 2010) supplements DOC with PEM information. Genome 
STRiP combines information from DOC, PEM, SR as well as other 
features of sequence data at population level (Handsaker et al., 
2011). Genome STRiP is one of the highest performing methods 
used in the 1000 Genomes pilot Project, indicating that there is 
benefit in combining different approaches (Mills et al., 2011).  
Table 1. Commonly used software for CNV detection using NGS data 
Program Reference Comments 
Depth of coverage 
CNVnator* 
Abyzov et al., 
2011 
Uses mean shift approach on 
fixed window GC-content adjust-
ed read counts. 
Rdxplorer* 
Yoon et al., 
2009 
Uses event-wise testing on fixed 
window GC-content adjusted read 
counts. 
SeqCBS 
Shen et al., 
2012 
Gives approximate confidence 
intervals for assessing confidence 
in the segmentation.  
CNVseq Xie et al., 2009 
Uses ratios between reads from 
target and reference genome. 
SegSeq 
Chiang et al., 
2009a 
Segments genomes of a tumour 
and matched normal sample by a 
sliding fixed size window. 
3 
 
Boundary is refined after change 
point is called. 
ExomeCNV 
Sathirapong-
sasuti et al., 
2011 
For exome sequencing data. Uses 
read count ratio to detect CNVs, 
and B allele frequencies to detect 
LOH 
Control-FREEC 
Boeva et al., 
2012 
Uses total coverage and B allele 
frequencies of SNPs to call CNVs 
and LOH.  





Based on maximum parsimony. 
Uses soft clustering. 
breakdancer* 
Chen et al., 
2009 
Consist of two complementary 
algorithms: BreakDancerMax 
predicts insertions, deletions, 
inversions, inter- and intra-
chromosomal translocations, 
BreakDancerMini predicts small 
indels. 
PEMer* 
Korbel et al. 
2009 
Clusters long and short events 
separately.  
Confidence value for each SV. 
Built in database and simulation 
program. 
Split read 
Pindel* Ye et al., 2009 
Uses pattern growth algorithm 
Identifies breakpoints of large 




Iqbal et al., 
2011 
capable of assembling multiple 
genomes simultaneously 
SOAP denovo* Li et al., 2010 
claims faster computation time 
and longer contig size and assem-
bly accuracy when compared to 
earlier methods such as ABySS 
and velvet  
Velvet 
Zerbino et al., 
2008 - 
ABySS 








Combines DOC, PEM and distri-
bution of evidence across samples 
and within a genomic locus 
HYDRA 
Quinlan et al., 
2010 






Mills et al., 
2011 
Uses PEM, able to find tandem 
duplications 
SVDetect       Zeitouni et al., 
2010 
DOC + PEM 
Competible with SoLiD and 
Illumina paired-end reads.  
*used in 1000 Genomes Project 
3 DATA SETS 
For the purpose of gaining insights to the issues we are about to 
discuss, we download sequenced data of individual NA12891 that 
was deeply sequenced (> 20X coverage) by the Illumina Genome 
Analyzer platform as part of the 1000 Genomes pilot Project (The 
1000 Genomes Consortium, 2010). The reads are paired, 36 bases 
in length and are aligned to the human reference build 36 (hg18) 
using the MAQ aligner (Li et al., 2008). The aligned reads are 
downloaded in BAM format from http://www.1000genomes.org/.  
MAQ calculates a phred-scaled quality score for each read/pair 
of reads that is equal to minus ten times the common logarithm of 
the probability that a read is wrongly aligned; a quality score of 30 
indicates a 1 in 1000 probability that the read is incorrectly 
mapped. When a read can be mapped equally well to more than 
one location, a random position is chosen out of all equally possi-
ble positions, and the reads are assigned a quality score of zero; 
these reads are termed multi-reads (Harismendy et al., 2009; 
Treangen et al., 2012). Different aligners have different approaches 
of dealing with multi-reads. For example, the aligner „micro-read 
fast alignment search‟ (mrFAST) reports all suitable positions of 
multi-reads (Alkan et al., 2009).  
3.1 Estimating depth of coverage 
We estimate DOC by counting the number of reads, based on their 
start positions, in non-overlapping windows of 100 bases. This is 
the current strategy of most DOC algorithms (Yoon et al., 2009; 
Abyzov et al., 2011).  
3.2 Pre-filtering criteria 
For DOC calculation, we keep only reads which are flagged 
properly aligned, termed „read mapped in proper pair‟ in Picard 
(http://picard.sourceforge.net/explain-flags.html), and reads that 
are not paired (i.e singletons). About 67% of the reads are flagged 
properly aligned and about 23% are singletons. We exclude reads 
which are technical duplicates, paired reads where one read in the 
pair is unmapped and other reads which are not „mapped in proper 
pair‟. Singletons are reads where only one end of the fragment is 
sequenced either due to library preparation or sequencing failure of 
one the reads in a pair (Alexej Abyzov, personal communication, 
Nov 2011). It should be differentiated from reads which are paired 
but where only one of the reads in the pair is mapped to the refer-
ence. Singletons are informative and should not be filtered. This is 
illustrated in Figure 1, which shows obvious signal of decreased 
DOC using only singleton reads in a region validated to be a dele-
tion by Mills et al., 2011. In the „Phred score filtered dataset‟, we 
further remove 7% of the reads whose mapping quality is less than 
30 (but not zero). About 14% of the reads have a mapping quality 
of zero. These multi-reads are reads that cannot be uniquely 
aligned to a single position in the genome, meaning that there 
exists more than one location where the read can be mapped to 
equally well. We observe the patterns of multi-reads in regions 
with known CNVs to investigate how these reads can affect CNV 
detection.  
3.3 Reference CNVs 
We use the integer copy-numbers for a total of 5,037 CNV loci 
from Conrad et al. (2010)‟s study as well as McCarroll et al. 
(2008)‟s study as a reference list. Conrad‟s experiments were done 
as follows: First, a set of 20 NimbleGen arrays, each comprising 
2.1-million oligonucleotide probes were used to generate a new 
map of CNV locations. Subsequently, a customized Agilent CGH-
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platform comprising of 105,000 oligonucleotide probes was used 
to detect the loci and the genotypes were estimated for 450 Hap-
Map samples using a Bayesian algorithm with stringent selection 
for optimal normalization and cluster locations for every locus 
(See Supplementary Methods in Conrad et al. 2010 for more de-
tails). In total, for individual NA12891, there are 517 deletions 
(copy-number less than 2) and 253 duplications (copy-number 
more than 2). It should be noted, however, that a true gold-standard 
reference list for CNVs is not available, and this list does not have 
100% sensitivity and specificity.  
 
 
Figure 1: DOC using singletons only (deletion region in Chromosome 22: 
35472901 – 35478000). This figure shows that singleton reads inde-
pendently provide informative evidence of a deletion in this region. 
 
3.4 SNP array intensities 
We download SNP array intensities for the Affymetrix 6.0 array 
for individual NA12891 from the HapMap 3 project raw data 
database 
(ftp://ftp.ncbi.nlm.nih.gov/hapmap/raw_data/hapmap3_affy6.0/). 
We use the PennCNV algorithm (Wang et al., 2007) to obtain Log 
R ratios (LRR), using samples from the third phase of the HapMap 
project as the reference panel.  
3.5 High-confidence regions 
In order to investigate the reasons for the discordance between the 
reference regions and DOC data, we plot DOC data for specific 
regions and observe patterns in the data. To narrow down our 
search for interesting regions, we limit this analysis to high-
confidence regions which we define as follows: A deletion region 
from the reference list is considered „high-confidence‟ if it also 
shows an average LRR of less than log(0.5) ~ -0.7. A duplication 
region is considered „high-confidence‟ if it shows an average LRR 
of greater than log(1.5) ~ 0.4. There are 60 high-confidence dele-
tions and eight high-confidence duplications. The regions range 
from 1Kb to 156Kb, and the number of SNP markers range from 1 
to 73.   
4 REPEAT REGIONS AND MAPPABILITY ISSUES 
NGS technology produces mainly short reads, and this poses a 
challenge in the alignment to the reference genome because reads 
that fall in repetitive regions in the genome cannot be mapped 
unambiguously. Furthermore, mutations or sequencing errors in 
one or two locations may also cause reads to be mapped wrongly 
(Li et al., 2008). In the 1000 Genomes trios Project, about 20% of 
the reference genome was considered inaccessible (defined as 
regions with many ambiguously placed reads or unexpectedly high 
or low numbers of aligned reads). The resulting low sensitivity in 
detecting CNVs in repeated/segmental-duplicated regions is a 
serious problem, because there is an observed enrichment of CNVs 
in segmental duplicated regions and many breakpoints lie in dupli-
cated regions (Medvedev et al., 2009). This class of CNVs is one 
of the most poorly studied variants as previous technologies for 
CNV detection such as aCGH and SNP arrays also have problems 
resolving them.  
 For AS methods, repeat regions create challenges because if 
the read length is shorter than the repeat region, it is not straight-
forward to decipher the original sequence since overlap between 
the reads or contigs will be ambiguous (Knudsen et al., 2010). For 
other methods that require mapping to a reference, there are differ-
ent alignment strategies for dealing with multi-reads, such as (1) 
discarding the reads, (2) choosing a position at random out of all 
equally good match positions, and (3) reporting all possible posi-
tions.  
 The first strategy limits the analysis only to unique regions of 
the genome, and may miss many CNVs. Moreover, when using 
DOC methods, excluding multi-reads may cause the identification 
of false deletions, i.e., regions with a large number of multi-reads 
will be falsely detected as a deletion if these reads were removed. 
This is illustrated in Figure 2, which shows a region in Chromo-
some 20 where several deletions would be falsely identified if 
multi-reads are excluded. This phenomenon was also observed by 
Abyzov et al. (2011), whose algorithm picked up ten times as 
many deletions when multi-reads are discarded.  
  
  
Figure 2: Fragment count for NA12891, Chromosome 20. (a) uses all 
fragments and shows a relatively flat DOC which varies around the aver-
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age. (b) uses only multi-reads and shows several small regions with spikes 
in multi-reads. (c) uses all fragments with multi-reads removed, we observe 
“holes” or dips in DOC that would be identified as deletions by DOC 
algorithms. Multi-reads are placed at random out of all equally possible 
locations.  
 Placing a multi-read at random (strategy 2) is also not ideal: 
For example, a true deletion may exist in a region where there exist 
similar sequences elsewhere in the genome, causing multi-reads to 
be mapped to the deletion region where there is supposed to be less 
or none, thereby diluting the signal (Figure 3). This suggests that 
the alignment strategy of discarding multi-reads or random place-
ment of multi-reads is inadequate for detecting duplications in 
repeated regions. A better strategy incorporating other alignment 
methods and other kinds of data is needed to identify these regions.    
He et al. (2011) developed a new algorithm for tandem copy 
number variation reconstruction in repeat-rich regions which con-
siders all locations of possible mappings and uses information on 
PEM and DOC. Alkan et al. (2009) developed a new alignment 
method, mrFAST; the aligner maps short sequence reads to a 
repeat-masked reference genome, meaning that all loci with known 
high-copy common repeats were first masked before alignment, 
and reports all mapping locations for multi-reads. It also keeps 
track of mutation in multi-reads. This method has been shown to 
be able to predict absolute copy number and multicopy differences. 
Sudmant et al. (2010) also uses a similar approach to identify and 
genotype CNVs within segmental duplications. However, these 
approaches seem to work only for deeply sequenced data (>20X), 
and more has to be done to extend these methods for lower cover-
age data (Chiang et al., 2009).   
Longer read lengths from third generation sequencing (TGS) 
may partially solve the problems with repeats, but even with a read 
length of 1kb, there still remains about 1.5% of the human genome 
sequence that is non-unique (Schatz et al., 2010). 
 
 
Figure 3: High-confidence deletion region in Chr. 4 (116148170 -
116151343) not identified by DOC methods in Mills et al. (2011). (a) Some 
evidence of deletion is seen when we include all reads. (b) Deletion signal 
becomes more obvious with multi-reads removed.  
5 GC CONTENT 
It has been observed that depth of coverage has a unimodal rela-
tionship with GC-content (Yoon et al., 2009; Abyzov et al., 2011; 
Benjamini et al., 2012), where regions with high or low GC-
content have decreased DOC. Harismendy et al. (2009) also ob-
served that unique sequences present at equimolar quantities in 
library generation end up being sequenced at vastly different DOC. 
This bias causes problems in all methods. For example, in PEM or 
SR methods, a region of low depth of coverage may have insuffi-
cient reads for enough evidence to discern the variants at that 
location. For AS methods, regions with low coverage may also 
result in insufficient information to infer a continuous sequence 
(Knudsen et al., 2010). The problem can however be solved by 
increasing the overall sequence depth. The most affected of four 
methods by GC-content bias is the DOC method. 
DOC algorithms rely heavily on the assumption that the se-
quencing process is uniform, so that the depth of coverage can be 
assumed to be proportional to the copy number. However, when 
there are biases that cause sequencing depth to differ for reasons 
other than the change in copy number, it makes differentiating true 
deletions/duplication from under/over-sampled regions in the 
genome difficult. Previous published algorithms correct for GC-
content by adjusting the DOC in the window using the GC-content 
of the window (Yoon et al., 2009; Abyzov et al., 2011). This 
method of correction may be inadequate as the choice of bin size is 
often arbitrary. Moreover, several studies have observed that it is 
the GC-content of the full DNA fragments, not only the reads, 
which cause most of the bias (Benjamini et al., 2012). 
 A recently developed algorithm for GC correction considers 
the GC-content of the fragment and can produce base-pair resolu-
tion predictions of GC-content bias (Benjamini et al., 2012). We 
applied the method on this dataset but observed an increase in 
overall variance of DOC after correction. Hence, we did not use 
the results of this correction for subsequent comparisons (see 
Supplementary Materials for more details).  
We download the GC-content per five bases from the UCSC 
genome bioinformatics website: 
http://hgdownload.cse.ucsc.edu/goldenPath/hg18/gc5Base/. We 
correct for GC-content bias in a similar fashion as described by 
Yoon et al. (2009). The GC-corrected DOC was calculated using 
the following equation:  
RDicorrected = RDglobal × RD
i
raw/RDgc, 
where i is the bin index, RDglobal is the average DOC over all bins 
in the chromosome (we used a trim mean, omitting 5% of bins 
from both extremes), RDiraw is the DOC for the i
th window before 
correction, and RDgc is the median DOC of all windows with the 
same GC-content. Since there are few windows with GC less than 
20 or greater than 75, for robustness, we set the lower/upper limits 
for GC in a window to 20 and 75 respectively. Figure 4 (left) plots 
the DOC of the windows versus the GC percentage of the win-
dows. We observe a similar unimodal relationship between DOC 
and GC-content as reported by previous papers. In AT rich regions, 
coverage increases with increasing GC, and in GC rich regions, 
coverage decreases with increasing GC. The peak coverage can be 
different for different data sets and different chromosomes but is 
usually located between 0.35 to 0.5 GC. Figure 4 (right) shows that 
GC-content bias is removed after correction. However, it is worth 
noting that even though GC-content bias is removed, the variance 
in DOC remains rather large, meaning that not all local variations 
in DOC are associated with GC-content and thus cannot be re-
moved by the GC-correction. 
The cause of GC-content bias is speculated to be largely due to 
PCR amplification step in NGS (Benjamini et al., 2012; Aird et al., 
2011). Since PCR amplification is not required in TGS, bias ob-
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served in DOC due to PCR may be resolved (Schadt et al., 2010). 
The longer read lengths of TGS will also improve challenges 
caused by the short read lengths of NGS. However, since TGS 
technology is still new, it is premature to comment on its perfor-
mance, and too soon to judge if TGS can fulfil its promises of 
advancement over NGS.  
  
  
Figure 4: Read depth versus GC percentage before and after correction. 
6 PHRED SCORE FILTERING 
There has been little documentation on how read mapping quality 
affects CNV calling. Most algorithms state a default filtering crite-
ria without any substantial evidence for the choice. For example, 
PEM algorithm, BreakDancer, uses a default filter of mapping 
quality > 10 (Chen et al., 2009) while DOC algorithm, Rdxplorer, 
uses a default filter of mapping quality > 30 (Yoon et al., 2009). 
 
7 COMPARISONS 
We perform sensitivity analysis to investigate the effects of GC- 
correction and Phred-score filtering. We compare three methods: 
(1) GC-corrected and Phred-score filtered, (2) GC-corrected but 
not filtered by Phred-score, and (3) Phred-score filtered but GC-
uncorrected. For each CNV in the reference list, we use the t-
statistic to determine if the DOC in the region is significantly 
increased/decreased. For each deletion region i, we calculate the t-














ix  is the average DOC in the region, gˆ  
is the global aver-
age DOC for the chromosome where the region lies, 
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standard deviation of the DOC in region i, ni is the number of 
windows in the region and c is a constant which we vary from 0.5 














where k varies from 1.2 to 1.6. For each set of tests, we account for 
multiple comparisons using the False Discovery Rate (FDR). A 
region is identifiable if the FDR is less than 0.01.  
Table 2 shows that there are little differences in sensitivities for 
all three methods, suggesting that both GC-correction and Phred-
score filtering does not seem to be crucial in the sensitivity of 
detection of CNVs. It should be noted however that this analysis 
does not investigate the specificity of CNV detection. Overall, GC-
correction and Phred-score filtering lowers the variance of DOC, 
indicating the potential of minimizing the number of false positive 
regions identified. However, this is a simple and limited analysis 
and further studies are needed to discern the benefits of GC-
correction and filtering by Phred score.  
Table 2. Sensitivity of Phred-score filtered and unfiltered datasets, and 
GC-corrected and non-GC-corrected datasets. 
 deletion duplication 




0.31 0.66 0.83 0.89 0.07 0.12 0.15 0.2 0.24 
Phred score unfil-
tered 
0.31 0.66 0.82 0.89 0.09 0.12 0.16 0.21 0.25 
GC-uncorrected 0.32 0.65 0.81 0.89 0.08 0.11 0.15 0.2 0.25 
8 INSERTIONS ARE HARDER TO DETECT THAN 
DELETIONS 
For all methods, identifying duplications has been acknowledged 
as more challenging as compared to identifying deletions. With 
regards to PEM methods, the bias against detection of insertions is 
because PEM detects insertions when the mapped reads are at a 
distance shorter than the fragment length and hence it is unable to 
detect insertions larger than the insert size of the reference library, 
or more specifically the length upper bound of an insertion detect-
ed is the average fragment length minus the length of the reads 
(Wang et al., 2008; Hormozdiari et al., 2009). This is evident in 
detection of CNVs using PEM of the diploid Asian „YH‟ genome, 
where 2441 deletions were identified as compared to 33 duplica-
tions (Wang et al., 2008). 
In DOC methods, we observe that the sensitivity of detecting 
deletions and duplications is around 89% and 25% respectively for 
the best case scenarios (Table 2). This observation is similar to that 
observed in Abyzov et al. (2011), who estimated that about 90% of 
deletions identified by aCGH or SNP arrays are DOC-accessible, 
while only 20-30% of duplications are DOC-accessible. This may 
be due to the lack of sensitivity of DOC methods in distinguishing 
a change in number of copies from N to N+1, especially if N is 
large. For example, suppose a sequence is repeated twice in the 
reference genome (N = 2) at locations A and B, while the studied 
genome has an additional copy (N = 3). Then, assuming an average 
of 20X coverage, locations A and B would have an average of 60 
reads shared among both locations (following strategy of random 
placement of multi-reads), meaning an average of 30 reads at both 
A and B, a 50% increase in DOC. If we increase N to 5 in the 
reference and 6 in the studies genome, then each repeated location 
in the reference would have an average of 120/5 = 24 reads, only 
20% more than the average, and likely to be undetectable due to 
the high variance in DOC. 
7 
 
In the list of high-confidence regions (see section „High-
Confidence Regions‟), all 60 deletions can be found in at least one 
release set from Mills et al. (2011), but four of the regions were 
not  detected by DOC methods. When we plotted the read depth in 
these regions, we observed that two regions have obvious de-
creased DOC (figure not shown) and should have been detected 
while the other two were not detected most likely due to the pres-
ence of multi-reads diluting the deletion signal (see Figure 3). 
On the other hand, all eight duplications are not identified in 
any of the release sets (see table S1 and Figures S1-8 in Supple-
mentary Materials). This is partly due to the fact that most release 
sets in Mills et al. (2011) focus mainly on deletions, with few sets 
reporting duplications/insertions. Even then, of the eight regions, 
only regions 2 and 5 show distinct elevated depth of coverage; 
these regions have little or no multi-reads. Among the other six 
regions that do not show obvious increase in DOC, four of them 
overlap with known segmental duplication regions (segmental 
duplicated regions as defined in 
http://humanparalogy.gs.washington.edu/). This is also supported 
by the presence of multi-reads in these regions; neither keeping nor 
removing multi-reads result in strong DOC signal of the presence 
of duplication.    
9 DISCUSSION 
Next-generation sequencing, with its ability to perform massive 
parallel sequencing in a single run, is becoming increasingly popu-
lar. This brings with it an unprecedented opportunity to sequence 
many genomes at a relatively inexpensive cost (as compared to 
using Sanger sequencing). However, with billions of reads gener-
ated per individual, the sheer and exponentially increasing amount 
of data demands for better bioinformatics support and computers 
with larger storage and higher computing powers. No less im-
portant than the production of the data is the information technolo-
gy infrastructure and bioinformatics team needed to analyse it, 
with speculations that the costs associated with handling, storing 
and analysis of the data could be more than the production of the 
data.  
Analysing NGS data for structural variants is a relatively new 
and challenging field, with no standard protocols or quality-control 
measures. The four methods of CNV detection are complementary. 
Comparing DOC, PEM and SR methods used in the 1000 Ge-
nomes Project, each approach uniquely discovered 30% to 60% of 
the CNVs (Abyzov et al., 2011). These three methods require first 
mapping the sequenced reads to a reference genome. Since the 
mapped reads are used in all downstream analysis, this first step of 
alignment is extremely crucial. As has been shown in the paper, 
how the aligner or subsequent algorithm deals with reads in repeat 
regions is very important for detecting variants that lie in these 
regions. Currently, the problem of CNV detection in repeated 
regions is still not completely solved.  
Using real data from the 1000 Genomes Project, this paper 
highlights and investigates challenges associated with current 
methodologies and areas of potential biases encountered when 
analysing NGS data for CNVs. In particular, we focus on issues 
pertaining to (1) mappability, (2) GC-content bias, (3) quality-
control measures of reads, and (4) difficulty in identifying duplica-
tions. We feel this is a timely critical review that would aid re-
searchers in a much needed well-validated pipeline for the analysis 
of structural variants.  
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Table S1. List of eight high-confidence duplications 
Region 
 
Copy Number Chr. Start End Overlap segmental duplications? 
1 4 3 127155055 127161736 Y 
2 3 4 34360003 34365018 N 
3 4 5 150860656 150863376 N 
4 4 10 81128690 81226767 Y 
5 3 10 90784968 90793035 N 
6 4 17 41626903 41724649 Y 
7 4 17 41568592 41626007 N 




The following plots S1 – S8 are known duplications for this individual found in previous studies 










Figure S2: One of the eight high-confidence duplications (Region 2). This example shows a 
positive duplication signal in the region. This region is not in a repeated region, indicated by the 


















Figure S6: One of the eight high-confidence duplications (Region 6). Top panel shows fragment 
count using all fragments. Middle panel shows fragment count using only multi-reads. Bottom 










Figure S8: High confidence duplication, region 8 in Chromosome 20: 1500338 – 1544222 
 
 
GC correction (Benjamini et al., 2012) 
The package ‘GCcorrect’ which implements the GC correction method described in Benjamini et 
al 2012 requires raw sequence reads for input into the aligner ‘Bowtie’. This step is required to 
generate a list indicating which positions in the reference are not mappable. Since, for this paper, 
our starting data contains reads that have been already aligned using MAQ, we skip this step and 
generate the list of unmappable positions as downloaded from 
http://wiki.rglab.org/index.php?title=Public:Mappability_Profile 
All other procedures follow defaults in the package. Using Chromosome 22 as an example, we 
observe a similar GC effect (as in our GC-correction analysis) using the default plotting 
parameters of read counts in 10kb windows (Figure S9). However, at the optimal bin size of 599-
bases bins, based on largest TV score as suggested in the paper, the correction did not improve 
overall variance (Figure S10). 
 
 






Figure S10: Normalized and un-normalized read depth. 
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A population-based study of copy number variants and
regions of homozygosity in healthy Swedish individuals
Shu-Mei Teo1,2,3,5, Chee-Seng Ku2,5, Nasheen Naidoo2, Per Hall1, Kee-Seng Chia1,2,4, Agus Salim4
and Yudi Pawitan1
The abundance of copy number variants (CNVs) and regions of homozygosity (ROHs) have been well documented in previous
studies. In addition, their roles in complex diseases and traits have since been increasingly appreciated. However, only a limited
amount of CNV and ROH data is currently available for the Swedish population. We conducted a population-based study to
detect and characterize CNVs and ROHs in 87 randomly selected healthy Swedish individuals using the Affymetrix SNP Array
6.0. More than 600 CNV loci were detected in the population using two different CNV-detection algorithms (PennCNV and
Birdsuite). A total of 196 loci were consistently identified by both algorithms, suggesting their reliability. Numerous disease-
associated and pharmacogenetics-related genes were found to be overlapping with common CNV loci such as CFHR1/R3,
LCE3B/3C, UGT2B17 and GSTT1. Correlation analysis between copy number polymorphisms (CNPs) and genome-wide
association studies-identified single-nucleotide polymorphisms also indicates the potential roles of several CNPs as causal
variants for diseases and traits such as body mass index, Crohn’s disease and multiple sclerosis. In addition, we also identified
a total of 14815 ROHs X500 kb or 2814 ROHs X1M in the Swedish individuals with an average of 170 and 32 regions
detected per individual respectively. Approximately 141Mb or 4.92% of the genome is homozygous in each individual of the
Swedish population. This is the first population-based study to investigate the population characteristics of CNVs and ROHs in
the Swedish population. This study found many CNV loci that warrant further investigation, and also highlighted the abundance
and importance of investigating ROHs for their associations with complex diseases and traits.
Journal of Human Genetics (2011) 56, 524–533; doi:10.1038/jhg.2011.52; published online 2 June 2011
Keywords: Affymetrix SNP Array 6.0; Birdsuite; copy number variants; PennCNV; regions of homozygosity; Swedish population
INTRODUCTION
There is a growing body of copy number variant (CNV) maps
covering different world populations.1–5 Most of these newer studies
used high-resolution methods for detecting CNVs, such as the
Affymetrix SNP Array 6.0, which has a higher density of single-
nucleotide polymorphism (SNP) and copy number probes than
previous microarray-based methods. This has led to an improved
performance of microarray-based methods to detect smaller CNVs
(o50 kb).1,6 In contrast, previous studies have used much lower
resolution arrays, such as the bacterial artificial chromosome (BAC)
clone or oligonucleotide comparative genomic hybridization arrays
and SNP genotyping arrays.7–10 Currently, there is only one CNV-
detection study in a Swedish population,10 but this was performed
in a small sample size of 33 individuals and used a low-resolution
32-K bacterial artificial chromosome clone microarray. This has
hampered the study from detecting less common and smaller CNVs
and from estimating the population frequency of CNVs. The ability to
detect smaller CNVs is critical as they are more numerous than the
larger CNVs.11
In addition, the study by Dı´az de Sta˚hl et al.10 was unable to detect
regions of homozygosity (ROHs) as the bacterial artificial chromo-
some clone microarray was unable to generate allelic intensity data.
Research on ROHs has started to gain impetus, as evidenced by the
increasing number of publications after the first study by Gibson
et al.12 reported the abundance of ROHs in the human genome of
outbred populations. Further studies have investigated the population
characteristics of ROHs in healthy individuals,13–15 and also per-
formed association analyses to identify ROHs that are associated
with complex diseases and traits in a case–control study design.16–18
To circumvent the limitations of the previous study by Dı´az de Sta˚hl
et al.,10 we conducted a study in a Swedish population by genotyping
100 individuals using the Affymetrix SNP Array 6.0 (Affymetrix, Santa
Clara, CA, USA). The main aim of this study was to perform a
more comprehensive detection of CNVs and ROHs in the Swedish
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population and to describe their population characteristics. Although
several studies have been performed to detect and characterize CNVs
and ROHs in multiple European populations, these studies have also
documented the genetic differences among these populations.14,15,19
The extension of the International HapMap Project to include an
additional seven populations in Phase III further suggests that multi-
ple populations from diverse ancestries or different geographical
locations are needed to study their population genetics.20 These
previous studies have justified the need for a population-based
study to characterize CNVs and ROHs in healthy Swedish individuals.
We also compared the Swedish population with the HapMap phase III
populations using principal component analysis.
MATERIALS AND METHODS
Samples and genotyping platform
A total of 100 randomly selected healthy Swedish individuals volunteering
as controls in case–control studies were studied. Peripheral blood samples of
the participants for genomic DNA extraction were drawn and stored at the
Karolinska Biobank. Identities of the participants were kept anonymous and no
personal identifiers were used. All 100 samples were genotyped using the
Affymetrix Genome-Wide Human SNP Array 6.0 as per the manufacturer’s
protocol. Two samples were removed from further analysis because their
genotype call rates were below 98% and the remaining 98 samples were used
for CNV detection.
CNV-detection algorithms and analyses
CNV calling using PennCNV. We used two CNV-detection algorithms, namely
PennCNV21 and Birdsuite,22 for both comparison and validation. This study
focused only on the CNVs in the 22 autosomes because of the inaccuracy of
Birdsuite to detect CNVs in sex chromosomes. Log R ratio and B allele
frequency were calculated according to the PennCNV algorithm (http://www.
openbioinformatics.org/penncnv/penncnv_tutorial_affygw6.html). Smaller CNVs
(o1 kb) were also included in our analysis, as PennCNV by default does not
limit its detection to CNVs41 kb in size. We applied a set of filtering criteria
as recommended by the algorithm, namely Log R ratio-s.d 40.35, B allele
frequency-median 40.55, B allele frequency-median o0.45 and B allele
frequency-drift40.006 to exclude samples with poor quality of signal intensity
data (http://www.openbioinformatics.org/penncnv/). This resulted in a further
exclusion of 11 samples, with the final set for analysis consisting of 87 samples.
For each sample, PennCNV generated a list of CNVs with their confidence
scores. The confidence score is a log Bayes factor that measures the likelihood
that the locus harbors an abnormal copy number. A confidence score of X10
has been recommended as the threshold to classify reliable CNVs. Therefore, we
retained all CNVs called with confidence scores X10 for subsequent analyses.
Although the confidence score is only a statistical measure of a true positive,
our previous study5 found that CNVs with a higher confidence score are more
likely to be detected consistently across two genotyping platforms. Therefore,
this justifies our decision to retain only reliable CNVs called with a sufficient
degree of confidence.
Construction of CNV loci using PennCNV output. The CNVs called by
PennCNV were shown to overlap across samples. Thus, we merged or grouped
these individual CNV calls into discrete, non-overlapping loci, with the
boundaries of each locus determined by the union of all CNVs that belonged
to that particular locus. This construction of CNV loci was needed to estimate
the population frequencies and these steps were performed using the methods
that we have developed previously.5,23 We classified the status of these CNV loci
into three categories, ‘del’ (loci containing deletions), ‘dup’ (loci containing
duplications) and ‘del/dup’ (loci containing both deletions and duplications).
Copy number polymorphism (CNP) calling using Canary (Birdsuite). Birdsuite
software22 was also used to analyze the Affymetrix SNP Array 6.0 data. There
are two components in the software for detecting copy number changes,
namely Canary and Birdseye. Canary was used to determine the integer copy
number at each of the predefined 1316 CNPs. The term ‘CNPs’ used by
McCarroll et al.1 is to describe common CNV loci. These 1316 CNPs were
found in more than one HapMap II individual and their sizes were
also accurately determined. Therefore, we used the Canary component in
Birdsuite to determine the integer copy number of the 1316 CNPs in the 87
Swedish samples. These 1316 CNPs are distributed in all the autosomes and sex
(X and Y) chromosomes. However, 25 CNPs located in the sex chromosomes
were removed because the CNP calling in these chromosomes was less accurate.
Thus, the results reported in this study comprised only 1291 CNPs in the 22
autosomes. Confidence statistics generated for the CNPs were also used to
identify poor-quality calls, and only integer copy numbers detected with high
confidence as recommended by the software (confidence score 40.1) were
used for subsequent analyses.
Correlation analysis of CNPs. We performed a correlation analysis of CNPs
and the nearby SNPs. Because the sizes of the CNPs were previously accurately
determined by McCarroll et al.,1 we restricted the analysis to only the CNPs
detected by Canary. For each of the 1291 CNPs, SNPs within a 200-kb window
from the start and end positions of the CNP were considered. We used the
squared Pearson’s correlation (r2) for correlation analysis. The genotype calling
of the Affymetrix SNP Array 6.0 was carried out using Birdsuite. In addition, to
investigate the potential associations of CNPs with human diseases and traits,
the same methods of r2 calculations for the 1291 autosomal CNPs and the
SNPs that were identified by genome-wide association studies (GWAS) were
adopted. The list of GWAS-SNPs was downloaded from the National Human
Genome Research Institute website (http://www.genome.gov/gwastudies/) on
26 October 2010.
CNV calling using Birdseye (Birdsuite). In addition to PennCNV, we also used
another algorithm, Birdseye, to analyze the same set of data as different
algorithms tend to have different sensitivities and specificities for detection
of CNVs in different regions throughout the genome. As such, CNV loci
detected by PennCNV and Birdseye can be cross-validated. Therefore, we used
the Birdseye component in Birdsuite to detect additional CNVs throughout the
genome, which was not restricted to the 1316 predefined CNPs. Similarly, only
CNVs in autosomal chromosomes were used because of the inaccuracy of
Birdseye in the sex chromosomes. CNVs with low confidence, as recommended
by the software (confidence scorep5), were removed from subsequent analysis.
Construction of CNV loci using Birdseye output. We also constructed CNV loci
based on the Birdseye output using methods similar to those applied to the
PennCNV output. The cutoff for the confidence score used by PennCNV (X10)
and Birdseye (X5) was recommended by both algorithms. This allowed for
greater comparability between the CNV loci detected by these two algorithms.
Comparison of CNV loci detected by PennCNV and Birdsuite. The CNV loci
identified by PennCNV and Birdseye were compared as a ‘validation’ step. We
used a ‘reciprocal 50% overlapping’ method to compare the CNV loci detected
by these two algorithms and considered a CNV locus ‘found’ by both
algorithms when this locus was detected in both PennCNV and Birdseye with
an overlap of X50% of their lengths.
Novel CNV loci. To identify novel CNV loci, we compared the CNV
loci detected by PennCNV and Birdseye with the data from the Database
of Genomic Variants (DGV).24 We used the latest data from the DGV
(variation.hg18.v8.aug.2009.txt and indel.hg18.v8.aug.2009.txt) downloaded
from the DGV Website (http://projects.tcag.ca/variation/). A CNV locus
identified by PennCNV and Birdseye was considered novel if it did not share
at least 50% of its length with any CNV loci cataloged in the DGV. All the
downstream analyses after PennCNV and Birdsuite were performed using the
statistical software package R (http://www.r-project.org/).
Comparison with HapMap phase III populations
The CEL files of the Affymetrix SNP Array 6.0 for the seven populations in
HapMap phase III project were downloaded from the ftp site (ftp://ftp.ncbi.
nlm.nih.gov/hapmap/raw_data/hapmap3_affy6.0/). The HapMap phase III
populations studied are people of African ancestry in the southwestern USA
(ASW), the Chinese community in Metropolitan Denver, Colorado, USA
(CHD), Gujarati Indians in Houston, Texas, USA (GIH), the Luhya in Webuye,
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Kenya (LWK), people of Mexican ancestry in Los Angeles, California, USA
(MEX), the Maasai in Kinyawa, Kenya (MKK) and the Tuscans in Italy (TSI).
All the samples were analyzed using Canary similarly to the analysis of the
Swedish population. Only unrelated samples were included in our study, that is,
family-related samples were removed using the ‘relationships’ file provided by
the International HapMap Project. After the sample exclusion step, a total of
594 unrelated samples from the seven HapMap III populations were analyzed:
ASW (n¼52), CHD (n¼89), GIH (n¼89), LWK (n¼90), MEX (n¼53), MKK
(n¼132) and TSI (n¼89). We performed principal component analysis to
compare the Swedish population with the HapMap phase III populations using
the CNP output generated by Canary.
ROH-detection algorithms and analyses
In addition to CNVs, we also detected ROHs using PennCNV in the 22
autosomes of the 87 Swedish individuals. However, we only focused on ROHs
X500 kb, as this cutoff was adopted in a previous study.18 For each of these we
confirmed that they are ROHs by determining the genotypes of the SNPs that
fall within each region. We then calculated the percentage of heterozygosity
(number of heterozygotes/total number of heterozygotes and homozygotes).
We also calculated the percentage of missingness genotypes (number of
missingness/total number of SNPs in each ROH). First, we used an arbitrary
cutoff of the median of the percentage of heterozygosity (2.5%) to allow for
some heterozygote calls resulting from calling or genotyping errors. As a result,
we removed half of the ROHs with a percentage42.5%. Second, we removed
ROHs with 41% for the missingness, to remove regions where genotype
calling was problematic. Finally, for the remaining ROHs, we also ensured a
density of one SNP per 10 kb to exclude those ROHs that could be spuriously
detected by a sparse number of SNPs. As such, for a 500-kb ROH, a minimum
of 50 SNPs is required. These three criteria were used as the filters to exclude
less reliable ROHs. Several summary statistics were then computed to describe
the characteristics of ROHs in the Swedish population.
RESULTS
Characteristics of CNVs identified by PennCNV
After filtering unreliable CNV calls, an average of approximately
36 CNVs per individual with a ratio of deletions to duplications of
approximately 2.6:1 was discovered (Supplementary Table 1). The
number of CNVs per individual ranged from 22 to 65. The median
size of a CNV was 28.6 kb and approximately 66% of the CNVs were
o50 kb and 26% wereo10 kb (Supplementary Figure 1). The median
size of deletions was approximately fourfold smaller than the median
size of duplications.
Characteristics of CNV loci identified by PennCNV
We merged overlapping CNVs to construct CNV loci and identified
623 loci, of which 476 loci contained deletions (‘del-loci’), 102 loci
contained duplications (‘dup-loci’) and 45 loci contained both dele-
tions and duplications (‘del/dup-loci’; Table 1). These 623 loci covered
approximately 61.52 Mb of the nucleotide sequence and the sum
of the lengths for del-loci (19.83 Mb) was smaller than that for dup-
loci (25.80 Mb). Similarly for the individual CNVs (Supplementary
Table 1), the average size of del-loci (41.66 kb) was much smaller than
that of dup-loci (252.93 kb; Table 1). More than 77% of the del-loci
wereo50 kb, and in comparison only 22.55% of dup-loci were within
this size range. The majority (62.75%) of dup-loci ranged from 50 to
500 kb. In summary, there were far more del-loci, but their sizes
tended to be smaller than those of dup-loci. A list of the 623 loci is
shown in Supplementary Table 2.
Of the 623 CNV loci, 268 loci were detected in X2 individuals
(Table 1). The remaining loci were detected in only one individual;
these loci were not necessarily ‘singleton loci’ as we only studied
Table 1 Summary statistics of CNV loci constructed from PennCNV output
Summary statistics of CNV loci (PennCNV output) Total Del Dup
Number of CNV loci 623 476 (76.40%)a 102 (16.37%)a
Number of CNV loci detected in X2 individuals 268 (43.02%)b 194 (40.76%)b 29 (28.43%)b
Sum of the length of loci (Mb) 61.52 19.83 25.80
Average length per locus (kb) 98.75 41.66 252.93
Average number of markers per locus 58 34 141
Size distribution
o10 kb 141 (22.63%) 132 (27.73%) 6 (5.88%)
X10–o50kb 265 (42.54%) 236 (49.58%) 17 (16.67%)
X50–o100 kb 79 (12.68%) 54 (11.34%) 21 (20.59%)
X100–o500 kb 110 (17.66%) 52 (10.92%) 43 (42.16%)
X500 kb 28 (4.49%) 2 (0.42%) 15 (14.71%)
Overlapping with DGV
CNV loci that overlap 388 (62.28%) 298 (62.61%) 54 (52.94%)
CNV loci that did not overlap 235 (37.72%) 178 (37.39%) 48 (47.06%)
Overlapping with UCSC genes
CNV loci that overlap 202 (32.42%) 135 (28.36%) 51 (50.00%)
CNV loci that did not overlap 421 (67.58%) 341 (71.64%) 51 (50.00%)
Overlapping with CNV loci from Birdseye data and consistent in CNV status that is, del/dup/del+dup
CNV loci that overlap 196 (31.46%) 160 (33.61%) 30 (29.41%)
CNV loci that did not overlap 427 (68.54%) 316 (66.39%) 72 (70.59%)
Abbreviations: CNV, copy number variant; DGV, database of genomic variants; UCSC, University of California Santa Cruz genes.
aThe percentage was calculated by dividing 623 loci.
bThe percentage was calculated by dividing 623, 476 and 102 loci, respectively.
Note: As there are only 45 CNV loci (7.22%) with status del+dup, the summary statistics of these loci are not shown in the table. A full colour version of this Table is available at the Journal of
Human Genetics Journal online.
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87 individuals. The proportion of del-loci detected inX2 individuals
(40.76%) was much higher than the proportion for dup-loci (28.43%).
Among the high-frequency CNV loci (loci that were detected in
multiple individuals), several overlapped with disease-related genes
such as WWOX and ERBB4 (gastric and pancreatic cancers and
melanoma)25–27 and CACNA1C (bipolar disorder)28 or drug-metabo-
lizing genes such as GSTT129 (Supplementary Table 2). For example, a
deletion locus overlapping with WWOX (a tumor suppressor gene)
was detected in 24 of the 87 individuals (27.6%), and a deletion locus
encompassing GSTT1 was deleted at a population frequency of 13.8%.
In addition, the proportion of del-loci encompassing the UCSC genes
(28.36%) was much lower than dup-loci (50.00%) overall.
Detection of CNVs using microarrays is usually plagued with poor
specificity or a high false-positive rate. In an effort to validate the 623
CNV loci constructed from the PennCNV output, we compared them
with the CNV loci detected by Birdseye. We found 196 loci (31.46%)
with X50% reciprocal overlap with the Birdseye data and the status
of ‘del’, ‘dup’ and ‘del/dup’ of the 196 loci were consistent with
the Birdseye data. For the remaining 427 CNV loci that were not
confirmed by Birdseye data, we found that 247 loci had been cataloged
in the DGV (please see Materials and methods). Therefore, by
applying two different ways of validation, 443 (71.1%) of the 623
CNV loci detected by PennCNV were considered reliable in this
study (Table 1).
Characteristics of CNPs identified by Canary (Birdsuite)
Approximately 49.81% of the 1291 autosomal CNPs were non-
polymorphic in the Swedish population (Supplementary Table 3).
The population frequency distribution pattern of the 1291 CNPs is
shown in Supplementary Figure 2. Among the polymorphic loci (648
CNPs) and non-polymorphic CNPs (643 loci) in the Swedish popula-
tion, 289 loci (44.60%) and 255 loci (39.66%) overlapped with genes
or entries from the UCSC annotation of the human genome, respec-
tively. No substantial difference was observed between the poly-
morphic and non-polymorphic loci.
The majority of the 648 polymorphic CNPs were biallelic (545
CNPs or 84.1%), of which the integer copy numbers were either
exclusively deletions, that is, copy number of 0 or 1 (387 CNPs or
59.7%), or exclusively duplications, that is, copy number of 3 or 4 (158
CNPs or 24.4%). Among the biallelic 545 CNPs, only one showed
significant deviation from HWE at an FDR o0.01.
Numerous CNPs were found to overlap with important known
disease- or pharmacogenetics-related genes (Table 2). The frequencies
of these CNPs ranged from relatively uncommon (2.78% for CNP118)
to completely polymorphic (100% for CNP88). For example, CNP88
overlapped with GSTM1 and GSTM2 was found to be completely
deleted in the Swedish population, where all except one carried two-
copy deletions. However, it is noteworthy that in approximately
half of the sample (47 individuals), the integer copy numbers were
successfully determined with high confidence scores. In addition, high
deletion frequencies were also found for CNPs overlapping with
other GST enzymes such as GSTT1 (60.00%), GSTT2, GSTT2B
and GSTTP1 (98.65%). Two-copy deletion was common for these
enzymes—17.6% of the individuals for GSTT1 (CNP2560) and 43.2%
for the other GST enzymes (CNP2559).
Besides these phase II metabolizing enzymes, several disease-asso-
ciated genes were also found to overlap with these CNPs, such as the
FCG receptor genes (autoimmune or inflammatory diseases),30
TP6331 and WWOX26 (lung adenocarcinoma, gastric, pancreatic and
other cancers), CFHR3 and CFHR1 (age-related macular degenera-
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and LCE3C and LCE3B (psoriasis and rheumatoid arthritis) among
others.35,36 The high deletion frequency of loci overlapping with
LCE3C and LCE3B (82.76%), UGT2B17 (47.13%) and WWOX
(79.76%) requires further studies to investigate their associations with
complex diseases such as psoriasis, rheumatoid arthritis and graft-
versus-host disease for hematopoietic stem cell transplantation patients.
For example, the mismatch of the copy numbers of UGT2B17 was
found to be associated with graft-versus-host disease in patients with
hematopoietic stem cell transplantation.34 Deletion of UGT2B17 was
also associated with an increased risk for prostate cancer.33
Correlation analyses between CNPs and nearby SNPs
To study the correlation patterns with SNPs, we calculated the r2
between the 648 polymorphic CNPs and nearby SNPs within a 200-kb
window from the start and end positions of the CNP. The proportion
of the CNPs with at least one SNP in strong correlation (r240.8) was
31.9%, that is, 207 CNPs were found to be in strong correlation with
at least one SNP. The median and maximum numbers of SNPs that
were in strong correlation with the 207 CNPs were 3 and 44,
respectively. This suggests that half of the 207 CNPs can be tagged
by more than three SNPs and some of the CNPs were tagged by tens of
SNPs. These results suggest that the majority of CNPs were not being
well tagged by the nearby SNPs in the Affymetrix SNP Array 6.0.
The strength of the r2 value decreases with distance between the CNP
and SNP (Figure 1a). We further investigated whether CNPs that
were not well tagged tend to be located in the genomic regions where
SNP markers are sparse. The correlation patterns do not appear to be
affected by the number of nearby SNPs and the frequencies of CNPs
(Figures 1b and c). In other words, there was no apparent difference
in the number of nearby SNPs and the frequencies of CNPs between
(a) the CNPs that were in strong correlation (r240.8) and (b) CNPs
that were not in strong correlation with SNPs (Figures 1b and c).
However, smaller-sized CNPs were generally in strong correlation with
more SNPs than the larger CNPs (Figure 1d).
Correlation analyses between CNPs and GWAS-SNPs
To investigate the potential role of CNPs in the etiology of complex
diseases or traits, we computed the r2 between CNPs and the SNPs on
the NHGRI GWAS Catalog (http://www.genome.gov/gwastudies/). Of
the 43000 GWAS-SNPs that have been found to be associated with
various complex diseases and traits, only eight GWAS-SNPs were
found to be in strong correlation with six CNPs (Table 3). Following
the methods of Conrad et al.,2 we define in our analysis a strong
correlation as r240.5. These eight SNPs were reported to be associated
with five diseases or traits, namely body mass index, childhood acute
lymphoblastic leukemia, early-onset myocardial infarction, Crohn’s
disease and multiple sclerosis. Several SNPs were in strong correlation
with a single CNP, for example, three SNPs (rs13361189, rs1000113
and rs11747270) were found to be in strong correlation with CNP874.
The most notable SNP was rs2815752 near the NEGR1 gene
(associated with body mass index), which was in perfect correlation
(r2¼1) with CNP60. This locus is a 42-kb deletion located in
Figure 1 (a) The correlation between the r2 and the distance between copy number polymorphism (CNP) and single-nucleotide polymorphism (SNP).
(b) Maximum r2 of CNP versus number of nearby SNPs in 200-kb windows. (c) Maximum r2 of CNP versus CNP frequency. (d) Number of SNPs in strong
correlation with the size of CNPs.
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chromosome 1 that did not overlap with any of the UCSC genes and is
located only 1.3 kb away from the SNP. The total deletion frequency in
the Swedish population was high (Table 3 and Supplementary Table
4), of which 51.72% were one-copy deletions and 29.89% were two-
copy deletions. CNP874 was found to be in nearly perfect correlation
(r2¼0.93) with three GWAS-SNPs located near the IRGM gene, which
is associated with Crohn’s disease. However, in comparison with
CNP60, the total deletion frequency for CNP874 was much lower,
with only 11.90% one-copy deletions and 1.19% two-copy deletions.
This locus spans 13 kb in chromosome 5 and does not overlap with
any of the UCSC genes. The three GWAS-SNPs were located 4.8 kb
(rs13361189), 21.4 kb (rs1000113) and 40.2 kb (rs11747270) away
from the deletion. The CNP877 locus is implicated in multiple sclerosis,
where it is in perfect correlation with the GWAS-SNP (rs4704970).
None of the individuals were deleted in both copies, and 32.56%
were one-copy deletions. The other CNPs were implicated in childhood
acute lymphoblastic leukemia (CNP147) and early-onset myocardial
infarction (CNP333). Interestingly, all the CNPs found to be in strong
correlation with GWAS-SNPs had only deletions in the loci.
Characteristics of CNV loci identified by Birdseye (Birdsuite)
Similar to the PennCNV output analysis, we also merged overlapping
CNVs to construct CNV loci for the Birdseye data and identified 641
loci, of which 451 were del-loci, 102 were dup-loci and the remaining
31 were del/dup-loci (Table 4). The proportion of del-loci (76.40%)
identified by PennCNV data was higher than that for the Birdseye data
(70.36%). In comparison, the Birdseye data identified a higher
proportion of dup-loci (24.80%) than the PennCNV data (16.37%).
However, these differences are not substantial.
The 641 loci identified by the Birdseye data cover approximately
35.23 Mb of the nucleotide sequence, and the sum of the length for
del-loci (13.10 Mb) is smaller than that for dup-loci (15.06 Mb).
Similar to PennCNV data, the average size of del-loci (29.04 kb) is
much smaller than that of the dup-loci (94.70 kb). However, sub-
stantial differences were observed for these parameters between the
PennCNV and Birdseye data (Tables 1 and 4). For example, the sum of
lengths covering CNV loci detected by the PennCNV data (61.52 Mb)
was approximately twice that for the Birdseye data (35.23 Mb), while
they have an almost similar number of CNV loci.
More than 60% of del-loci were o10 kb, and in comparison, only
18.24% of dup-loci fall within this size range. The majority (52.20%)
of dup-loci ranged from 10 to 100 kb. In summary, there were more
del-loci, but their sizes tended to be smaller than those of the dup-loci.
This is in agreement with the PennCNV data. However, the size
distribution pattern of the CNV loci for the Birdseye data is skewed
towards the ‘smaller’ end compared with the PennCNV data. This is
apparent when comparing the proportions in the first two strata:
(a)o10 kb and (b)X10–o50 kb between the two sets of data (Tables
1 and 4). The list of the 641 loci is shown in Supplementary Table 2.
Of the 641 CNV loci, 280 loci were detected in X2 individuals
(Table 4), and the remaining loci in only one individual. The
proportion of del-loci detected in X2 individuals (43.90%) was
much higher than the proportion for dup-loci (32.08%). Among
the high-frequency CNV loci (loci detected in multiple individuals),
several overlapped with disease-associated or pharmacogenetics-
related genes such as WWOX and GSTT1, which have also been
observed in the PennCNV data (Supplementary Table 2). Further-
more, the deletion frequencies were comparable between the Birdseye
and PennCNV data. For example, a deletion locus overlapped with
WWOX was also found in the Birdseye data. It was detected in 29 of
the 87 individuals (33.33%), and a deletion locus encompassing
GSTT1 was deleted at a population frequency of 11.49%. Among
the 196 CNV loci (160 del-loci, 30 dup-loci and 6 del/dup-loci) that
were detected by both the Birdseye and PennCNV data and consistent
in their CNV status, only 21 loci differed significantly (FDRo0.01) in
their frequencies estimated by both sets of data. In addition, the
proportion of del-loci encompassing UCSC genes (24.83%) was much
lower than dup-loci (45.28%); this finding is again consistent with the
PennCNV data.
For the CNV loci detected with the Birdseye data, we also
performed the ‘validation’ steps for overlap with the PennCNV data
and the DGV. As mentioned earlier, we found 196 loci with X50%
reciprocal overlap between the Birdseye and PennCNV data. For the
remaining 445 CNV loci that were not confirmed by PennCNV data,
we found that 322 loci have been cataloged in the DGV (please see
Materials and methods). Therefore, by applying two different ways of
validation, 518 (80.81%) of the 641 CNV loci detected by Birdseye
were considered reliable in this study (Table 4).
Comparison with HapMap phase III populations
The principal component analysis showed distinct clusters for popula-
tions with different ancestries. The first two principal components
(PC1 and PC2) separated the African (ASW, MKK and LWK) and
non-African (CHD, GIH, MEX, SWED and TSI) populations
(Figure 2a). This suggests that the CNP profiles of the African
populations were substantially different from those of the non-African
populations. From the second and fourth principal components (PC2
and PC4), three distinct clusters were observed (Figure 2b). The three
African populations remained as a distinct cluster; however, CHD was
separated from the European populations (MEX, SWED and TSI) and
the Gujarati Indians (GIH). This indicates that the CNP profile of
Gujarati Indians in Houston (Texas, USA) resembles that of the
European populations. Principal component analysis was also per-
formed by restricting only the ‘European cluster’ populations
Table 3 Correlation between CNPs and GWAS-SNPs at r240.5
CNP ID Chromosome Start position End position Length GWAS-SNP r2 value Gene Complex disease/trait
60 1 72541 504 72 583 736 42232 rs2815752 1 NEGR1 BMI
147 1 194 997 658 195 068 695 71037 rs6428370 0.647399825 Intergenic Acute lymphoblastic leukemia (childhood)
333 2 203 608 045 203 610 291 2246 rs6725887 0.84632626 WDR12 Myocardial infarction (early onset)
874 5 150 185 693 150 198 797 13104 rs13361189 0.927251567 IRGM Crohn’s disease
874 5 150 185 693 150 198 797 13104 rs1000113 0.927251567 IRGM Crohn’s disease
874 5 150 185 693 150 198 797 13104 rs11747270 0.927251567 IRGM Crohn’s disease
877 5 155 409 350 155 415 307 5957 rs4704970 1 SGCD Multiple sclerosis
933 6 32539 530 326 81 749 142 219 rs3129934 0.664781909 HLA-DRB1 Multiple sclerosis
Abbreviations: BMI, body mass index; CNPs, copy number polymorphisms; GWAS, genome-wide association studies; SNP, single-nucleotide polymorphism.
A full colour version of this Table is available at the Journal of Human Genetics Journal online.
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(GIH, MEX, SWED and TSI) in PC2 versus PC4 (Figure 2b). More
interestingly, we also found that the CNP profile of the Swedish
population was substantially different from that of the other popula-
tions such as GIH and MEX, but it was also appreciably different
from that of TSI (Figure 2c). These differences further justify the
need to detect and characterize the CNV/CNP profile of the Swedish
population.
Characteristics of ROHs
By restricting ROHs toX500 kb, a total of 14 815 regions were found
in the 87 Swedish individuals with an average of 170 ROHs (Supple-
mentary Table 5). The number of ROHs ranged from 105 to 220. The
majority of these ROHs wereo1 Mb in length (Supplementary Figure
3). However, by restricting ROHs to X1 Mb, 2814 ROHs with an
average of 32 ROHs per individual were found. The median size of the
ROHs was approximately 686 kb, with the largest ROH spanning a
length of approximately 25 Mb in chromosome 11. This ROH con-
tained 9034 homozygotes, 29 heterozygotes and 2 missing genotypes,
and had a density of 3.6 SNPs per 10 kb. The second largest ROH was
12 Mb in length and was detected in a different individual. This ROH
contained 1571 homozygotes and 19 heterozygotes and had a density
of 1.3 SNPs per 10 kb. The sum of the length of ROHs in each
individual (that is, the total length of all the ROHs in one individual)
was then computed. It ranged from approximately 87 to 179 Mb
with a median and mean of approximately 141 Mb, respectively.
This finding suggests that, on average, 141 Mb or 4.92% of the
human genome (2867 Mb) was homozygous in these Swedish indivi-
duals (Table 5).
The distribution pattern of these ROHs in the 22 autosomes was
also studied. The larger chromosomes (chromosomes 1–8) tended to
have a higher average number of ROHs per individual (Table 5).
For example, these chromosomes had an average number of 49
ROHs per individual, and in contrast, an average number of o5
ROHs per individual was detected in chromosomes 16–22. As a
result, chromosomes 1–8 also had a higher average sum of length of
ROHs per individual (47 Mb) than the smaller chromosomes,
that is, o4 Mb for chromosomes 16–22. However, this pattern was
less obvious when the parameters were adjusted for the sizes of the
chromosomes. For example, the proportion of the chromosome
encompassed by ROHs for the largest chromosome 1 (4.78%) was
smaller than that for the other chromosomes such as chromosome 17
(5.14%). An apparent trend is not observed for the proportion
of the chromosome encompassed by ROHs across the 22 autosomes.
However, chromosomes 3, 4, 8 and 12 tended to have the highest
proportions (5.90–6.16%), and, in contrast, chromosomes 16, 19, 21
and 22 had the lowest proportions (1.76–2.59%). These results were not
due to differences in the density of SNPs across the 22 autosomes, as we
found no substantial differences in the density of SNPs across the
chromosomes (except for chromosome 19, which had a density ofo2
SNPs per 10 kb when compared with the other chromosomes).
Although chromosomes 3 and 4 had 46% of the proportion of the
chromosome encompassed by ROHs, the density of SNPs of these
chromosomes was similar to that of chromosome 16, where only
approximately 2% of this chromosome was covered by ROHs (Table 5).
DISCUSSION
In this study,4600 CNV loci were detected in the Swedish population
using two different CNV-detection algorithms, that is, PennCNV (623
loci) and Birdsuite (641 loci). From these, 196 loci were consistently
identified by both algorithms, suggesting their reliability. In addition,
Table 4 Summary statistics of CNV loci constructed from Birdseye (Birdsuite) output
Summary statistics of CNV loci (Birdseye output) Total Del Dup
Number of CNV loci 641 451 (70.36%)a 159 (24.80%)a
Number of CNV loci detected in X2 individuals 280 (43.68%)b 198 (43.90%)b 51 (32.08%)b
Sum of the length of loci 35.23 Mb 13.10Mb 15.06Mb
Average length per locus 54.96 kb 29.04 kb 94.70 kb
Average number of markers per locus 30 22 42
Size distribution
o10 kb 303 (47.27%) 272 (60.31%) 29 (18.24%)
X10–o50kb 193 (30.11%) 119 (26.39%) 63 (39.62%)
X50–o100 kb 52 (8.11%) 27 (5.99%) 20 (12.58%)
X100–o500 kb 79 (12.32%) 31 (6.87%) 40 (25.16%)
X500 kb 14 (2.18%) 2 (0.44%) 7 (4.40%)
Overlapping with DGV
CNV loci that overlap 465 (72.54%) 335 (74.28%) 106 (66.67%)
CNV loci that did not overlap 176 (27.46%) 116 (25.72%) 53 (33.33%)
Overlapping with UCSC genes
CNV loci that overlap 202 (31.51%) 112 (24.83%) 72 (45.28%)
CNV loci that did not overlap 439 (68.49%) 339 (75.17%) 87 (54.72%)
Overlapping with CNV loci constructed from Birdseye and consistent in CNV status, that is, del/dup/del+dup
CNV loci that overlap 196 (30.58%) 160 (35.48%) 30 (18.87%)
CNV loci that did not overlap 445 (69.42%) 291 (64.52%) 129 (81.13%)
Abbreviations: CNV, copy number variant; DGV, database of genomic variants; UCSC, University of California Santa Cruz genes.
aThe percentage was calculated by dividing 641 loci.
bThe percentage was calculated by dividing 641, 451 and 159 loci, respectively.
Note: as there are only 31 CNV loci (4.84%) with status del+dup, the summary statistics of these loci were not shown in the table.
A full colour version of this Table is available at the Journal of Human Genetics Journal online.
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we also identified a total of 14 815 ROHs X500 kb or 2814 ROHs
X1 Mb in the Swedish individuals with an average of 170 and 32
regions detected per individual, respectively.
CNVs have been increasingly recognized as a significant source of
genetic variation or diversity in human populations. Detection of
CNVs using SNP genotyping arrays is more cost-effective and afford-
able for population-based studies as compared with sequencing-based
methods, which are limited to only a few individuals.37–39 This has
enabled our study to investigate the population characteristics of
CNVs. Although 4600 CNV loci were identified, only 268 were
detected in at least two individuals by PennCNV. Similarly, Birdseye
also found 280 common CNV loci in the 87 Swedish individuals.
More importantly, these common CNV loci were found to encompass
several disease-related and important drug-metabolizing genes, sug-
gesting that these loci warrant further characterization and study for
their associations with the relevant diseases or traits.
We applied two different algorithms to detect CNV loci as a
validation step; 196 loci were found by both the algorithms and
these loci were also consistent in their CNV status (‘del’, ‘dup’ or
‘del+dup’). In the majority of the 196 loci, the population frequencies
were also in good agreement between PennCNV and Birdseye data,
indicating that these CNV loci are highly reliable. In addition, most of
the CNV loci detected by PennCNV (470%) and Birdseye (480%)
can be ‘validated’ by comparing them with each other and with the
DGV. The proportion of CNV loci overlapping with the DGV was
approximately 62% and 72% for PennCNV and Birdsuite, respectively.
These percentages could be overestimated because of the false-positive
entries in the DGV. Of the 196 CNV loci that were identified by both
algorithms, 53 loci had not been previously cataloged in the DGV,
which represents a subset of reliable novel CNV loci identified in our
study. The list of CNV loci in the DGV is not as yet complete as results
from only 42 published studies were documented as of November
2010 (http://projects.tcag.ca/variation/).
On performing the correlation analysis between CNPs and
GWAS-SNPs, our results also indicated that several CNPs could be
potential causal variants because of their strong correlation with the
GWAS-SNPs. Notably, the strong correlation between the CNPs and
the GWAS-SNPs near NEGR1 and IRGM for body mass index and
Crohn’s disease, respectively, are consistent with previous studies.40,41
Our study has a higher sensitivity than the study by Dı´az de Sta˚hl
et al.,10 which only detected an average of 15 CNVs per individual
compared with our study, which detected an average of 36 CNVs per
individual. An average of 4 clones per CNV was detected in the Dı´az
de Sta˚hl et al. study, whereas in our study, each CNV was detected by
an average of 51 markers (Supplementary Table 1). The ability to
detect smaller CNVs was also demonstrated in our study, because the
average size of CNVs detected by Dı´az de Sta˚hl et al. was approxi-
mately 3.5-fold (358 kb) larger than that in our study. Although Dı´az
de Sta˚hl et al. also clustered individual overlapping CNVs into loci,
their analysis was performed using data from different ancestries
(33 Europeans, 24 Africans and 14 Asians), whereas the CNV loci
constructed in our study were based entirely on the data from 87
Swedish individuals. Therefore, our list of CNV loci and their
frequencies was more representative of the Swedish population.
We did not compare our results with existing data from published
studies because of the methodological issues in CNV and ROH
detection in the different studies. As different studies have used
different platforms, quality control criteria and methods to construct
CNV loci and detect ROHs, comparisons with published studies
would not be valid. Therefore, we would need to analyze the
data from different populations with same analytical procedure.
Furthermore, such a comparison is beyond the scope of the current
paper and will be addressed in a future publication. However, to
provide some preliminary insight into the population differences, we
compared the CNP profiles of the Swedish population with the





















































Figure 2 Principal component analysis comparing the populations. (a)
Swedish and HapMap phase III populations—PC 1 versus PC 2. (b) Swedish
and HapMap phase III populations—PC 2 versus PC 4. (c) Swedish and
three HapMap III populations (GIH, MEX and TSI)—PC 3 versus PC 4.
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we analyzed the CNP output for the HapMap III populations
generated by Canary similar to the Swedish population output. As
expected, the results of our analysis showed that the CNP profile of the
Swedish population was substantially different from that of the African
populations (ASW, MKK and LWK) and CHD. More interestingly, the
CNP profile of the Swedish population was also considerably different
from that of other European populations (MEX and TSI) and GIH.
This further supports the importance of delineating the population
characteristics of CNVs/CNPs in the Swedish population.
There are a number of limitations when using SNP genotyping
arrays to detect CNVs and ROHs, and the CNV and ROH list reported
in our study is not complete. Future studies will require higher
sensitivity methods and larger sample sizes for a more thorough
detection of CNVs and ROHs. Nevertheless, this is the first popula-
tion-based study to investigate the population characteristics of CNVs
and ROHs in the Swedish population. This study found many reliable
CNV loci and also highlighted numerous loci that warrant further
investigation for their medical or pharmacogenetic importance. The
abundance of ROHs detected in the human genome also suggests the
importance of studying their associations with complex phenotypes.
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9 566 6.5 439 197 494 5 048247 140 273252 3.60 42710 3.0
10 722 8.3 612 229 774 7 037124 135 374737 5.20 49608 3.7
11 722 8.3 650 352 277 7 475314 134 452384 5.56 45944 3.4
12 725 8.3 679 233 723 7 807284 132 349534 5.90 43833 3.3
13 482 5.5 360 268 323 4 141015 114 142980 3.63 35158 3.1
14 571 6.6 448 210 796 5 151848 106 368585 4.84 28942 2.7
15 438 5.0 371 570 656 4 270927 100 338915 4.26 26905 2.7
16 192 2.2 159 973 057 1 838771 88827254 2.07 28658 3.2
17 428 4.9 352 288 646 4 049295 78774742 5.14 21347 2.7
18 330 3.8 234 464 335 2 694992 76117153 3.54 27219 3.6
19 184 2.1 143 788 195 1 652738 63811651 2.59 12419 1.9
20 271 3.1 220 116 198 2 530071 62435964 4.05 23487 3.8
21 100 1.1 71684 424 823959 46944323 1.76 12948 2.8
22 112 1.3 100 622 242 1 156577 49691432 2.33 12059 2.4
Abbreviations: ROHs, regions of homozygosity; SNPs, single-nucleotide polymorphisms; UCSC, University of California Santa Cruz genes.
aThe size of chromosome was obtained from UCSC Genome Browser.
A full colour version of this Table is available at the Journal of Human Genetics Journal online.
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ORIGINAL ARTICLE
Copy number polymorphisms in new HapMap III and
Singapore populations
Chee-Seng Ku1,2,8, Shu-Mei Teo1,2,3,8, Nasheen Naidoo1,2, Xueling Sim1,2, Yik-Ying Teo1,2,4,5, Yudi Pawitan6,
Mark Seielstad7, Kee-Seng Chia1,2,6 and Agus Salim1,2,8
Copy number variations can be identified using newer genotyping arrays with higher single nucleotide polymorphisms (SNPs)
density and copy number probes accompanied by newer algorithms. McCarroll et al. (2008) applied these to the HapMap II
samples and identified 1316 copy number polymorphisms (CNPs). In our study, we applied the same approach to 859 samples
from three Singapore populations and seven HapMap III populations. Approximately 50% of the 1291 autosomal CNPs were
found to be polymorphic only in populations of non-African ancestry. Pairwise comparisons among the 10 populations showed
substantial differences in the CNPs frequencies. Additionally, 698 CNPs showed significant differences with false discovery rate
(FDR)o0.01 among the 10 populations and these loci overlap with known disease-associated or pharmacogenetic-related genes
such as CFHR3 and CFHR1 (age related macular degeneration), GSTTI (metabolism of various carcinogenic compounds and
cancers) and UGT2B17 (prostate cancer and graft-versus-host disease). The correlations between CNPs and genome-wide
association studies–SNPs were investigated and several loci, which were previously unreported, that may potentially be implicated
in complex diseases and traits were found; for example, childhood acute lymphoblastic leukaemia, age-related macular degeneration,
breast cancer, response to antipsychotic treatment, rheumatoid arthritis and type-1 diabetes. Additionally, we also found
5014 novel copy number loci that have not been reported previously by McCarroll et al. (2008) in the 10 populations.
Journal of Human Genetics (2011) 56, 552–560; doi:10.1038/jhg.2011.54; published online 16 June 2011
Keywords: Affymetrix SNP Array 6.0; Birdsuite software; copy number polymorphisms; International HapMap III populations;
Southeast Asian populations
INTRODUCTION
The term copy number variation (CNV) was first introduced in 2006
and it is generally defined as additions or deletions in the number of
copies of a particular segment of DNA (larger than 1 kb in length)
when compared with a reference genome sequence.1 The ubiquitous
nature of CNVs in the human genome was underappreciated until
2004,2,3 when these reports stimulated a series of efforts to detect and
characterise CNVs in different populations.4–8 This development has
also resulted in several new terminologies such as copy number
polymorphisms (CNPs), which have been defined as common
CNVs with a population frequency of at least 1%.4
CNVs can be detected using microarray-based methods, but these
have relatively poor resolution when compared with sequencing-based
approaches.9,10 The low resolution of microarray-based methods also
led to imprecise mapping of the breakpoints. This is important when
constructing copy number loci to estimate population frequencies.
Newer genotyping arrays, such as the Illumina Human 1M Beadchip
(Illumina, San Diego, CA, USA) and the Affymetrix SNP Arrays 6.0
(Affymetrix, Santa Clara, CA, USA), have higher single nucleotide
polymorphisms (SNPs) density and copy number probes, resulting
in improved performance of microarray-based methods to detect
CNVs. However, even with higher resolution arrays, the challenge
of identifying common breakpoints still remains. This is largely
due to the early CNV-calling algorithms that identified breakpoints
sample-by-sample, resulting in significant variation of breakpoints.
The Canary algorithm in the Birdsuite software overcomes this
problem by calling CNPs simultaneously across multiple indivi-
duals at pre-defined genomic locations.11 McCarroll et al.4 used the
Canary algorithm to identify 1316 CNPs in the HapMap Phase II
populations. These CNPs were well validated and their sizes were in
agreement with the results from the fosmid paired-end sequencing
experiment.9
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To provide a more global map of CNPs, our study aims to
determine integer copy numbers of the 1316 CNPs set of three
Southeast Asian populations in Singapore, namely Chinese (Sing–
Chinese), Malay (Sing–Malay) and Asian Indian (Sing–Indian), and
the seven populations from the HapMap Phase III.12 The HapMap III
populations studied are people of African ancestry in the southwestern
USA (ASW), the Chinese community in Metropolitan Denver, Colo-
rado, USA (CHD), Gujarati Indians in Houston, Texas, USA (GIH),
the Luhya in Webuye, Kenya (LWK), people of Mexican ancestry in
Los Angeles, California, USA (MEX), the Maasai in Kinyawa, Kenya
(MKK) and the Tuscans in Italy (TSI). The characteristics of CNPs in
the 10 populations will be described and compared. In addition, the
correlation between CNPs and SNPs in the 10 populations will also be
characterised and compared. A special emphasis will be given to
studying the correlation between SNPs in the genome-wide associa-
tion studies (GWAS) catalog (GWAS–SNPs) and CNPs in the 10
populations. Additionally, novel copy number loci that have not been
reported previously by McCarroll et al.4 will also be reported on from
the 10 populations.
MATERIALS AND METHODS
DNA samples and genotyping
The detailed information on the sources of DNA samples, demographic data of
the samples, sample selection and the origin and migration history of the three
Singapore populations (Chinese, Malay and Asian Indian) have been described
in our previous publication.8,13 This study was approved by the National
University of Singapore Institutional Review Board (Reference Code: 07-199E).
In total, 292 DNA samples (99 Chinese, 98 Malay and 95 Indian) were
genotyped using the Affymetrix Genome-Wide Human SNP Array 6.0. Of
the 292 samples, 27 were excluded from subsequent analysis. The final set of
265 samples (93 Chinese, 88 Malays and 84 Indians) was available for analysis
using Birdsuite. There were 135 females and 130 males in the final dataset. The
detailed information on the quality control and sample filtering have also been
described in our previous papers.8,13
HapMap III samples
The CEL-files of the Affymetrix SNP Array 6.0 for the seven populations in
HapMap III were downloaded from the ftp site (ftp://ftp.ncbi.nlm.nih.gov/
hapmap/raw_data/hapmap3_affy6.0/). All the samples were analysed by Bird-
suite, with only unrelated samples included in our study; that is, family-related
samples were removed using the ‘relationships’ file provided by the Interna-
tional HapMap Project. After the sample exclusion step, a total of 594 unrelated
samples from the seven HapMap III populations were analysed: ASW (n¼52),
CHD (n¼89), GIH (n¼89), LWK (n¼90), MEX (n¼53), MKK (n¼132) and
TSI (n¼89).
CNP calling using Canary
The Birdsuite software was used to analyse the Affymetrix SNP Array 6.0
dataset, which consisted of two components for detecting copy number
changes. The first component, Canary, was used to determine the integer copy
number at each of the predefined 1316 CNPs identified by McCarroll et al.4
in the HapMap II samples. These CNPs were found in more than one
HapMap II individual and the sizes of these CNPs were also determined.
The 1316 CNPs were distributed in all the autosomes and sex chromosomes.
However, 25 CNPs located in the sex chromosomes were removed, as CNP
calling in sex chromosomes is more problematic and less accurate. Therefore,
the results reported in this study comprised of only 1291 CNPs in the 22
autosomes. Confidence statistics was used to identify poor quality calls and
only integer copy numbers detected with high confidence (confidence score
o0.1) were reported and used for subsequent analyses. We performed the
Hardy–Weinberg equilibrium analysis as a quality control measure for biallelic
CNPs in all 10 populations. It is recommended that the samples should be
analysed on the basis of the genotyping batches using Birdsuite; therefore, the
samples for Singapore and HapMap III populations were analysed by batch
without separating the samples into each specific population.
FDR correction for population comparisons of the integer copy
numbers of the CNPs
Population differences in the integer copy numbers were examined using the
Fisher’s exact test as implemented by the ‘fisher test’ command in R. The false
discovery rate (FDR) was used in place of the P-value to account for the
multiple-testing problem. We calculated the FDR using the Benjamini and
Hochberg method. We performed two different test procedures: (1) comparing
the integer copy numbers among the 10 populations simultaneously and (2)
pairwise comparisons of the integer copy numbers among the 10 populations.
For each procedure, FDR was computed once to control for all the tests (that is,
in the second procedure, we calculated the FDR once by combining the
P-values from 451291 tests).
Correlation analysis
All the correlation analyses of CNPs and nearby SNPs were done separately for
each of the 10 populations. For each autosomal CNP (restricted to biallelic
CNPs with MAFX5%), SNPs in close proximity with the CNP; that is, within a
200-kb window from the start- and end-position of the CNP were considered.
The square of the Pearson correlation coefficient (r2) for each of the SNPs
(excluding the SNPs used for CNP-calling) found within the 200-kb windows
of the respective CNP was then calculated.
The r2 is the square of the Pearson correlation coefficient between the copy
number genotypes and the SNP genotypes. The copy number genotypes were
obtained using Canary in the Birdsuite algorithm. The SNP genotypes were
obtained using Larry Bird in the Birdsuite algorithms. Larry Bird outputs the
number of allele A (0, 1, 2) and number of allele B (0, 1, 2) for each SNP. We
used the number of allele A for the calculation. Larry Bird generates the number
of allele A and number of allele B for each SNP. As each SNP has two alleles in
total, knowing the number of allele A will inform the number of allele B;
for example, if the number of allele A is 2, then number of allele B should be 0.
The same r2 calculations used for the autosomal CNPs and the
SNPs identified by GWAS were used to explore the potential associations
of CNPs with human diseases and traits. The list of GWAS–SNPs was
downloaded from the National Human Genome Research Institute’s website
(http://www.genome.gov/gwastudies/) on 24 May 2010.
Copy number loci calling using Birdseye and validation
The Birdseye component in Birdsuite was used to detect additional copy
number loci located outside the 1316 CNPs in the 10 populations. Similarly,
only the copy number loci in autosomal chromosomes were detected because
of the inaccuracy of Birdseye in detecting copy number loci in the sex
chromosomes. Copy number calls with low confidence (confidence score
o5) were removed. On the basis of the copy number calls generated by
Birdseye, we constructed novel copy number loci using the methods that we
developed previously.14 All the downstream analyses after Canary and Birdseye
were performed using the software package R (http://www.r-project.org/). The
novel copy number loci identified by Birdseye were compared with data from
the Database of Genomic Variants (http://projects.tcag.ca/variation/) as a
validation step. We defined a copy number locus overlapped with the Database
of Genomic Variants, if the locus overlapped by450% of its length with one or
more entries in the Database of Genomic Variants.
RESULTS
Characteristics of CNPs in the 10 populations
In each of the 10 populations, among the polymorphic CNPs
(Table 1), most were biallelic, where the integer copy numbers were
either exclusively deletions (copy number¼0, 1) or exclusively dupli-
cations (copy number¼3, 4). Among the biallelic CNPs, the majority
did not show significant deviation from Hardy–Weinberg equilibrium
with less than 2% failing a Hardy–Weinberg equilibrium test at
P-value o0.01 in all except three populations—Sing–Chinese
(2.2%), ASW (4.2%) and LWK (2.8%).
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In terms of the proportion of non-polymorphic loci and loci with
varying population frequencies, the Singapore populations were
similar to the HapMap III populations of non-African descent
(CHD, GIH, MEX and TSI) (Table 1 and Supplementary Figure 1).
More than half of the CNPs were non-polymorphic in the Singapore
and HapMap III populations of non-African descent. This was in
contrast to the populations of African descent (ASW, LWK and
MKK), where only 26.41–37.72% of the CNPs were not polymorphic.
They also had higher proportions of CNPs with frequencies ranging
from 1 to 10%, ASW (45.86%), LWK (35.48%) and MKK (39.27%),
compared with the other populations (ranging from 24.63 to 27.50%).
In addition, among all the populations, there were no substantial
differences in the proportion of CNPs with a population frequency
410%. The discrepancy between populations of African descent
and others is largely due to these populations having a larger number
of rarer CNPs with a population frequency o10%. Hence, the
differences between populations of African descent and the others
were primarily in the proportion of non-polymorphic loci and those
with population frequencies o10%. It is also worth noting that the
Sing–Indian and Sing–Chinese populations have almost similar
distributions of polymorphic loci, when compared with the HapMap
III populations with whom they share a similar ancestry (that is, GIH
and CHD, respectively) (Table 1 and Supplementary Figure 1).
The proportion of common (MAFX0.05) biallelic CNPs that were
highly correlated with at least one SNP (r240.8) was approximately
50% for non-African populations, but a lower proportion for African
populations; that is, ASW (35.34%), LWK (34.84%) and MKK (37.39%).
The majority of the common biallelic CNPs were ‘deletions’. There
was a substantial difference in the proportion that was highly corre-
lated with at least one SNP for CNPs categorised as ‘deletions’ and
‘duplications’. However, this substantial difference could be biased
because of the small number of ‘duplications’ (Table 2). The strength
of correlation or the r2 value decreased with distance between the
CNP and SNP (Supplementary Figure 2).
We further investigated whether CNPs that were not well tagged
were located in the genomic regions where SNP markers are sparse.
The correlation patterns did not seem to be affected by the number
of nearby SNPs and the MAF of CNPs. There was no apparent
difference in the number of nearby SNPs and the MAF of CNPs
between (a) the CNPs that were in strong correlation (r240.8) and
(b) CNPs that were not in strong correlation with SNPs (Supplementary
Figures 3a and b). However, smaller sizes of CNPs were generally in
strong correlation with more SNPs than the larger CNPs (Supplemen-
tary Figure 3c). These results were consistent across the 10 populations.
Population differences in the integer copy numbers of the CNPs
Out of the 698 CNPs (FDRo0.01) that differed between the 10 popula-
tions, several loci encompassed known disease- or traits-associated or
pharmacogenetic-related genes (Supplementary Table 1). These included
WWOX, ERBB4 and TP63 (cancers), ADAMTSL3 (height), CFHR3
and CFHR1 (age-related macular degeneration), GSTT1 (metabolism
of various carcinogenic compounds and cancers), UGT2B17 (prostate
cancer and graft-versus-host disease) and CYP2A6 (metabolism of
various drugs). There was a large interpopulation difference in the
frequencies of some of the CNPs overlapping these genes. For
example, CNP2203, which overlaps with the tumour suppressor
geneWWOX, was not polymorphic in CHD, whereas it had a deletion
frequency of 2.38% in Sing–Chinese and 7.32% in Sing–Malay
(Table 3 and Supplementary Table 2). In contrast, the deletion
frequency was 51.81% in Sing–Indian and 48.86% in GIH. Similarly,
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deletion frequencies in Sing–Chinese (10.75%), Sing–Malay (12.64%)
and CHD (15.73%) that was substantially lower than the other
populations.
Another CNP of interest was CNP2560, a 46-kb deletion that overlaps
with GSTT1. GSTT1 is an important detoxification enzyme and has a
key role in metabolism of carcinogenic compounds. The total deletion
frequency of this CNP was high in all the 10 populations ranging from
56.63 to 96.77% (Table 3 and Supplementary Table 2). Sing–Indians
had a considerably lower total deletion frequency (56.63%) than
Sing–Malays (85.06%) and Sing–Chinese (96.77%). This difference
is attributable to two-copy deletion, as the difference in two-copy
deletion frequency ranged from 15.66% in Sing–Indian, 32.18% in
Sing–Malay and 46.24% in Sing–Chinese. The two Chinese popula-
tions had the highest two-copy deletion frequency (CHD, 41.57%).
Conversely, both the Indian populations had the lowest two-copy
deletion frequency (GIH, 17.98%).
CNP603 is a 125-kb deletion that overlaps with TMPRSS11E and
UGT2B17. The entire UGT2B17 gene is within the deletion locus, but
only one exon from TMPRSS11E was deleted. The deletion frequency
of CNP603 was very different in Asian and non-Asian populations
(Table 3 and Supplementary Table 2). Asian populations (Sing–
Chinese, Sing–Malay, Sing–Indian, CHD and GIH) had higher fre-
quencies, which ranged from 82.14 to 100%, when compared with
populations of European and African ancestry (48.08–67.18%). The
differences were even more apparent for two-copy deletions with the
highest frequencies in CHD (70.79%), Sing–Chinese (65.59%) and
Sing–Malay (52.87%), followed by the two Indian populations, GIH
(37.04%) and Sing–Indian (30.95%), whereas the European and
African populations were in the lower end of the spectrum with
frequencieso20%. Generally, this trend was reversed for the frequency
of one-copy deletions especially in the Singapore populations
(Sing–Chinese 33.33%, Sing–Malay 42.53% and Sing–Indian 51.19%).
The number of CNPs that showed significant differences
(FDRo0.01) in pairwise comparisons of the 10 populations are
shown in Table 4. Only 19 CNPs showed significant differences
between Sing–Chinese and CHD, and 12 CNPs between Sing–Indian
and GIH, suggesting that the CNPs profile in the two Chinese and two
Indian populations were very similar (Supplementary Figure 4).
Through these pairwise comparisons (Table 4 and Supplementary
Figure 4), the 10 populations can be divided into three groups
representing Asian, European and African ancestry: (a) Sing–Chinese,
Sing–Malay and CHD, (b) Sing–Indian, GIH, MEX and TSI, (c) ASW,
LWK and MKK. The CNPs profiles of Sing–Indian and GIH were
closer to European populations (MEX and TSI).
Correlation analysis between CNPs and GWAS-SNPs
To investigate the potential role of CNPs in the aetiology of complex
diseases or traits, we computed the r2 between CNPs and the SNPs in
Table 2 The number and proportion (%) of common (MAFX0.05) biallelic (a) CNPs, (b) deletions, (c) duplications that were highly correlated























Sing–Chinese 194 104 53.61 174 103 59.20 20 1 5.00
Sing–Malay 190 106 55.79 170 105 61.76 20 1 5.00
Sing–Indian 210 115 54.76 190 112 58.95 20 3 15.00
ASW 266 94 35.34 241 94 39.00 25 0 0.00
CHD 201 112 55.72 181 110 60.77 20 2 10.00
GIH 216 117 54.17 197 117 59.39 19 0 0.00
LWK 263 89 33.84 242 87 35.95 21 2 9.52
MEX 229 105 45.85 204 104 50.98 24 1 4.17
MKK 230 86 37.39 210 86 40.95 20 0 0.00
TSI 205 105 51.22 183 103 56.28 22 2 9.09
Abbreviations: ASW, African ancestry in the southwestern USA; CHD, Chinese community in Metropolitan Denver, Colorado, USA; CNPs, copy number polymorphisms; GIH, Gujarati Indians in
Houston, Texas, USA; LWK, Luhya in Webuye, Kenya; MAF, minor allele frequency; MEX, Mexican ancestry in Los Angeles, California, USA; MKK, Maasai in Kinyawa, Kenya; Sing, Singapore;
SNPs, single-nucleotide polymorphisms; TSI, Tuscans in Italy.
r2, Square of the Pearson correlation coefficient.
Table 3 CNPs (FDRo0.01) that overlap with known disease-associated or pharmacogenetic-related genes
CNP Gene Sing–Chinese Sing–Malay Sing–Indian ASW CHD GIH LWK MEX MKK TSI
CNP2203 WWOX 2.38a 7.32 51.81 66.67 0.00 48.86 40.00 67.31 28.35 68.18
CNP340 ERBB4 0.00 2.33 12.05 7.69 0.00 17.24 0.00 0.00 0.00 4.49
CNP530 TP63 64.84 48.24 27.38 30.77 68.54 31.82 31.82 9.62 32.06 6.90
CNP2118 ADAMTSL3 67.05 46.84 11.54 38.46 51.19 4.49 49.40 24.32 48.80 19.51
CNP147 CFHR3, CFHR1 11.83 12.64 53.57 59.62 15.73 58.43 59.09 18.87 42.42 43.82
CNP2560 GSTT1 96.77 85.06 56.63 72.00 92.13 70.79 75.56 71.70 80.15 67.06
CNP603 UGT2B17 100.00 95.40 82.14 48.08 98.88 86.42 63.33 58.49 67.18 58.43
CNP2415 CYP2A6 18.89 36.25 5.13 6.00 23.86 11.49 8.05 2.04 8.80 4.60
Abbreviations: ASW, African ancestry in the southwestern USA; CHD, Chinese community in Metropolitan Denver, Colorado, USA; CNPs, copy number polymorphisms; FDR, false discovery rate;
GIH, Gujarati Indians in Houston, Texas, USA; LWK, Luhya in Webuye, Kenya; MEX, Mexican ancestry in Los Angeles, California, USA; MKK, Maasai in Kinyawa, Kenya; Sing, Singapore; TSI,
Tuscans in Italy.
aPopulation frequency (%)¼deletion frequency+duplication frequency.
CNPs in HapMap III and Singapore populations
C-S Ku et al
555
Journal of Human Genetics
the National Human Genome Research Institute GWAS catalog.
Out of the 42500 GWAS–SNPs that have been found to be associ-
ated with various complex diseases and traits, only 17 GWAS–SNPs
were found to be in strong correlation with 12 CNPs (Table 5 and
Supplementary Tables 3 and 4). In this analysis, we defined a strong
correlation as r240.5, following Conrad et al.5 These 17 SNPs were
reported to be associated with 14 diseases or traits and the notable
phenotypes that were observed consistently across the populations
were body mass index, Crohn’s disease, multiple sclerosis, myocardial
infarction and prostate cancer. Several SNPs were in strong correlation
with a single CNP; for example, three SNPs (rs13361189, rs1000113,
rs11747270) were found to be in strong correlation with CNP874.
Of the 33 copy number loci identified by Conrad et al.,5 which were
in strong correlation with GWAS–SNPs, seven were also identified in
our study which had 450% overlap in length. The remaining five
CNPs in our study were associated with childhood acute lympho-
blastic leukaemia, age-related macular degeneration, breast cancer,
response to antipsychotic treatment, rheumatoid arthritis and type-1
diabetes (Table 5 and Supplementary Tables 3 and 4).
Several SNPs were consistently found to be in strong correlation
with four CNPs (CNP60, CNP874, CNP877 and CNP333) in all
populations. The most notable was rs2815752 near the NEGR1
gene (associated with body mass index), which is in perfect correla-
tion (r2¼1) with CNP60 in all the 10 populations (Table 5 and
Supplementary Table 3). This locus is a 42-kb deletion located
in chromosome 1, which did not overlap with any of the UCSC
(University of California, Santa Cruz) genes and it is located only
1.3 kb away from the SNP. The total deletion frequency in the
three Singapore populations was high (Figure 1a and Supplementary
Table 5). There were, however, differences in the frequency of two-
copy deletion. More than 80% of the Sing–Chinese and Sing–Malay
samples were deleted in both copies, but only about 41% for the
Sing–Indian samples. The pattern is similar between Sing–Chinese
and CHD, as well as Sing–Indian and GIH. The frequency of two-
copy deletion frequency varied substantially across the 10 popula-
tions, from the lowest in the LWK population (26.97%) to the highest
in Sing–Chinese (87.10%). A significant difference in the two-copy
deletion frequency of CNP60 was seen between Asian populations
(480% for Sing–Chinese, Sing–Malay and CHD) compared with
African populations (o35% for ASW, LWK and MKK), whereas the
frequency of the Sing–Indian and GIH resembles European popula-
tions (MEX and TSI) (Supplementary Table 5).
CNP874 was found to be in strong correlation with three GWAS–
SNPs located near the IRGM gene, which is associated with Crohn’s
disease. This strong correlation pattern was consistent across the 10
populations (Table 5). Most of the individuals carried either deletions
or had a diploid copy. This locus spans 13 kb in chromosome 5 and
did not overlap with any of the UCSC genes. The SNPs were located
4.8 kb (rs13361189), 21.4 kb (rs1000113) and 40.2 kb (rs11747270)
away from the deletion. The differences in the frequency of two-copy
deletion of CNP874 appeared to divide the 10 populations into two
clusters. The populations of European ancestry (MEX and TSI) and
Indian populations (Sing–Indian and GIH) had a frequencyp6.41%,
but the other populations had higher frequencies, which ranged from
10% to 20.69% (Figure 1b and Supplementary Table 5). We also found
a substantially lower frequency of two-copy deletion in the Sing–
Indian (6.41%) compared with the Sing–Chinese (15.22%) and the
Sing–Malay (11.49%) populations.
The CNP877 locus has been implicated in multiple sclerosis. It was
however not polymorphic in the Sing–Chinese (Figure 1c and Sup-
plementary Table 5). The total deletion frequencies for Sing–Malay
and CHD were 2.30 and 1.14%, respectively. However, we found a
much higher total deletion frequency for the other seven populations,
which ranged from 17.05 to 42.53%.
Novel copy number loci in the 10 populations
The second component of the Birdsuite software, Birdseye, was used
to identify novel copy number loci in the 10 populations. We
subsequently found 5947 copy number loci, of which 933 loci were
excluded because of overlap with the 1291 autosomal CNPs identified
by McCarroll et al.4 As a result, only 5014 were novel copy number
loci; that is, had not been previously found by McCarroll et al.4
Of these, 1448 loci were detected in two or more individuals in
the 10 populations (Table 6). The list of these loci is available
in Supplementary Table 6. Using a more stringent definition of
‘common’ novel copy number loci (population frequency X1%),
there were only 170 loci and of these, 42 loci had a population
frequency X5%.
Of the 1448 novel copy number loci, 763 (52.69%) were found to
overlap with the data from the Database of Genomic Variants.
Although for the 170 loci, the overlap was 78.82% (Table 6). Addi-
tionally, we also found that 86.54% of the 1448 loci were biallelic; that
is, these loci contained either deletions (48.76%) or duplications
(37.78%). The remaining loci were found to have both deletions
and duplications. The majority of these loci did not overlap with the
UCSC genes (62.43%). Of the 170 loci, 37.06% contained both
deletions and duplications and the majority of these loci also did
not overlap with the UCSC genes (52.35%).
Table 4 The number of CNPs that showed significant differences (FDRo0.01) in the pairwise comparisons among the 10 populations
Population Sing–Chinese Sing–Malay Sing–Indian ASW CHD GIH LWK MEX MKK TSI
Sing–Chinese — 6 84 137 19 106 209 81 199 141
Sing–Malay — — 46 125 26 72 197 59 180 126
Sing–Indian — — — 93 88 12 186 32 147 54
ASW — — — — 132 95 13 69 18 90
CHD — — — — — 113 196 77 192 130
GIH — — — — — — 170 35 155 52
LWK — — — — — — — 123 33 176
MEX — — — — — — — — 97 27
MKK — — — — — — — — — 146
TSI — — — — — — — — — —
Abbreviations: ASW, African ancestry in the southwestern USA; CHD, Chinese community in Metropolitan Denver, Colorado, USA; CNPs, copy number polymorphisms; FDR, false discovery rate;
GIH, Gujarati Indians in Houston, Texas, USA; LWK, Luhya in Webuye, Kenya; MEX, Mexican ancestry in Los Angeles, California, USA; MKK, Maasai in Kinyawa, Kenya; Sing, Singapore;
TSI, Tuscans in Italy.
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DISCUSSION
The finding that approximately 50% of the CNPs identified by the
McCarroll et al.4 study were not polymorphic in all of the three
Singapore populations and the HapMap III populations (CHD, GIH,
MEX and TSI) suggests that the CNPs found in the ‘reference’
HapMap II populations are not necessarily polymorphic or common
in other populations. This finding, together with the identification of
novel copy number loci other than those found using the HapMap II
populations, highlights the importance of characterising CNPs in
different populations.
In addition, we also found several hundred CNPs that showed
significant differences in integer copy numbers among the 10 popula-
tions. More interestingly, many of these loci encompass genes of
medical relevance. For example, we found a markedly lower deletion
frequency at CNP2203 (which is associated with the WWOX gene) in
Sing–Chinese and Sing–Malay compared with other populations.
WWOX is a tumour suppressor gene affected in multiple cancers.15
On the other hand, deletion of the UGT2B17 gene was also been found
to be associated with an increased risk of prostate cancer.16,17 The
functional role of the UGT2B17 enzyme is clear in prostate cancer, as it
is involved in steroid hormone (androgen) metabolism. The mismatch
of UGT2B17 copy numbers in donors and recipients of stem cell
transplantation were also associated with an increased risk of graft-
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Figure 1 Total, two-copy and one-copy deletion frequencies of (a) CNP60, (b) CNP874 and (c) CNP877 in 10 populations.
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show substantial differences between the Singapore and HapMap III
populations. Although a direct association between the CNPs and
phenotypic differences is not established in our study, collectively our
results suggest that CNPs distributions are substantially different
between populations and thus, may account for phenotypic differ-
ences between them.
We found 12 CNPs that may have potential implications in various
diseases and traits; however, only five of them have not been reported
by Conrad et al.,5 who found evidence of correlations for 33 copy
number loci with GWAS–SNPs at r240.5. The difference in the
number of loci found to be in correlation with GWAS–SNPs between
our study and the Conrad et al.5 study is likely due to the limitation
that we only focused on the 1291 CNPs, whereas Conrad et al.5
studied the whole genome. Furthermore, it could also be due to the
difference in the marker density of the microarrays used in our study
and the Conrad et al.5 study. We used the Affymetrix SNP Array 6.0,
whereas they used a set of 20 oligonucleotide-CGH arrays, comprising
42 million probes. The differences in marker density will contribute to
the differences in sensitivity of detection.5
Several previous studies have reported correlations between CNVs
and GWAS–SNPs. For example, deletions near IRGM and NEGR1
genes, which were in perfect linkage disequilibrium (LD) with the
GWAS–SNPs, were identified for Crohn’s disease and body mass
index, respectively.19,20 Our study also showed strong correlations
between CNPs and GWAS–SNPs near IRGM and NEGR1 in all
10 populations, but the deletion frequencies varied substantially
among the populations. GWAS–SNPs are potentially indirect markers
of disease variants, which include CNPs. This may have important
clinical implications if these deletions are true disease variants.
A recent paper published by the International HapMap Consortium
also studied CNPs in the HapMap III populations.12 However, they
merged and analysed the probe-level intensity data from both the
Affymetrix SNP Array 6.0 and the Illumina 1M Beadchip arrays. In
contrast, we only analysed the Affymetrix SNP Array 6.0 data and
focused primarily on the 1291 CNPs identified previously, as only the
raw signal intensity files of this array were available from the HapMap
website. A total of 1610 CNPs with an estimated frequency of at least
1% of the cohort were identified in the HapMap III populations by the
International HapMap Consortium. They also found that most CNPs
also occurred at a low frequency.12 This was consistent with our study
where among the polymorphic CNPs, the majority also occurred at a
low frequency (o10%). Similarly, the finding that the frequency
spectrum of common CNPs (410%) was similar across populations
by the International HapMap Consortium was in good agreement
with our results (Table 1).
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CNPs in HapMap III and Singapore populations
C-S Ku et al
559
Journal of Human Genetics
10 Korbel, J. O., Urban, A. E., Affourtit, J. P., Godwin, B., Grubert, F., Simons, J. F. et al.
Paired-end mapping reveals extensive structural variation in the human genome.
Science 318, 420–426 (2007).
11 Korn, J. M., Kuruvilla, F. G., McCarroll, S. A., Wysoker, A., Nemesh, J., Cawley, S. et al.
Integrated genotype calling and association analysis of SNPs, common copy number
polymorphisms and rare CNVs. Nat. Genet. 40, 1253–1260 (2008).
12 International HapMap 3 Consortium. Integrating common and rare genetic variation in
diverse human populations. Nature 467, 52–58 (2010).
13 Teo, Y. Y., Sim, X., Ong, R. T., Tan, A. K., Chen, J., Tantoso, E. et al. Singapore Genome
Variation Project: a haplotype map of three Southeast Asian populations. Genome Res.
19, 2154–2162 (2009).
14 Mei, T. S., Salim, A., Calza, S., Seng, K. C., Seng, C. K. & Pawitan, Y. Identification of
recurrent regions of Copy-Number Variants across multiple individuals. BMC Bioinfor-
matics 11, 147 (2010).
15 Lewandowska, U., Zelazowski, M., Seta, K., Byczewska, M., Pluciennik, E. & Bednarek,
A. K. WWOX, the tumour suppressor gene affected in multiple cancers. J. Physiol.
Pharmacol. 60, 47–56 (2009).
16 Park, J., Chen, L., Ratnashinge, L., Sellers, T. A., Tanner, J. P., Lee, J. H. et al. Deletion
polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in
African American and Caucasian men. Cancer Epidemiol. Biomarkers Prev. 15,
1473–1478 (2006).
17 Karypidis, A. H., Olsson, M., Andersson, S. O., Rane, A. & Ekstro¨m, L. Deletion
polymorphism of the UGT2B17 gene is associated with increased risk for prostate
cancer and correlated to gene expression in the prostate. Pharmacogenomics J. 8,
147–151 (2008).
18 McCarroll, S. A., Bradner, J. E., Turpeinen, H., Volin, L., Martin, P. J., Chilewski, S. D.
et al. Donor-recipient mismatch for common gene deletion polymorphisms in graft-
versus-host disease. Nat. Genet. 41, 1341–1344 (2009).
19 McCarroll, S. A., Huett, A., Kuballa, P., Chilewski, S. D., Landry, A., Goyette, P. et al.
Deletion polymorphism upstream of IRGM associated with altered IRGM expression
and Crohn’s disease. Nat. Genet. 40, 1107–1112 (2008).
20 Willer, C. J., Speliotes, E. K., Loos, R. J., Li, S., Lindgren, C. M., Heid, I. M. et al.
Six new loci associated with body mass index highlight a neuronal influence on body
weight regulation. Nat. Genet. 41, 25–34 (2009).
Supplementary Information accompanies the paper on Journal of Human Genetics website (http://www.nature.com/jhg)
CNPs in HapMap III and Singapore populations
C-S Ku et al
560
Journal of Human Genetics




Regions of homozygosity and their impact on complex diseases 
and traits
Chee Seng Ku · Nasheen Naidoo · Shu Mei Teo · 
Yudi Pawitan 
Received: 8 August 2010 / Accepted: 4 November 2010 / Published online: 23 November 2010
©  Springer-Verlag 2010
Abstract Regions of homozygosity (ROHs) are more
abundant in the human genome than previously thought.
These regions are without heterozygosity, i.e. all the genetic
variations within the regions have two identical alleles. At
present there are no standardized criteria for deWning the
ROHs resulting in the diVerent studies using their own crite-
ria in the analysis of homozygosity. Compared to the era of
genotyping microsatellite markers, the advent of high-den-
sity single nucleotide polymorphism genotyping arrays has
provided an unparalleled opportunity to comprehensively
detect these regions in the whole genome in diVerent popula-
tions. Several studies have identiWed ROHs which were
associated with complex phenotypes such as schizophrenia,
late-onset of Alzheimer’s disease and height. Collectively,
these studies have conclusively shown the abundance of
ROHs larger than 1 Mb in outbred populations. The homo-
zygosity association approach holds great promise in identi-
fying genetic susceptibility loci harboring recessive variants
for complex diseases and traits.
Introduction
Human genetic variations are the diVerences in DNA
sequences within the genome of individuals within popula-
tions. These variations can take many forms, including sin-
gle nucleotide variants or substitutions, tandem repeats
(short tandem repeats and variable number of tandem
repeats), small indels (insertions and deletions of a short
DNA sequence), duplications or deletions that change the
copy number of a larger segment of a DNA sequence
(¸1 kb) i.e. copy number variations (CNVs), and other
chromosomal rearrangements such as inversions and trans-
locations (also known as copy-neutral variations) (Nakamura
2009; Frazer et al. 2009; Ku et al. 2010a). The amount of
genetic variation in the human genome is more abundant
than previously thought, and this has been further corrobo-
rated with the Wndings from whole genome resequencing
studies where several million single nucleotide polymor-
phisms (SNPs) and several hundred thousand indels and
structural variants were identiWed (Wheeler et al. 2008;
Bentley et al. 2008; Wang et al. 2008; Kim et al. 2009).
In addition to SNPs (Altshuler et al. 2008; HindorV et al.
2009), other genetic variations have also been found to be
associated with various complex diseases and traits
(Haberman et al. 2008; Hannan 2010; Wain et al. 2009;
Stankiewicz and Lupski 2010).
By comparison, the region of homozygosity (ROH) is
not currently classiWed as a type of genetic variation as
there is no consensus on whether it should be classiWed as
one type of ‘structural’ genetic variation. The reasons for
this are two fold: (a) the ROH is not a ‘genetic alteration’ of
the DNA sequence like other genetic variations and, (b) the
research on their genome-wide mapping is still relatively
new. However, the extent of ROHs varies among individu-
als and between diVerent populations. In comparison to
other types of genetic variations where the inter-population
diVerences have been well documented (International
HapMap Consortium 2005, 2007; Jakobsson et al. 2008;
Teo et al. 2009), published data has increasingly shown the
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inter-individual and inter-population variations in the pro-
Wles of homozygosity (Gibson et al. 2006; McQuillan et al.
2008; Nothnagel et al. 2010; O’Dushlaine et al. 2010).
Research on ROHs has started to gain impetus, as is evi-
denced by the increasing numbers of publications after the
Wrst study by Gibson et al. (2006) reporting its abundance
in the human genomes of outbred populations. Further
studies have investigated the population genetics aspects of
ROHs in healthy individuals (Li et al. 2006; McQuillan
et al. 2008; Nothnagel et al. 2010; Nalls et al. 2009b), and
also performed association analyses to identify ROHs that
are associated with complex diseases and traits in a case–
control study design (Lencz et al. 2007; Nalls et al. 2009a;
Vine et al. 2009; Yang et al. 2010b).
The aim of this paper is to review the recent progress
and to elaborate on the issues and challenges in genome-
wide mapping of ROHs in the human genome using high-
density SNPs genotyping arrays in normal populations and
in disease association studies. We also highlight the Wnd-
ings showing associations between ROHs and complex
phenotypes. Finally, we discuss the future directions and
the potential applications of ROHs as surrogate markers in
identifying recessive loci for complex phenotypes. This
approach is also known as ‘genome-wide homozygosity
association’ and could be a promising alternative to Wnding
the ‘missing heritability’ for complex phenotypes (Manolio
et al. 2009). Population genetics and selection pressure on
ROHs are brieXy discussed, as these topics are beyond the
scope of this review paper. Other interesting areas of ROHs
research such as studies of homozygosity in inbreeding and
isolated populations and Wndings from animal and plant
genetics deserve to be reviewed in a separate paper.
What is a region of homozygosity?
A ROH deWnes a continuous or uninterrupted stretch of a
DNA sequence without heterozygosity in the diploid state,
that is in the presence of both copies of the homologous
DNA segment. Thus, all the genetic variations, such as
SNPs (biallelic marker) or microsatellites (multiallelic
marker) within the homologous DNA segments have two
identical alleles that create homozygosity (Gibson et al.
2006). The ROH is diVerent from one-copy deletion (or
hemizygous deletion), which could also lead to the homo-
zygosity, e.g. in genome-wide SNPs genotyping data. How-
ever this is considered as a ‘spurious homozygosity’
because only one allele of the SNPs is present in the deleted
region for one-copy deletions. Thus, the DNA fragments
with only the single allele are hybridized on the genotyping
array. As a result, the signal intensity of only one allele is
measured and subsequently used in genotype calling, and
hence it would be incorrectly labeled a homozygote
genotype. Therefore, the result of ‘homozygosity’ is due to
the absence of the other allele, instead of ‘true homozygos-
ity’ where two identical alleles are present (PeiVer et al.
2006). The distinction between ‘true homozygosity’ as
opposed to ‘spurious homozygosity’ due to one-copy dele-
tion is diYcult to determine just by inspection of the geno-
type data alone. The allelic signal intensity ratio (the
relative ratio of the Xuorescent signals between two probes/
alleles at each SNP) is needed to diVerentiate between the
two types of homozygosity (PeiVer et al. 2006; Wang et al.
2007). Therefore, for studies that used only SNPs genotype
data to identify the ROHs, i.e. to screen regions with a mini-
mum consecutive homozygote SNPs, the possibility that
some regions are caused by one-copy deletion cannot be
Wrmly excluded, because deletions are also widespread in
the human genome (McCarroll et al. 2008; Conrad et al.
2010).
Cytogenetic abnormalities such as uniparental isodisomy
can also result in homozygosity where two copies of a sin-
gle parental homologous DNA segment are inherited from
one parent. As such it cannot be distinguished from homo-
zygosity resulting from other factors such as parental con-
sanguinity using the allelic signal intensity ratio as in the
case of one-copy deletion. Thus for studies that involved
unrelated samples where checking the Mendelian transmis-
sion errors in the ROHs is not possible, the possibility of
uniparental isodisomy leading to homozygosity cannot be
deWnitively ruled out. Assessing the transmission errors
requires data from trios or families. However, the likeli-
hood that a considerable fraction of ROHs will be
accounted for by uniparental isodisomy is low given that
this cytogenetic abnormality is rare (Curtis 2007).
Currently, there is no consensus or standardized criteria
used to deWne the ROH. However, previous studies have
focused on regions ¸1 Mb, and thus the true extent of
homozygosity in the human genome could be underesti-
mated (Gibson et al. 2006; Li et al. 2006). More recent
studies have deWned a ROH at a minimum length of 500 kb
(Yang et al. 2010b) with the intention of avoiding underes-
timation of the numbers of regions in the human genome.
This is because shorter ROHs are now also thought to be
associated with complex phenotypes. However, setting a
shorter length for deWnition will increase the number of
false positive signals i.e. increase the sensitivity at the
expense of speciWcity. Therefore, in discovery studies, bal-
ancing both the sensitivity and speciWcity when setting the
criteria to identify ROHs is critical.
By focusing only on regions ¸500 kb or 1 Mb, the
‘noise’ introduced by one-copy deletions is likely to be
minimal, thus reducing the potential to cause spurious
homozygosity. This is because large deletions of ¸500 kb
are relatively rare in the human genome—as supported by
data from high-resolution genome-wide mapping of CNVs
Hum Genet (2011) 129:1–15 3
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studies (McCarroll et al. 2008; Conrad et al. 2010; Ku et al.
2010b; Park et al. 2010a; Yim et al. 2010). Therefore, a crit-
ical issue to be addressed in future homozygosity mapping
studies is determining the optimal cutoV of the length of the
ROH to be adopted, as this will avoid over-estimating the
homozygosity when the length is set too low and which can
then be easily confounded by one-copy deletion of hundreds
of kilobases or smaller. Although some studies have
reduced the cutoV length to 500 kb (Yang et al. 2010b), it is
still uncertain whether this new cutoV can readily reXect the
true extent of homozygosity in the human genome.
DeWning criteria and terminologies
Before the term ‘copy number variation (CNV)’ was Wrst
introduced in 2006 (Freeman et al. 2006), various diVerent
terms were used to describe these copy number variable
regions such as ‘large-scale copy number variants’ and
‘intermediate-sized variants’ (Sebat et al. 2004; Iafrate
et al. 2004). To date, various terminologies have also been
used to describe the ROHs such as ‘extended tracts of
homozygosity’ (Gibson et al. 2006), ‘long contiguous
stretches of homozygosity’ (Li et al. 2006), ‘runs of homo-
zygosity’ (Nothnagel et al. 2010; McQuillan et al. 2008),
‘autozygosity regions’ (Nalls et al. 2009b) and ‘homozy-
gosity-by-descent’ (Polasek et al. 2010). DiVerent studies
have used their own criteria in identifying ROHs with some
studies employing more stringent criteria compared to oth-
ers applying a more liberal deWnition (Gibson et al. 2006;
Li et al. 2006; Nothnagel et al. 2010; McQuillan et al.
2008; Nalls et al. 2009b; Curtis et al. 2008). For example,
Curtis et al. (2008) used their own developed software and
the criteria of a minimum of 10 consecutive, homozygous
SNPs extending over 1 Mb. In comparison, other studies
employed the default deWnition implemented in the ‘Runs
of homozygosity’ function in the PLINK software (http://
pngu.mgh.harvard.edu/»purcell/plink/). These criteria are
(a) the length of the ROH ¸1 Mb, (b) a minimum of 100
SNPs per ROH, and (c) a density of at least 1 SNP per
50 kb (Nothnagel et al. 2010). As all the studies are refer-
ring to the same type of ‘DNA sequence feature’ it is essen-
tial to standardize the terminology to be used in describing
these regions to avoid confusion.
Polymorphic markers used to detect ROHs
Although long continuous ROHs have been documented a
decade ago in reference families from the Centre D’etude
Du Polymorphisme Humain (CEPH) (Broman and Weber
1999), no large-scale population-based study had been per-
formed to interrogate the extent of ROHs in the human
genome until the Wrst study by Gibson et al. (2006). The
recent advances in genome-wide mapping or detection of
ROHs have been driven mainly by the availability of highly
accurate SNPs databases such as the International HapMap
Project, and the technology to genotype several hundred
thousand to several million SNPs throughout the human
genome (International HapMap Consortium 2005, 2007;
Gibbs and Singleton 2006; Ragoussis 2009). The early
study in the CEPH families used approximately 8,000 short
tandem repeat markers and detected long continuous
ROHs. In contrast, subsequent studies have applied SNPs
as the polymorphic markers to detect the ROHs (Gibson
et al. 2006; Li et al. 2006; McQuillan et al. 2008; Nothna-
gel et al. 2010; Nalls et al. 2009b). At the single marker
level, short tandem repeats are more informative than SNPs
because they are multiallelic markers. However, SNPs are
more numerous and collectively can yield more informa-
tion than short tandem repeats and oVer a higher resolution
compared to other genetic markers—both of which are
important to accurately identify the numbers and sizes of
ROHs.
Genotyping a large number of SNPs in a microarray
platform presents a powerful tool to detect ROHs compre-
hensively across the whole genome (Gibbs and Singleton
2006; Ragoussis 2009). This also enables investigation into
the number, length or size, and location or distribution of
the ROHs in the human genome in a more unbiased manner
compared to microsatellite markers (Gibson et al. 2006; Li
et al. 2006; McQuillan et al. 2008; Nothnagel et al. 2010;
Nalls et al. 2009b). The SNPs genotyping platforms also
allow studies of the relationship between ROHs and recom-
bination or linkage disequilibrium (LD) patterns, as the
SNPs data can be used for haplotype analyses and to calcu-
late the recombination rates (Curtis et al. 2008). The ability
to investigate the co-occurrence of ROHs in the areas with
extensive LD or low recombination is important in investi-
gating the mechanisms contributing towards the high fre-
quency of ROHs in the human genome.
Genotyping of a suYciently large number of SNPs is
required to accurately detect the ROHs. The study by Gib-
son et al. (2006) used data from the International HapMap
Phase I Project comprising of approximately 1 million
SNPs (International HapMap Consortium 2005), whilst
other studies have used lower density genotyping arrays
ranging from 300,000 to 550,000 SNPs. The importance of
having high-density polymorphic markers was shown by
Gibson et al. (2006) who found the largest ROH of 17.9 Mb
containing 3,922 SNPs from the SNPs data from HapMap
Phase I. However, using the data from HapMap Phase II
comprising of >3 million SNPs (International HapMap
Consortium 2007), a total of 12,778 SNPs were found in
the region with 11 heterozygotes. These heterozygotes
interrupted the ROH and have divided it into 12 smaller
4 Hum Genet (2011) 129:1–15
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segments (Gibson et al. 2006). However, it is unclear
whether these 11 heterozygotes are genotyping errors or
true heterozygotes occurring as a result of recent mutations.
Thus, to account for genotyping errors, studies have
allowed some missing genotypes and heterozygotes for
each ROH to avoid artiWcially splitting the region
(Table 1).
This hints that the sizes of ROHs may be over-estimated
in previous studies when using lower density SNPs geno-
typing arrays. Therefore, the numbers and sizes of ROHs
identiWed by previous studies are likely to be diVerent or
altered when higher density SNPs data is available for anal-
ysis on the same samples. This also implies that a cautious
interpretation should be imposed for ROHs of several
megabases for studies using lower resolution SNPs data. A
higher density of SNPs is needed for a deWnitive assess-
ment of ROHs. Although the SNPs genotyping array is an
invaluable tool to detect ROHs, it is not without limitations.
Similar to CNV detection using SNPs genotyping plat-
forms, the boundaries of the ROHs cannot be determined
accurately at a single nucleotide resolution, as accuracy
depends on the SNPs resolution. Therefore, like CNVs, the
sizes of ROHs could be inXated, i.e. the ROHs detected in
previous studies could be smaller than currently estimated.
However, there is currently no data supporting this specula-
tion for ROHs as compared to CNVs (McCarroll et al.
2008; Perry et al. 2008).
Methods of detecting ROHs
Several targeted and genome-wide molecular methods are
available to detect structural variations such as CNVs (dele-
tions and duplications) and copy-neutral variations (translo-
cations and inversions). However, unlike with structural
variations, ROHs cannot be detected with technologies
used in molecular genetics such as Xuorescence in situ
hybridization (FISH) and bacterial artiWcial chromosome
(BAC) clone or oligonucleotide-based comparative geno-
mic hybridization (CGH) arrays (Carson et al. 2006; Feuk
et al. 2006; Carter 2007). Furthermore, several new
sequencing-based approaches for detecting structural varia-
tions such as paired-end sequencing mapping and depth-of-
coverage of the sequence read are also unWt to detect ROHs
(Korbel et al. 2007; Kidd et al. 2008; Yoon et al. 2009).
The genome-wide mapping of ROHs can only be done
using SNPs genotyping arrays or direct sequencing. The
whole-genome resequencing or de novo genome assembly
using the next or third generation sequencing technologies
will oVer an almost complete solution to detecting most of
the genetic variations including ROHs within the human
genome. However, these high-throughput sequencing tech-
nologies were not readily available until recently, and the
cost is still prohibitively expensive to sequence the whole
human genome in a population-based study (Mardis 2008;
Metzker 2010). As a result, SNPs genotyping arrays are the
main tools for ROH mapping. The SNPs data can be used
in two diVerent ways to detect the ROHs. The Wrst approach
is to screen the whole genome in a sliding window manner
for consecutive SNPs showing homozygotes over a certain
length such as 1 Mb, as implemented in PLINK (Purcell
et al. 2007). Since this approach only uses genotype data, it
is unable to distinguish between true homozygosity and the
spurious homozygosity caused by one-copy deletion with-
out further investigations of CNVs in the samples.
This limitation has been overcome by the second
approach which relies on the signal intensity data. Two
types of signal intensity data are generated by the SNPs
genotyping array: (a) the total signal intensity or log R ratio
(LRR) and (b) the allelic intensity ratio or B allele fre-
quency (BAF). The combination of LRR and BAF can be
used to determine several diVerent states of copy numbers
such as homozygous and hemizygous deletions, and one-
copy and two-copy duplications, and ROHs as imple-
mented in the PennCNV algorithm. The BAF is needed to
diVerentiate between ROH from normal diploid copies and
one-copy deletion (Wang et al. 2007). Figure 1 illustrates
the diVerence in LRR and BAF patterns between ROH and
one-copy deletion. For the one-copy deletion, there is a
decrease in LRR in addition to the absence of heterozygosity
as shown in the BAF panel. Conversely, no reduction in
LRR will be seen for ROH, but the absence of heterozygosity
is observed. Most of the genome-wide studies of ROHs
have used SNPs genotyping arrays. In comparison, the
commonly used oligonucleotide-based CGH arrays in
detecting CNVs produced only total signal intensity data.
This renders them unable to be used for identifying ROHs.
In addition to the most commonly used PLINK software
for detecting and analyzing ROHs (Table 1), other methods
have also been recently developed for these purposes
(Seelow et al. 2009; Browning and Browning 2010; Polasek
et al. 2010). The development of powerful and accurate
tools or methods for the detection and analysis is a prereq-
uisite for the success of research into ROHs. Furthermore,
new algorithms to identify disease-related segments based
on homozygosity using case–control data have also been
developed. This will enhance studies to identify ROHs that
diVer between cases and controls, as these regions may con-
tain recessive variants underlying the diseases (Wang et al.
2009). All the ROHs detection methods have their own
strengths and limitations with varying rates of false-
positive and false-negative results and as such, a combina-
tion of methods would be more ideal to minimize these
limitations.
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Mechanisms generating ROHs
Several mechanisms and factors have been postulated to
explain the high frequency of ROHs in the human genome
namely, parental consanguinity, uniparental isodisomy and
the presence of ‘common extended haplotypes’. One of the
most common and well established mechanisms leading to
ROHs of several megabases is parental consanguinity, in
which the oVspring inherits chromosomal segments that are
identical-by-descent from each parent. Published data has
shown that the number of ROHs of several megabases
increased markedly in the oVspring of consanguineous mar-
riages (Li et al. 2006; Woods et al. 2006) with up to 6% of
homozygosity anticipated in the genome of the oVspring of
Wrst cousin marriages (Broman and Weber 1999). Li et al.
(2006) showed that in a family with 4 children from Wrst
cousin marriages, multiple ROHs ranging from 3.06 to
53.17 Mb were observed in all the children. Woods et al.
(2006) also showed a marked increase in homozygosity
levels in individuals with a recessive disease whose parents
were Wrst cousins, where 11% of their genomes were homo-
zygous on average. Additionally, the cumulative length of
ROHs per genome was found to be larger in two isolated
rather than in two more cosmopolitan (non-isolated) Euro-
pean populations (McQuillan et al. 2008). Therefore, when
compared to outbred populations, there is an expected
increase in the level of homozygosity or number of ROHs
in populations where consanguineous marriages are preva-
lent, as well as in isolated populations where limited ran-
dom mating or a restricted mate choice has taken place.
However, this is unlikely to be the main factor responsible
for the high frequency of ROHs in outbred populations in
which parental consanguinity is uncommon.
Another widely discussed mechanism is cytogenetic
abnormalities such as uniparental disomy, which can be
divided into uniparental isodisomy and uniparental hete-
rodisomy. Only uniparental isodisomy can cause homozy-
gosity as the oVspring inherits two identical copies of a
homologous chromosomal segment from only one parent.
As a result, no heterozygosity would be observed in that
particular homologous chromosomal segment (Ting et al.
2007). Similarly, this is also an unlikely explanation for
the abundance of ROHs reported in the literature; given
that uniparental disomies are rare genetic abnormalities
that can cause severe and rare genomic disorders when
their locations aVect imprinted genes. Examples of these
disorders are Prader–Willi Syndrome, Angelman Syn-
drome and Silver–Russell syndrome (Gurrieri and Acca-
dia 2009; Van Buggenhout and Fryns 2009; Abu-Amero
et al. 2008). This is further supported by previous studies
concluding that the ROHs are not due to genetic abnor-
malities as no excess apparent deviation from Mendelian
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sion errors occur more rarely in ROHs than would be
expected by chance as shown by the observed number of
Mendelian transmission errors within a ROH which is less
than the expected number (Curtis 2007). Since this study
has clearly demonstrated that the ROHs are not usually
due to cytogenetic abnormalities, it then indirectly sup-
ports the presence of common extended haplotypes as the
mechanism contributing toward the high frequency of
ROHs in human genomes.
The presence of common extended haplotypes therefore
becomes the most likely factor responsible for the high fre-
quency of ROHs which are passed on from both parents to
the oVspring in the genomes of outbred populations. Data
demonstrating the co-occurrence of ROHs in regions with
extensive LD and low recombination rates also support the
hypothesis of common extended haplotypes in generating
homozygosity in the genomes of outbred populations
(Gibson et al. 2006; Curtis et al. 2008). A further process
believed to be driving the increasing frequency of common
extended haplotypes is positive selection. ROHs resulting
from common extended haplotypes may be indicative of
positive selection pressure of functional importance of
these regions. Several methods have been used to quantify
the positive selection pressure on ROHs namely, the inte-
grated haplotype score (iHS), Tajima’s D test and the Fixa-
tion index (FST). Numerous large (several megabases) and
common (>25%) ROHs were found to have high values for
these metrics indicating the signal for positive selection
(Enciso-Mora et al. 2010; Hosking et al. 2010).
Genome-wide mapping of ROHs in the human genome
It was not previously expected that the genomes of outbred
populations contain ROHs of several megabases until the
Wrst few early reports in 2006 and 2007 (Gibson et al. 2006;
Li et al. 2006; Simon-Sanchez et al. 2007). One study
found ROHs of >5 Mb in 26 of the 272 unrelated samples
assessed (Simon-Sanchez et al. 2007). Similarly, another
study performed in Han Chinese also observed the high fre-
quency of ROHs, where 34 of the 515 unrelated individuals
contained ROHs ranging from 2.94 to 26.27 Mb (Li et al.
2006). While Gibson et al. (2006) studied the samples from
the International HapMap Projects and identiWed 1,393
ROHs exceeding 1 Mb in 209 unrelated HapMap individu-
als. Several hundreds of ROHs were found in each of the
HapMap populations, and the average number of ROHs
(>1 Mb) per individual was found to be lowest in the
Yoruba Ibadan Nigerian (YRI) population compared to other
populations within the HapMap Phase I Project (Gibson
et al. 2006). In addition to demonstrating that ROHs are
remarkably common, even in the unrelated individuals
from the apparently outbred populations, Gibson et al.
(2006) also demonstrated the value of including diverse
Fig. 1 Plots of the diVerences in the LRR (Log R Ratio) and BAF (B
Allele Frequency) patterns for the ROH (left panels) and one-copy
deletion (right panels) generated from a sample derived from our pre-
vious study (Ku et al. 2010b) and genotyped by the Illumina 1 M Bead-
chip. The ROH and one-copy deletion were detected using the LRR
and BAF information by PennCNV algorithm (LRR: total Xuorescent
intensity signals from both sets of probes/alleles at each SNP, BAF: the
relative ratio of the Xuorescent signals between two probes/alleles at
each SNP) (Wang et al. 2007). The size of the ROH is approximately
1.06 Mb (1,064,933 bases) spanning from 125374832 to 126439764 in
chromsome 2. This region contains 246 markers. The size of the one-
copy deletion is approximately 250 kb (250,186 bases) spanning from
23994408 to 24244593 in Chromosome 22. This region contains 101
markers. The regions aVected by the ROH and one-copy deletion were
shaded and the blue dots represent markers in the genotyping array
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populations to examine the diVerences in ROHs. In the YRI
population, the samples have the least number of ROHs per
individual. This Wnding is expected, because the popula-
tions of African ancestry are older in human history and
hence have more generations and a higher number of
recombination events than other populations (recombina-
tion occurs during meiosis in each generation). Recombina-
tion is one of the important processes to interrupt the long
continuous ROHs into smaller segments over the genera-
tions. Population diVerences in ROHs have also been well
documented in other studies (Nothnagel et al. 2010).
Each of the previous studies identiWed a diVerent number
of ROHs per individual (Li et al. 2006; Nothnagel et al.
2010; McQuillan et al. 2008; Nalls et al. 2009b; Curtis
et al. 2008). These diVerences are likely reXective of tech-
nical and methodological variations such as diVering geno-
typing platforms or SNPs data, diVering deWning criteria
and diVering analytical techniques used. Both the genotyp-
ing platform and deWning criteria can signiWcantly inXu-
ence the proWle of ROHs by way of number, size,
cumulative length and genomic distributions. Slight altera-
tions in deWning criteria can substantially aVect the number
of ROHs detected and as a result comparisons between
studies are diYcult. Therefore, it is critical to develop a set
of standardized criteria in identifying ROHs and to estab-
lish a database to catalog these regions in the human
genome from published studies, similar to other databases
developed for SNPs and structural variants (CNVs) such as
the dbSNP and Database of Genomic Variants, respectively
(Day 2010; Iafrate et al. 2004). This database will enable
researchers to quickly compare their results with published
data. Consensus on deWning the ROHs and the construction
of a database to serve as a reference will help in expediting
research in ROHs.
LD-pruning of SNPs in mapping of ROHs
The SNPs genotyping data is undoubtedly invaluable for
identifying ROHs. However, there is an issue of whether
pruning the list of SNPs to remove local LD (i.e. to remove
SNPs that are in strong LD) should be done before the data
can be used for ROHs. The idea of LD-pruning of SNP data
is that the LD between the SNPs can inXate the chance of
occurrence of biologically meaningless ROHs. However,
there are still uncertainties with regards to the LD-pruning
step such as the optimal cutoV of LD (measured by r2) to be
used, although some studies have used the conventional
and arbitrary cutoV of r2 > 0.8. More importantly, it is
unclear about the quality and performance in terms of sen-
sitivity and speciWcity for mapping ROHs using LD-prun-
ing SNPs data compared to data without the LD-pruning
step. This is an interesting research subject worth pursuing
and studies should be done to assess the importance of this
LD-pruning step. However, unless signiWcant diVerences in
the sensitivity and speciWcity are shown using LD-pruning
SNP data, the LD-pruning step may not necessarily be
needed.
Some of the studies using whole-genome SNPs genotyp-
ing arrays have omitted the LD-pruning step before the data
was used for mapping ROHs, even though Gibson et al.
(2006) used the SNP data from the International HapMap
Project where the LD information is readily available.
However, others have taken the LD between SNPs into
account and used the pairwise LD SNP pruning function in
PLINK, with a default value of r2 > 0.8 (Enciso-Mora et al.
2010; Hosking et al. 2010). For example, one study found
370,611 separate tag groups which is a 27.6% reduction of
information compared with the original number of SNPs.
To account for this, the study adopted a more stringent
cutoV of a minimum of 80 consecutive SNPs (instead of 58)
to identify ROHs (Enciso-Mora et al. 2010). Similarly
Lencz et al. (2007) also took into consideration the LD
between the SNPs through setting a more stringent thresh-
old of 100 consecutive SNPs that are homozygous. In com-
parison, another study removed SNPs in LD with r2 < 0.1
leaving only 30,307 SNPs to form the ‘low-LD panel’ for
some analyses (Spain et al. 2009). Although these studies
have taken LD between SNPs into account, it is unclear
whether an improvement in sensitivity and speciWcity was
achieved by implementing this LD-pruning step since no
evaluation was done to directly compare the diVerences
between the ROHs proWle with and without the LD-pruning
step. Therefore, the LD-pruning step is conceptually cor-
rect; however to warrant this step to be performed in future
genome-wide mapping of ROHs, more published data dem-
onstrating its advantages is needed.
Implications on complex diseases and traits
Many novel pathogenic genes or mutations underlying
autosomal recessive disorders have been identiWed
through homozygosity mapping. This approach has been
shown to be powerful and is particularly useful in investi-
gating autosomal recessive disorders especially in popula-
tions with a high prevalence of consanguinity. This is
evident from the enormous number of studies identifying
causal mutations for autosomal recessive disorders in con-
sanguineous families (Abu SaWeh et al. 2010; Harville
et al. 2010; Walsh et al. 2010; Pang et al. 2010; Lapunz-
ina et al. 2010; Nicolas et al. 2010; Uz et al. 2010; Iseri
et al. 2010; Collin et al. 2010). However, the Wrst study
applying the homozygosity association approach at the
genome-wide scale for complex diseases only appeared
in 2007 (Lencz et al. 2007). Table 1 summarizes the
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genome-wide ROH association studies of complex pheno-
types using high-density genotyping arrays.
The ‘homozygosity analysis’ has been shown to be use-
ful for the identiWcation of disease susceptibility genes in
both monogenic and complex diseases (Miyazawa et al.
2007; Jiang et al. 2009). The eVects of inbreeding or con-
sanguinity and recessive variants or heterozygosity levels
on the risk of complex phenotypes (diseases and quantita-
tive traits) have been previously well established (Rudan
et al. 2003a, 2003b, 2006; Campbell et al. 2007). A strong
linear relationship between the inbreeding coeYcient and
blood pressure was found and several hundred recessive
loci were predicted as contributing to blood pressure vari-
ability. Recessive or partially recessive genetic variants
account for 10–15% of the total variation in blood pressure
(Rudan et al. 2003a). Higher levels of relative heterozygos-
ity were shown to be associated with lower blood pressure
and total and low-density lipoprotein cholesterol by mea-
suring genome-wide heterozygosity (Campbell et al. 2007).
In addition to quantitative traits, inbreeding was also found
to be a signiWcant positive predictor for a number of late-
onset complex diseases such as coronary heart diseases,
stroke, cancer and asthma (Rudan et al. 2003b). These stud-
ies have strongly supported the hypothesis that the genetics
of complex phenotypes include a component of recessively
acting variants; however, these studies did not directly
investigate the associations of complex phenotypes with
ROHs detected using polymorphic markers.
Although the information regarding the extent of ROHs
in the human genome is still limited compared with SNPs,
indels and CNVs, their potential impact on complex dis-
eases and traits could also be signiWcant as other genetic
variations. The importance of ROHs to complex pheno-
types remains largely unexplored; however, several studies
have shown signiWcant diVerences in ROHs between cases
and controls in a genome-wide investigation for schizo-
phrenia (Lencz et al. 2007), late-onset Alzheimer’s disease
(Nalls et al. 2009a) and height (Yang et al. 2010b). The
idea underlying the homozygosity association approach is
to uncover recessive variants contributing to complex phe-
notypes. The success of this approach has been demon-
strated in several studies. Nine common ROHs signiWcantly
diVerentiated schizophrenia cases from controls. More
interestingly, four of the regions contained or were located
near to the genes that are known to be associated with
schizophrenia such as NOS1AP, ATF2, NSF, and PIK3C3
(Lencz et al. 2007). This proof-of-principle study has dem-
onstrated the applications of the whole-genome homozy-
gosity association approach in identifying genetic risk loci
for complex phenotypes and it represents an alternative and
new avenue in addition to SNPs analysis.
Similarly in a large-scale association study involving
837 late-onset Alzheimer’s disease cases and 550 controls,
one ROH on chromosome 8 was identiWed, and three of the
genes (STAR, EIF4EBP1 and ADRB3) in the region are bio-
logically plausible candidates (Nalls et al. 2009a). Success
was also achieved for complex quantitative traits such as
height (Yang et al. 2010b), where strong statistical evi-
dence showing association of one ROH with height was
obtained in a total sample size of >10,000 in both the
genome-wide discovery and replication studies. The height
of individuals with the particular ROH was signiWcantly
higher (increased by 3.5 cm) than the individuals without
the region. The identiWcation of this ROH added further
support to the contribution of recessive loci to adult height
variation (Kimura et al. 2008; Xu et al. 2002). Nonetheless,
other studies produced negative results, as no evidence of
homozygosity was found for bipolar disorder (Vine et al.
2009).
To date, the results showing the association between
homozygosity with various cancers are also controversial
(Hosking et al. 2010; Assié et al. 2008; Enciso-Mora et al.
2010). For example, two studies investigating the homozy-
gosity in colorectal cancers derived an opposing conclusion
which is likely due to the diVerences between the two studies
such as the sample sizes, the density of genotyping platforms
and the analysis (Bacolod et al. 2008; Spain et al. 2009).
Although studies have found statistically negative results
after imposing the stringent Bonferroni correction for multi-
ple-testing, a number of ROHs warrant further investigation
as these regions overlapped with biologically plausible genes
for the phenotypes. One ROH was found to encompass the
gene encoding erythropoietin receptor (EPOR) protein.
Over-expression of this protein has been documented in
acute lymphoblastic leukemia (Hosking et al. 2010).
Many reasons can be speculated for the inconsistencies
as to why associations of ROHs were only found in some
diseases or studies but not others. This could also indicate
that the eVects of homozygosity on the risk of complex phe-
notypes may be disease or trait-dependent, for example
some quantitative traits have shown signiWcant variance
due to recessive alleles such as systolic blood pressure,
total cholesterol and low-density lipoprotein cholesterol.
This implies that the eVects of homozygosity may be
greater in inXuencing the variation of these traits than oth-
ers (Campbell et al. 2009). On the other hand, it could also
be population-dependent since diVerences in homozygosity
between populations have been documented. Although a
number of genome-wide homozygosity association studies
have been performed, the optimum study design or analysis
methods for assessing the associations or eVects of ROHs
on the disease risk has not yet been well established. This
is, however, vital before breakthrough discoveries can be
made in this research area.
The idea for using the homozygosity association
approach to dissect the genetics of complex phenotypes is
Hum Genet (2011) 129:1–15 11
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to reveal the recessive loci that only express their eVects (or
increase the risk of complex diseases) in the presence of
two deleterious recessive alleles, in a recessive disease
model. In addition to autosomal recessive disorders, com-
plex diseases can also be aVected by recessive variants. The
conventional single-SNP analysis approach applied in
GWAS may not be statistically powerful enough to identify
recessive alleles with small eVect sizes and moreover, the
recessive model is not usually tested. Until the eVect of
homozygosity on complex phenotypes is better understood,
it is premature to make any conclusions, as the Weld is still
in its infancy compared to association studies between
SNPs and CNVs for complex diseases and traits. However,
collectively these studies have demonstrated the feasibility
of using the homozygosity association approach to identify
susceptibility loci for complex phenotypes and have pro-
duced encouraging results. This also further underscores
the need to further investigate and catalog the extent of
ROHs in diVerent populations. Similar to the other genetic
variations, ROHs have the potential of becoming the
genetic markers in GWAS. In fact, homozygosity mapping
has been commonly used to identify the loci for recessive
diseases in consanguineous families.
Strengths and shortcomings of genome-wide 
homozygosity association studies
From the statistical analysis point of view, the advantage of
the genome-wide homozygosity association approach is
that it suVers lesser penalty from Bonferroni correction for
multiple-testing as signiWcantly fewer ROHs are involved
compared to the number of SNPs tested in GWAS. Thus, it
needs a less stringent p value cutoV to declare genome-wide
signiWcance. Thus, the genome-wide ROHs association
approach has a higher statistical power or requires a fewer
number of samples in the studies than the ‘conventional
GWAS’.
GWAS is an indirect approach that relies on LD to iden-
tify the causal variants, thus the results from GWAS are
pinpointing genetic loci rather than revealing the causal
variants directly (Wang et al. 2005; Hirschhorn and Daly
2005). Similarly in genome-wide homozygosity association
studies, one or more ROHs are identiWed as susceptibility
risk loci rather than revealing the actual recessive variants
causing the disease. For example, the homozygous consen-
sus region in chromosome 8 was found to be associated
with late-onset Alzheimer disease contains seven genes.
However, the number of recessive variants within these
genes or this region responsible for this 'statistical associ-
ation signal' and which are functionally important in caus-
ing the diseases is unknown (Nalls et al. 2009a). The
approaches to be taken from identifying the disease or
trait-associated ROHs to locating the functional recessive
variants is also unclear. Moreover, the sizes of ROHs are
many folds larger than the LD blocks detected by conven-
tional SNP analysis in GWAS, thus making the Wne mapping
of recessive variants harder. Therefore, the genome-wide
association of ROHs, at best, can only pinpoint to a rela-
tively large region harboring as yet to be identiWed
recessive variants.
One common issue and problem in case–control associa-
tion studies of CNVs and ROHs is how to construct the
common CNV and ROH regions in the Wrst place. This step
is required to group the individual CNVs or ROHs into a
common and discrete region. Similar to CNVs, it is unclear
how to partition the individual ROHs into ROH groups so
that the frequencies can be used for association analysis.
This represents an important analytical challenge in these
studies. Genome-wide studies investigating the association
of common CNVs with complex phenotypes have so far
yielded limited successes (Wellcome Trust Case Control
Consortium 2010). As for ROHs, diVerent studies have
used their own methods to deWne ROH groups as no stan-
dardized criteria are available. Alternatively this step can be
easily performed as the individual ROHs can be divided
into diVerent ROH groups by using the ‘homozyg-group’
command in the ‘Runs of Homozygosity’ program in
PLINK. As a result, each ROH group is actually the over-
lapping region among all the individual ROHs in the group
i.e. the consensus region (the region shared by all overlap-
ping ROHs) (Fig. 2). Using this approach, Yang et al.
(2010b) identiWed 3,322 ROH groups containing more than
50 individual ROHs. While Nalls et al. (2009a) identiWed
1,090 consensus regions from overlapping ROHs, but each
consensus region was found in 10 or more individuals.
Besides identifying the ROH groups for association
analysis, attempts were also made to compute other
parameters such as the total length of the genome com-
prised by ROHs (the sum of the length of all ROHs), average
length of each ROH (the total length divided by the number
of ROHs) and the number of ROHs per individual and
Fig. 2 Schematic diagram illustrating the ROH group or consensus
region (shadowed rectangle) of several individual ROHs (blue line).
Only 8 individual ROHs are shown for illustrative purposes with each
individual ROH extending in both directions from the consensus
region
ROH group/consensus region
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compare these parameters between cases and controls.
Nonetheless, no signiWcant result was observed for late-
onset Alzheimer disease (Nalls et al. 2009a). Likewise, no
signiWcant diVerence was found in the average number of
ROHs between acute lymphoblastic leukemia, breast and
prostate cancers with their controls (Hosking et al. 2010;
Enciso-Mora et al. 2010).These analyses may not be very
fruitful and have a limited interpretation. Even though sig-
niWcant results were obtained for all the three parameters,
the Wndings are not informative in pointing to speciWc
ROHs that are important to the disease. It can only be con-
cluded that the overall extent of homozygosity is signiW-
cantly greater in cases compared to controls and thus some
recessive variants may be predisposed to the disease risk.
Conclusions
Published data have conclusively demonstrated the high
frequency of ROHs in the genomes of outbred populations,
and previous studies have also successfully unraveled the
associations between ROHs and several complex pheno-
types such as schizophrenia, late onset Alzheimer’s dis-
eases and height. These studies have shown the promise of
the homozygosity association approach in identifying
recessive loci for complex phenotypes. However, to what
extent this approach contributes toward dissecting the
genetics of complex phenotypes is yet to be determined.
The analysis of ROHs is now feasible and convenient given
the readily available high-density SNPs genotype data and
the powerful detection tools such as the PLINK and Penn-
CNV algorithms. Cataloging ROHs in diVerent populations
is important, as it lays the foundation for exploring the
recessive variants for complex phenotypes.
Currently, the results from GWAS focusing on SNPs
analysis alone, explains only a small fraction of the heritabil-
ity of complex phenotypes (Manolio et al. 2009). Several rea-
sons accounting for the missing heritability have been
postulated (Eichler et al. 2010). The missing heritability has
challenged the validity of the common-disease common vari-
ant (CD/CV) hypothesis (Schork et al. 2009), and has also
diverted the research focus to rare variants (Bodmer and
Bonilla 2008; Gorlov et al. 2008; Dickson et al. 2010). How-
ever, more recent studies have shown that common variants,
or more speciWcally common SNPs, can explain a greater
proportion of the heritability than what has been accounted
for by GWAS done to date. These SNPs, however, are hid-
den within the GWAS data, and require larger sample sizes
to be discovered (Yang et al. 2010a; Park et al. 2010b). The
homozygosity association approach will oVer an additional
avenue to discovering genetic risk loci that may be missed by
the conventional SNPs analysis in GWAS. The homozygos-
ity analysis can be ‘easily’ performed using the SNPs
genotype data and the available detection algorithms, and
this is also in line with the ethos of maximizing the informa-
tion from the GWAS dataset. However several issues and
problems still remain as has been discussed.
The power of the homozygosity mapping approach in
identifying genes and mutations for autosomal recessive
disorders has been previously shown, but currently avail-
able data is limited in order to evaluate the success of this
approach when applied to complex phenotypes. Hence
more studies are needed in the future. Finally we advocate
the use of the homozygosity association approach as an
additional method of identifying loci harboring recessive
variants for complex diseases and traits, which may have
been undetected when conventional SNPs analysis was per-
formed alone. The success of this approach has been dem-
onstrated in several complex phenotypes applying the
approach. The results so far are encouraging enough to war-
rant further studies on ROHs to investigate their impacts on
complex phenotypes.
Cataloging the ROHs in human genomes and investigat-
ing their associations with complex phenotypes should
build on the existing GWAS data and these are important
areas to pursue in future. The contribution and the role of
ROHs in complex phenotypes have been considerably
neglected in GWAS; therefore we encourage researchers to
explore the associations of ROHs with various phenotypes
using their existing SNP data. As the high-density SNPs
genotype data have already been generated by several hun-
dred GWAS, the studies of ROHs should be relatively
uncomplicated. The availability of these SNP datasets will
facilitate the assessment of the roles that ROHs have in
complex phenotypes.
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A new era of copy number variants (CNVs) discovery
beganwhen two separate studies, published concurrently
in 2004, identified several hundred deletions and dupli-
cations in the humangenome.Over the past several years,
most of the CNV data were generated by microarrays.
These methods have several shortcomings, such as the
inability to detect copy-neutral variants (e.g. inversions
and translocations), limited sensitivity to detect smaller
CNVsandpoorresolution indeterminingCNVbreakpoints
especially with lower resolutionmicroarrays. A paradigm
shift in the discovery of copy-neutral variants was attrib-
uted to the development of a sequencing-based method
known as paired-end mapping. This method was first
demonstrated to be powerful in detecting structural
variants using next-generation sequencing technologies
in 2007. Further studies have also leveraged an important
feature of sequencing data, where several hundred mil-
lion short sequence reads are produced by next-gener-
ation sequencers, to detect CNVs based on the abundance
or density of the sequence reads aligned to a reference
genome. This approach is known as depth-of-coverage.
These emerging sequencing-basedmethodswill continue
playing an important role in the discovery of structural
variants until de novo genome assembly becomes more
feasible.
Introduction
A new era of copy number variants (CNVs) discovery
began when two separate studies, published concurrently
in 2004, identiﬁed several hundred deletions and dupli-
cations in the human genome (Sebat et al., 2004; Iafrate
et al., 2004). However, these genetic abnormalities were
documented decades ago in clinical cytogenetics studies
and found to cause various genomic or cytogenetic dis-
orders (Lee et al., 2007). The distinguishing feature of the
recent studies were that these CNVsweremore prevalent in
the human genome than expected. These changes in copies
number also did not result in any apparent phenotype or
disorder and these regions of variable copies were found in
the genomes of phenotypically normal individuals (Sebat
et al., 2004; Iafrate et al., 2004). As these submicroscopic
(53–5Mb) deletions and duplications are beyond the
detection limit of traditional cytogenetics tools such as
molecular ﬂuorescence in situ hybridisation (FISH), these
recent discoveries can be credited to the use of whole gen-
ome microarray technologies (Carter, 2007). See also:
Copy Number Variation in the Human Genome; Genetic
Variation: Human; Relevance of Copy Number Variation
to Human Genetic Disease
Whole Genome Microarray and
Sequencing Technologies and Their
Progress
The early whole genome microarray studies discovered
several hundred CNVs (Sebat et al., 2004; Iafrate et al.,
2004), for example, Sebat et al. (2004) detected a total of
221 CNVs in 20 individuals with an average CNV length
of 465Kb.However, it waswidely believed that the number
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studies used ‘low-resolution’ microarrays such as ROMA
(representational oligonucleotide microarray analysis)
containing 85 000 probes with a resolution of approxi-
mately one probe for every 35Kb (Sebat et al., 2004) and
the BAC-CGH (bacterial artiﬁcial chromosome-com-
parative genomic hybridisation) array with a resolution of
approximately one probe for every 1Mb (Iafrate et al.,
2004). Furthermore, these studies investigated a small
sample size of only tens of individuals which limits the
detection of less common CNVs. CNVs smaller than 50–
100Kb will also not be detected as their size is below the
resolution limits of these microarrays. Thus, both the
sample size and the resolution of microarray are critical
factors in determining the discovery of less common and
smaller CNVs.
A later study by Tuzun et al. (2005) showed that
approximately 85%of the 297 identiﬁed structural variants
(139 insertions, 102 deletions and 56 inversions) were not
detected by earlier studies. However, this study used a
sequencing-based method, where the fosmid paired-end
sequences were sequenced, instead of microarrays. Many
of the structural variants that are being identiﬁed using this
sequencing-based method are beyond the resolution limit
of ROMA and the BAC-CGHmicroarrays. Inversions are
also undetected by microarrays (Tuzun et al., 2005; Sebat
et al., 2004; Iafrate et al., 2004). The discovery of many
novel structural variants is likely due to the diﬀerence
between the resolution of sequencing- and microarray-
based methods in detecting structural variants.
The contribution of CNVs as a signiﬁcant source of
genetic variation in human populations has since been
appreciated despite the limitations usingmicroarrays. This
is evident from the enormous amount of interest and eﬀorts
generated towardsmapping CNVs in diﬀerent populations
(Redon et al., 2006; Zogopoulos et al., 2007; Wong et al.,
2007). The ﬁrst comprehensive mapping of CNVs in the
270 samples from the International HapMap I Project was
completed in 2006 (Redon et al., 2006). ‘Human Genetic
Variation’ was then recognised as the ‘Breakthrough of
The Year’ in 2007 by the journal Science. This was partly
accomplished due to the signiﬁcant progress made in the
research of CNVs in addition to the numerous single
nucleotide polymorphisms (SNPs) identiﬁed by genome-
wide association studies for complex phenotypes (Pennisi,
2007). The limitations of ROMA and the BAC-CGH
arrays have been overcome in later studies by using higher
resolution microarrays and larger sample sizes of several
hundred samples (McCarroll et al., 2008; Matsuzaki et al.,
2009; Conrad et al., 2010; Park et al., 2010;Yim et al., 2010;
Ku et al., 2010). For example, a set of 20 high-resolution
oligonucleotide-CGHmicroarrays comprised of 42million
probes with amedian spacing of 56 bases was designed and
used by Conrad et al. (2010) in mapping CNVs in the
HapMap samples (Conrad et al., 2010). Other studies have
also used the highest resolution SNP microarrays that are
commercially available such as the Aﬀymetrix SNP Array
6.0 and the Illumina Human 1M BeadChip (McCarroll
et al., 2008; Ku et al., 2010).
Other types of chromosomal rearrangements, particularly
inversions and balanced translocations, have received rela-
tively less attention (Feuk et al., 2006; Feuk, 2010; Stankie-
wicz and Lupski, 2010). Inversions and translocations are
also known as ‘copy-neutral variants’ or ‘balanced
chromosomal rearrangements’ and do not involve changes
in copies number (or losses or gains of deoxyribonucleic acid
(DNA) sequences). Collectively these copy number and
copy-neutral variants are broadly classiﬁed as ‘structural
variants’. The genome-wide mapping or detection of CNVs
in diﬀerent populations has advanced considerably since
2004 and was driven mainly by high-resolution microarray
technologies such as oligonucleotide-CGH and SNP
microarrays. In contrast, the pace in identifying inversions
and translocations in the human genome has been slower as
morepowerful and eﬀectivemethodswere not available until
the advent ofnext-generation sequencing (NGS) technologies
(Mardis, 2008; Shendure and Ji, 2008; Metzker, 2010).
Although sequencing-based methods such as paired-end
mapping (PEM), which uses cloning and Sanger sequencing
methods to sequence the fosmid paired-end sequences, have
been shown to be powerful in identifying copy-neutral vari-
ants, this method is laborious and expensive (Tuzun et al.,
2005). Even with the arrival of NGS technologies, PEM has
still not as yet been applied in population-based studies
(Korbel et al., 2007), as opposed to microarrays which are
commonly applied to several hundred or thousand samples
for CNV detection. However, it is foreseeable in the near
future that sequencing-based methods will eventually be
routinely andwidely applied in large-scale population-based
studieswhen the costof sequencingbecomesmoreaﬀordable
and the challenges in the analysis have been addressed.
The mechanisms that generate structural variants such
as nonallelic homologous recombination and non-
homologous end joining are beyond the scope of this article
(Hastings et al., 2009). Similarly, genome-wide detection of
CNVs in population-based studies and the population
characteristics of CNVs or structural variants, and their
associations with various complex diseases or genomic
disorders have been reviewed extensively in several excel-
lent review papers (Conrad and Hurles, 2007; McCarroll
and Altshuler, 2007). This article will focus on the new and
emerging research on structural variants using high-
throughput sequencing technologies (Mardis, 2008; Shen-
dure and Ji, 2008; Metzker, 2010; Schadt et al., 2010;
Gupta, 2008). We also discuss the relative strengths and
weaknesses of sequencing-based approaches in com-
parison to microarrays, and elucidate the potential
approaches for a more comprehensive and thorough
detection of structural variants in the human genome
before de novo genome assembly becomes more practical
(Li et al., 2010a, b; Paszkiewicz and Studholme, 2010).
Microarray-based Methods
Over the past few years, most of the CNV data were gen-
erated by CGH and SNP microarrays where ﬂuorescence
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signal intensity information was used to detect deletions
and duplications. These microarrays are highly accessible
and aﬀordable for population-based studies. Additionally,
the analysis methods and tools for detecting CNVs using
microarray data have been well-developed (Wang et al.,
2007; Korn et al., 2008). This has enabled studies of
population characteristics of CNVs in many diﬀerent
populations (McCarroll et al., 2008;Matsuzaki et al., 2009;
Yim et al., 2010; Ku et al., 2010). However, because of the
reliance on the relative or diﬀerence in signal intensity
compared to a reference in inferring regions with copy
number changes, this has hindered microarrays from
detecting copy-neutral variants (Carter, 2007). Further-
more, due to the limitations inmarker density or resolution
of microarrays used in the previous studies, these methods
had poor sensitivity to detecting smaller CNVs (550Kb)
(Redon et al., 2006). However, the ability to detect smaller
CNVs is critical as they are known to be more numerous
than the larger CNVs (Estivill and Armengol, 2007). The
accuracy in determining the sizes or breakpoints ofCNVs is
highly dependent on the resolution of the microarrays as
the sizes of CNVs found by previous studies were fre-
quently over-estimated. It is notable that 88% of 1153
CNV loci were smaller than sizes reported in the Database
of Genomic Variants and that a reduction of450% in size
was observed for 76% of the CNV loci (Perry et al., 2008).
The latest developments in SNP microarrays such as an
increase inmarker density anduniformity of distribution in
the genome and copy number probes to cover regions with
sparse SNPs have improved the sensitivity of microarrays.
Nonetheless, these SNP microarrays still lack the sensi-
tivity todetectCNVs smaller than 5–10Kbevenwith use of
the highest resolution microarrays such as the Illumina
Human 1M Beadchip and the Aﬀymetrix SNP Array 6.0
(McCarroll et al., 2008; Cooper et al., 2008). Although
designing a set of high-resolution CGH microarrays com-
prising tens of millions of probes oﬀers an unprecedented
resolution, this method is more costly for several hundred
samples (Conrad et al., 2010). However, these improve-
ments inmicroarrays are still unable to detect copy-neutral
variants. Thus, developments of other methods that can
overcome the limitations of microarrays and simul-
taneously detect both CNVs and copy-neutral variants are
needed.
Sequencing-based Methods
Several previous studies have used sequencing data to
detect structural variants. For example, a study by Feuk
et al. (2005) discovered regions that are inverted between
the chimpanzee and human genomes by performing a
comparative analysis of their DNA sequence assemblies.
This study identiﬁed approximately 1600 putative regions
of inverted orientation in the genomes (Feuk et al., 2005),
whereas Khaja et al. (2006) identiﬁed various types of
genetic variants, including structural variants, through
comparison of two human assemblies (Khaja et al., 2006).
However, the paradigm shift in the discovery of copy-
neutral variants was attributed to the development of the
PEM and concurrent advances in NGS technologies
(Korbel et al., 2007). The PEM method has also contrib-
uted greatly to the discoveryofCNVs in thehumangenome
(Wang et al., 2008; Ahn et al., 2009). See also: Comparing
the Human and Chimpanzee Genomes; Human Genome
Project: Importance in Clinical Genetics; Sequencing the
Human Genome: Novel Insights into its Structure and
Function
Further studies have also leveraged on an important
feature of sequencing data generated by NGS technologies
where several hundred million short sequence reads are
produced per instrument run to detect CNVs. It is based on
the abundance or density of the sequence reads aligned to
the reference genome. This approach is known as depth-of-
coverage (DOC) and is similar to microarray-based
methods in that it is also unable to detect copy-neutral
variants (Yoon et al., 2009). Although de novo genome
assembly is still developing, the established PEMandDOC
methodswill continue toplay important roles in identifying
new structural variants. Table 1 shows the comparison




In the PEM method, a library of DNA fragments with a
ﬁxed insert size is prepared and both ends of the DNA
fragments are sequenced to generate ‘paired-end
sequences’ (the sequences at both ends of the DNA frag-
ments). This sequence information is then aligned against
the reference genome. The underlying principle of PEM to
detect structural variants is reliant on the discrepancy or
discordance in insert size and orientation of the paired-end
sequences being aligned to the reference genome to infer
‘simple’ deletion, insertion and inversion. The use of the
term ‘simple’ is to distinguish from other more complex
structural variants such as ‘everted duplication’, ‘linked
insertion’ and ‘hanging insertion’. Thus, the terms deletion,
insertion and inversion used throughout this paper refer to
the ‘simple’ types unless otherwise speciﬁed (Tuzun et al.,
2005; Korbel et al., 2007).
When paired-end sequences that are being aligned to the
reference sequence display discordance from the expected
insert size or distance, this is an indication of deletion and
insertion, whereas discordance in orientation suggests the
presence of inversion (i.e. paired-end sequences are incor-
rectly oriented comparing to the reference genome). Since
the insert size of theDNA fragment library is known, when
paired-end sequences that align to the reference are sub-
stantially shorter than expected, this indicates the presence
of insertion. Conversely, a longer than the expected insert
size suggests the presence of deletion while other more
complicated patterns of discordance when aligning the
Characterising Structural Variation by Means of NGS
ENCYCLOPEDIA OF LIFE SCIENCES & 2011, John Wiley & Sons, Ltd. www.els.net 3
Table 1 Comparison between microarrays and sequencing-based methods for detecting structural variants
Microarraysa PEMb DOC
Principle Based on the relative or
diﬀerence in ﬂorescence
signal intensity compared
to a reference (one sample
or a set of samples) to infer
CNVs
Based on the discrepancy or
discordance in insert size
and orientation of the
paired-end sequences being
aligned to the reference
genome to infer ‘simple’
deletion, insertion and
inversion
Based on the density of
sequence reads being
aligned to the reference
genome to infer CNVs
Ability to detect CNVs Yes Yes Yes
Ability to detect copy-
neutral variants
No Yes No







Has not yet been applied Has not yet been applied
Sensitivity to detect smaller
CNVs e.g.510Kb
Generally poor, but
depends on the resolution
of themicroarrays, e.g. a set
of oligonucleotide CGH
arrays containing 42
million probes has provided
an unprecedented
resolution
Yes, preparation of several
libraries of diﬀerent insert
sizes are able to detect
insertions and deletions of
varying sizes, but the
detection of insertions is
limited by the insert sizes
It may not be powerful
enough to detect smaller
CNVs (related to the
strength of DOC signatures
and the coverage of the
sequencing data or the
number of sequence reads)
Sensitivity to detect larger
CNVs
Yes, even low resolution
BAC clone CGH arrays
(with a resolution of
approximately one probe
for every 1 Mb) have been
used to detect CNVs of
several hundred kilobases
to megabases
Yes, however, the detection
of insertions is limited by
the insert sizes, thus
preparation of fosmid or
BAC clone libraries with
larger insert sizes are
needed for detecting larger
insertions
Yes, the DOC signatures




Generally poor, however, it
can be improved by
increasing the resolution of
microarrays
Good, theoretically the
breakpoints can be mapped
to a single nucleotide
resolution
The precision to map the
breakpoints can be
improved by increasing the
density or coverage of
sequence reads
Role in ‘discovery’ and
‘genotyping’
Can be used as an eﬀective




Powerful for discovery of
new structural variants
Discovery of CNVs
especially in regions such as
segmental duplications
where PEM is less eﬀective
Weakness as a result of
technology limitation




compared to BAC clone
CGH arrays
Short sequence reads are
less speciﬁc in aligning
uniquely to the reference
genome especially in
segmental duplications
Sequencing biases may lead
to certain regions of the
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paired-end sequences provide hints at more complex
rearrangements or structural variants (Tuzun et al., 2005;
Korbel et al., 2007; Medvedev et al., 2009).
As such, the paired-end sequences are usually classiﬁed
as ‘concordant pairs’ or ‘discordant pairs’ and only the
discordant pairs are informative for inferring structural
variants. The presence of both concordant and discordant
pairs spanning a locus suggests a heterozygote state with
respect to the structural variant, for example a deletion
occurs only in one homologous chromosome. In addition,
usually multiple paired-end sequences are needed to reli-
ably infer if a locus is harbouring a structural variant. The
requirement of multiple paired-end sequences spanning a
locus to detect structural variants will reduce the number of
false-positive signals. It will also minimise the false-nega-
tive rate, for example, a heterozygous deletion will be
missed by the presence of one concordant pair. However,
with multiple paired-end sequences, it is more likely that
both the concordant pair and the discordant pair will be
observed to detect the heterozygous deletion. As a result, a
suﬃcient amount of sequencing is needed to ensure that
there are multiple paired-end sequences spanning across
the genome. This also means that a substantial amount of
sequencing is needed for the PEM method and thus this
method will be more costly using Sanger sequencing com-
pared to NGS technologies (Tuzun et al., 2005; Korbel
et al., 2007; Medvedev et al., 2009).
The detection of structural variants using PEM ‘signa-
tures’ depends on the clustering strategies and criteria used
in the analysis, and the results can be varied for the same
dataset by applying diﬀerent strategies and criteria.
‘Clustering’ refers to steps to group PEM signatures (e.g.
several discordant pairs) that support the presence of a
structural variant into clusters. As such, clustering will
improve reliability in inferring or predicting structural
variants and also increase the precision in estimating
breakpoints or the sizes of structural variants. The
important criteria to be determined in clustering are (a) the
minimum number of discordant pairs for a cluster and
(b) the number of standard deviations of the insert size to
distinguish between concordant and discordant pairs. The
strategies and criteria used will then aﬀect the sensitivity
and speciﬁcity in detecting structural variants (Tuzun et al.,
2005; Korbel et al., 2007; Medvedev et al., 2009).
Physical coverage and mate-pair library
‘Physical coverage’ is important in detecting structural
variants using PEM. Physical coverage measures the
number of fragments spanning a site and this aﬀects the
ability to detect structural variants. It is diﬀerent from
‘sequence coverage’ which measures the number of
sequence reads that cover a site and this sequence coverage
aﬀects the ability to detect single nucleotide variants or
point mutations. Thus, physical coverage can be increased
by creating a library of larger insert sizes.Whenpreparing a
‘shotgun library’ using standard methods, the sizes of
DNA fragments are usually several hundred bases, with
approximately tens of bases on both ends of the DNA
fragments sequenced using NGS technologies (Meyerson
et al., 2010).
However, the insert size can be increased to several
kilobases by creating a ‘jumping library’ or a ‘mate-pair
library’. Additional steps are involved in preparing amate-
pair library in comparison to a paired-end library, where







hundred samples can be
genotyped by SNP arrays
per week as evident in
genome-wide association
studies
Tens of gigabases of
sequencing data can be
produced per instrument
run in several days by NGS
technologies, and the
sample throughput can be
scaled up by ‘barcoding’ i.e.
labelling the samples by
barcodes
Tens of gigabases of
sequencing data can be
produced per instrument
run in several days by NGS
technologies, and the
sample throughput can be
scaled up by ‘barcoding’ i.e.
labelling the samples by
barcodes
Level of analytical and
computational challenges
Lesser, analytical methods
for detecting CNVs using
microarray data are well-
developed
Greater, an emerging and
maturing method
leveraging on the large
amount of NGS data
Greater, an emerging and
maturing method
leveraging on the large
amount of NGS data
Diﬃculty in sample
preparation










aWhole genome oligonucleotide-CGH and SNP microarrays.
bPaired-end and mate-pair libraries and clone-based libraries (such as fosmid and BAC clones) for PEM.
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3Kb in theKorbel et al. (2007) study)were ﬁrst ligatedwith
biotinylated hairpin adapters. The DNA fragments were
then circularised and randomly sheared. The fragments
attached to biotinylated hairpin adapters were isolated to
form a mate-pair library and then followed by sequencing
(Korbel et al., 2007). Mate-pair library construction
enables sequencing at both ends of longer DNA fragments
of several kilobases. The mate-pair library with a larger
insert size will increase the physical coverage of the gen-
ome. For example, by sequencing 50 bases from both ends
of the DNA fragments from a library with a 3-Kb insert
size, the physical coverage of the genome is 10-fold higher
than that from a librarywith a 300-bp insert size. However,
the sequence coverage is similar between both libraries as
only 50 bases of paired-end sequences were generated with
regards to the library insert size (Meyerson et al., 2010).
Thus the paired-end andmate-pair libraries diﬀer only in
the steps of constructing these libraries, as the sequencing
and aligning of the paired-end sequences to the reference to
detect structural variants follow the same principle.
Although creating a mate-pair library increases physical
coverage, a larger insert size is less sensitive in detecting
smaller structural variants because of the diﬃculty in
tightly controlling the sizes of the DNA fragments in the
library. Therefore, depending on the ‘tightness’ or ‘nar-
rowness’ of the distribution pattern (standard deviation) of
the insert sizes in the library, it can be diﬃcult to distinguish
a true PEM signature caused by a small indel (i.e. indel of
several or tens of bases) because of the variance in insert
sizes in the library. This is because it is not practically
possible to generate an exact similar size for each of the
DNAfragmentswhenpreparing a library (Medvedev et al.,
2009).
Strengths and weaknesses
In comparison to microarray-based methods, PEM has a
higher sensitivity to detect smaller CNVs in addition to
identifying copy-neutral variants, and it also has a greater
precision in determining the breakpoints or boundaries of
structural variants. For example, the PEM method has
been applied in a number of whole genome resequencing
studies where several thousand structural variants were
detected (Wang et al., 2008; Ahn et al., 2009). Wang et al.
(2008) identiﬁed a total of 2682 structural variants (the
majority wereCNVs) in theHanChineseYanHuang (YH)
genome with a median length of approximately half a
kilobase. These sizes aremuch smaller than those identiﬁed
bymicroarrays ranging from tens to hundreds of kilobases
depending on their resolution (Redon et al., 2006; Zogo-
poulos et al., 2007; Wong et al., 2007). This has clearly
shown the greater sensitivity of PEM to detect smaller
structural variants.
Nonetheless, this method could be biased against
detection of duplications or insertions. This has been
clearly shown in the YH genome, where most of the iden-
tiﬁedCNVs are deletions, namely 2441 deletions compared
to 33 duplications. This is because PEM is unable to detect
insertions larger than the insert size of the library. This also
reveals the major limitation of PEMwith a ﬁxed insert size
in detecting insertions (Wang et al., 2008). Deletions are
easier to be detected because they are identiﬁed by a longer
than expected insert size when aligned to the reference,
whereas detection of insertions is restricted by the insert
size. This means that insertions larger than the insert size
are beyond the detection range. Therefore, several paired-
end and mate-pair libraries with short and long insert sizes
will be needed to capture structural variants of varying
sizes. This will also nevertheless increase the sequencing
costs several fold dependingon the number of libraries. For
the YH genome, the two paired-end libraries had a small
insert size of 135 and 440 bp (Wang et al., 2008). Since the
bias against detection of insertions is partly due to the small
insert size, larger insert sizes of several kilobases should
improve the ability to detect more insertions. Indeed, this
has been demonstrated by Korbel et al. (2007) who pre-
pared libraries of 3Kb insert size for two individuals and
found1297 structural variants, including 853 deletions, 322
insertions and 122 inversions (Korbel et al., 2007).
Although the number of deletions is still higher than
insertions, it is signiﬁcantly less biased compared to the
numbers detected by Wang et al. (2008).
Human Genome Structural Variation
Working Group
The PEM method to detect structural variants was ﬁrst
demonstrated by Tuzun et al. in 2005 by mapping paired-
end sequences data from a human fosmid DNA genomic
library. The average insert size of a fosmid library is
approximately 40Kb. However, sequencing of fosmid
clones is laborious and costly using Sanger sequencing
(Tuzun et al., 2005). These limitations have been overcome
by NGS technologies which directly sequence the paired-
end or mate-pair libraries without the need for cloning
steps (Korbel et al., 2007). Both of these studies applied the
PEM approach to investigate structural variants in the
same sample (NA15510) from the International HapMap
Project. However, their library insert sizes diﬀered and this
has enabled a comparison of the sensitivity between these
studies. Korbel et al. (2007) were able to conﬁrm 41%of all
deletion and inversion events detected by fosmid paired-
end sequencing. Additionally, they identiﬁed an additional
407 structural variants in NA15510 that had not been
previously detected by fosmid paired-end sequencing
(Korbel et al., 2007; Tuzun et al., 2005). This further sug-
gests that several libraries with diﬀerent insert sizes are
needed to increase the sensitivity of PEM. The majority of
structural variants detected by PEM were relatively small
where approximately 65% were 510Kb and 30% were
55Kb (Korbel et al., 2007). This represents a signiﬁcant
improvement in resolution over microarrays.
Inaddition to these studies, a large-scale eﬀort is currently
being undertaken by the Human Genome Structural
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Variation Working Group to comprehensively map struc-
tural variants in phenotypically normal individuals using
the PEM approach as demonstrated by Tuzun et al. (2005)
(Eichler et al., 2007). More speciﬁcally, the objective is to
characterise the pattern of human structural variants at the
nucleotide level from a collection of 48 individuals of
European,Asian andAfrican ancestry.This project plans to
make fosmid clone libraries of approximately 40Kb insert
size from the genomic DNA of 48 unrelated females. These
samples have already been genotyped in the HapMap Pro-
ject. A larger insert size of approximately 150Kb prepared
from BAC clone libraries will also be constructed from 14
unrelatedHapMapmales. Thiswill aim toprovide sequence
information on structural variants that are too large to be
included in the fosmid libraries, such as those associated
with segmental duplications (Eichler et al., 2007). As such,
both the fosmid and BAC libraries will ensure a com-
prehensive capture of structural variants of varying sizes
across the human genome. A preliminary report was pub-
lished for eight individuals (Kidd et al., 2008).
Depth-of-coverage
Principle, strengths and weaknesses
Depth-of-coverage (DOC) is another method using the
NGS data for CNVs detection. As the name implies, this
method is based on the depth of coverage of the sequence
reads to infer deletions andduplications. TheDOCmethod
is enabled by the production of several hundred million
short sequence reads per instrument run by NGS technol-
ogies. The principle underlying theDOCapproach is based
on the assumptions that the sequencing process is uniform
so that the number of sequence reads mapping to a region
follows a Poisson distribution. As such, the number of
sequence reads should be proportional to the number of
times that a particular region appears in the genome.
Therefore, it is expected that a duplicated region will have
more reads aligned to it, with the converse true for deletions
(Yoon et al., 2009; Medvedev et al., 2009). However, the
assumption that the sequencing process is uniformmay not
be valid. This is because of the sequencing bias of the NGS
technologies which leads to certain regions of the genome
being over or under-sampled resulting in spurious signals
(Harismendy et al., 2009).
Based on the principle of the DOCmethod, the strength
of a DOC signature (i.e. ‘gain’ or ‘loses’) is thus directly
related to the coverage of the sequencing data (the number
of sequence reads) and also to the size of the CNVs. This
means that the DOC signatures will be stronger for larger
CNVs, and is thus more powerful for detecting larger
CNVs compared to PEM. In contrast, unlike PEM, the
DOC method cannot detect copy-neutral variants. More-
over, the DOC method may not be powerful enough to
identify smaller CNVs (related to the strength of DOC
signatures) and it is also limited in deﬁning breakpoints
(Medvedev et al., 2009). In comparison to microarrays,
copies number can only be inferred to four (CN=4) as the
upper boundary for SNP microarray or copy number
changes will be denoted as ‘gain’ or ‘loses’ for CGH
microarrays (McCarroll et al., 2008; Wang et al., 2008).
The DOC method is also more robust and accurate at
determining higher copies number.
Merging DOC with PEM
Studies comparing the results between the DOC and PEM
methods found that only a small fraction of the CNVs
overlapbetween thesemethods.Furthermore, the identiﬁed
CNVs that are speciﬁc to the DOC method are more
enriched in segmental duplications than the PEM-speciﬁc
CNVs. This is complementary to the PEMmethod as it has
diﬃculty detecting structural variants in segmental dupli-
cations because the paired-end sequences from these
repetitive regions cannot uniquely map to a single site or
location in the genome, especially for short sequence reads.
In comparison, this problem is less signiﬁcant for DOC as
this method does not rely on uniquely mapping sequence
reads to a region to infer CNVs. This suggests that a com-
bination of the methods is ideal to further improve the
sensitivity of detection throughout the genome. In fact,
both methods have their own advantages and limitations
(Yoon et al., 2009; Medvedev et al., 2009). As discussed
earlier, the main assumption of the DOC method may not
be valid because of the sequencing biases that cause certain
regions to be over or under-sampled. To overcome this
limitation, a recent study by Medvedev et al. (2010) has
developed a method to detect CNVs by supplementing the
DOC with the PEM data by integrating both types of
sequencing data. Using this integrative method, the dis-
cordant pairs will be used to indicate the presence of CNVs
forDOC. It hasbeen shownthatPEMcan improveboth the
sensitivity and the speciﬁcity of the DOC method. Several
advantagesof integrating theDOCandPEMdatahavealso
been demonstrated which addresses some of the limitations
of each method when used independently. For example, by
using this integrative approach, the size of the variants that
can be detected is no longer limited by the insert size of
library and this approach is also more robust in detecting
variants in segmental duplications (Medvedev et al., 2010).
Choosing a Sequencing Platform for
PEM and DOC
The applications of high-throughput sequencing technol-
ogies that are commercially available and accessible by
end-users or researchers for PEM andDOCwill be further
discussed. It is noteworthy that the development of
numerous other sequencing technologies such as single
molecule real time (SMRT) sequencing (to be marketed
commercially soon) are on the horizon (Schadt et al., 2010).
Although others such as nanopore sequencing may take
several years to become a mature technology (Branton
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et al., 2008). In comparison, companies such as Complete
Genomics provides a sequencing service rather than selling
their sequencing machines to end-users (Drmanac et al.,
2010). The sequencing technologies that are currently
available can be broadly grouped into NGS technologies
such as the Roche 454 Genome Sequencer FLX (GS FLX)
System, Illumina Genome Analyzer (GA) and Applied
Biosystems (ABI) Supported Oligonucleotide Ligation
Detection System (SOLiD) and third generation sequencing
(TGS) technologies such as the HeliScope SingleMolecule
Sequencerwhich is now commerciallymarketed byHelicos
Biosciences. See also: Next Generation Sequencing Tech-
nologies and Their Applications; Whole Genome Rese-
quencing and 1000 Genomes Project
Although Roche 454 GS FLX, Illumina GA and ABI
SOLiD are classiﬁed as NGS technologies, several features
diﬀer substantially between them.They are characterised by
the ability of parallel sequencing of a very large number of
sequence reads. However, the Roche 454 GS FLX can only
generate approximately one million sequence reads per
instrument run, in comparison to the Illumina GA and
ABI SOLiD where several hundred million sequence reads
are produced. Similarly, the HeliScope Single Molecule
Sequencer can also produce several hundred million
sequence reads (Mardis, 2008; Shendure and Ji, 2008;
Metzker, 2010; Li and Wang, 2009). One of the major dis-
tinctions between NGS and TGS is that TGS requires no
whole genome ampliﬁcation steps such as emulsion poly-
merase chain reactionandbridgeampliﬁcation compared to
NGS. Therefore, TGS has the potential to further increase
the number of sequence reads or throughput per instrument
run than their current capacity. Therefore, the IlluminaGA,
ABI SOLiD and HeliScope Single Molecule Sequencer
provide an advantage for the DOC method that requires a
highdensityof sequence reads to inferCNVs.The speciﬁcity
of DOC to detect CNVs and the precision to map the
breakpoints can be improved by increasing the density or
coverage of sequence reads (Yoon et al., 2009;Medvedev et
al., 2009). However, the length of sequence reads produced
by Roche 454 GS FLX is on average 400–500 bp, which is
substantially longer than that for the other three sequencing
technologies which range from 32 to 125 bp (Li and Wang,
2009). Although PEM and DOC methods are targeting
large structural variants, the sequence read length produced
byRoche 454GSFLX is better for detecting small indels of
several to tens of bases.Moreover, the longer sequence read
length of Roche 454 GS FLXmay also be more suitable for
de novo genome assembly before read lengths of several
kilobases is generated by future sequencing technologies.
The PEM method, when applying it alone rather than
integratedwithDOCdata,must ensure that the paired-end
sequences are uniquely aligned to the reference genome to
infer structural variants compared to ambiguous paired-
end sequences which align to multiple locations. As such,
shorter sequence read lengths may be less speciﬁc in
aligning against the reference genome especially in repeti-
tive regions such as segmental duplications. Moreover, the
number of paired-end sequences is also important as
usually multiple discordant pairs are needed to reliably
detect structural variants. In terms of preparing the PEM
libraries for sequencing, all three NGS technologies are
able to generate both paired-end and mate-pair libraries,
thus allowing for sequencing of short and longer insert sizes
(Robison, 2010; Koboldt et al., 2010). Each of the
sequencing technologies has its own strengths and weak-
nesses, and a combination of these technologies in an
experiment may be the ideal approach to detecting new
structural variants and also to address the systematic biases
in sequencing (Harismendy et al., 2009).
A Comprehensive Detection of
Structural Variants in the Human
Genome
Currently no single approach can detect all CNVs or
structural variants within a human genome. A combination
of diﬀerent approaches is thus ideal where bothmicroarrays
and sequencing-based methods can be utilised for this pur-
pose before de novo genome assembly is feasible. In com-
parison to whole genome resequencing that relies on a
reference genome for aligning the sequence reads (Wang
et al., 2008; Bentley et al., 2008; Ahn et al., 2009), de novo
genome assembly will enable a more thorough and com-
prehensive detection of various genetic variants in the
human genome ranging from single nucleotide variants,
small indels (insertions and deletions) to large structural
variants. Currently de novo genome assembly is challenging
and less practical because of the short sequence reads gen-
eratedbyNGS technologies especially the IlluminaGenome
Analyzer and Applied Biosystems SOLiD.However, recent
studies have attempted to perform de novo human genome
assembly using short sequence readswith limited success (Li
et al., 2010a, b; Paszkiewicz and Studholme, 2010).De novo
genome assembly will become more feasible with longer
sequence read lengths of several to tens of kilobases gener-
ated by future sequencing technologies. The number of de
novo genome assembly studies is anticipated to increase
exponentially with the arrival of third generation or single-
molecule sequencing technologies in the next few years
(Schadt et al., 2010; Gupta, 2008; Branton et al., 2008).
In anticipation, a recent study has used sequencing and
microarray-based strategies to detect various genetic vari-
ants which complement the results of the assembly com-
parison approach used in theHuRef genome (CraigVenter)
(Levy et al., 2007). This study detected genetic variants by
aligning the original Sanger sequence reads generated for
theHuRef genome to the reference genome (NCBIbuild-36
assembly). In addition, high density microarrays were cus-
tom-designed to probe the HuRef genome to identify
variants in regions where sequencing-based approaches
may have diﬃculties. Thousands of new structural variants
(i.e. copy number and copy-neutral variants) were dis-
covered and approximately 1.58% (48.8Mb) of the HuRef
haploid genome consisted of structural variants. In
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addition, the study also found biases in each method in
detecting these variants. This further justiﬁes the need to
combine diﬀerent methods for a more thorough detection
of structural variants (Pang et al., 2010).
Conclusions
Microarrays have been widely used in the discovery of
CNVs over the last several years. However, with the devel-
opment of PEM and DOC, this raises the question of
whether these sequencing-based methods will eventually
replace microarrays in structural variant research. The
answer is likely to be a resounding ‘yes’, but at present the
microarrays and sequencing-based methods are proving to
be valuable by being complementary to each other in
population studies of structural variants. The role of
microarrays will likely need to be switched from that of
‘discovery’ to ‘genotyping’. Although sequencing-based
methods are more powerful in the discovery of new struc-
tural variants, these methods are costly for several hundred
or thousand samples especially when several libraries of
diﬀerent insert sizes are needed for PEM. This would limit
the number of future studies of population characteristics
and disease association.However, the newly discovered and
the currently known structural variants canbe characterised
in population-based studies for investigating their associ-
ations with diseases using custom-designed oligonucleotide
microarrays. However, this is limited to CNVs which are
believed to be in the majority in structural variants. Thus
other high-throughput methods to assay newly discovered
and known copy-neutral variants need to be developed.
Although thePEMandDOCmethodshaveovercome the
major shortcomings of microarrays in detecting structural
variants, these methods have their own weaknesses.
Nevertheless, these emerging sequencing-based methods
will continue to play a role in the discovery of structural
variants until de novo genome assembly is more feasible (Li
et al., 2010a, b; Paszkiewicz and Studholme, 2010).De novo
genome assembly will be more practical with the promise of
third generation sequencing technologies to increase the
sequence read length to tensofkilobases so that a full human
genome can be assembled (Schadt et al., 2010; Gupta, 2008;
Branton et al., 2008). In addition to advancing the know-
ledge of human genetic variation, these methods are also
useful in dissecting somatically acquired rearrangements in
cancer genomes (Campbell et al., 2008; Stephens et al.,
2009). Finally, the discovery of various genetic variants
including structural variants in the human genome has been
greatly accelerated by 1000 Genomes Project (Genomes
Project Consortium, 2010; Sudmant et al., 2010).
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